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1 Cardiometabolic risk and lifestyle 
Chronic diseases, such as diabetes, cardiovascular disease, and dementia, are one of the main challenges 
for the health system (1, 2), partly through the ageing population and increasing prevalence of obesity 
and paucity of physical activity. Wide scale prevention of these diseases remains elusive, because they 
are caused by multiple, often additive, complications arising from cardiometabolic risk factors. 
Cardiometabolic risk factors include hyperglycemia, physical inactivity, sedentary behavior, central 
obesity, hypertension, and dyslipidemia, and are factors that increase the risk of cardiovascular 
problems, including (pre)diabetes, and dementia. 
What is (pre)diabetes? 
Type 2 diabetes is a chronic disease that occurs when the body has become resistant to the 
hormone insulin, which leads to raised blood glucose levels called hyperglycemia. Additionally, the 
insulin producing cells become damaged and stop the production. Prediabetes is an intermediate 
hyperglycemic condition between normal glucose metabolism and type 2 diabetes. Subjects with 
prediabetes have an increased risk of developing type 2 diabetes (3, 4). Over time, hyperglycemia 
leads to tissue damage and macro- and microvascular complications such as cardiovascular disease, 
nephropathy, retinopathy, and neuropathy. The cardiovascular effects  are thought to disturb the 
blood supply in the brain (5). 
Accumulating evidence shows that cardiometabolic risk factors are associated with a higher risk of late-
life (65+ years) cognitive impairment and eventually brain diseases such as dementia and depression (6-
13). In particular, these risk factors affect the smallest brain vessels and are thought to lead to cerebral 
small vessel disease (cSVD) and neurodegeneration (brain atrophy) (14, 15), which represent early 
features in the pathophysiology of cognitive decline and dementia (16). More specifically, at mid-life age 
(40-65 years), the most important risk factor for cognitive decline is hypertension, while later in life 
(65+), diabetes imposes the greatest risk factor (17, 18). Currently, it is not fully understood how these 
risk factors exactly contribute to cognitive decline. Therefore, this thesis aims to gain more insight into 
the brain alterations underlying cognitive decline and brain pathology (Figure 1.1). 
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Figure 1.1: Schematic description of the underlying concept of this thesis on the association between 
cardiometabolic risk factors, the developing, or expressing alterations of the brain tissue and the 
emerging health detriments and disorders. 
Added value of MRI 
The brain tissue is difficult to access for scientific research, because it is protected by the skull. However, 
magnetic resonance imaging (MRI) enables the visualization of the anatomical structures within the skull. 
MRI is a noninvasive method that uses a powerful magnetic field to examine internal body structures. 
MRI provides information to describe shape, size, and integrity of white and gray structures in the brain. 
The gray matter contains most of the brain’s neuronal cell bodies and small vessels. The white matter is 
composed of long-range nerve fibers connecting the neurons. Structural brain MRI techniques can also 
detect macroscopically visible morphological brain abnormalities, such as atrophy and microvascular 
lesions. Brain lesions interfere with the trajectories of the white matter, and may disrupt the connections 
between gray matter regions. These changes in white matter connectivity may contribute to general 
cognitive decline, and decline in various specific cognitive domains, as information processing speed, 
executive function and attention, and memory (19, 20). Additionally, advanced MR imaging methods can 
provide detailed insights into subtle brain changes, and thus early development of pathology, enhancing 
our understanding of brain disease (21). Multiple advanced MRI techniques are available to assess 
different characteristics of the brain. Intermezzo 1 and 2 provides more information about the advanced 
imaging (Intermezzo 1) and image quantification (Intermezzo 2) methods to assess the brain’s network in 




1 Intermezzo 1: Advanced MRI methods used in this thesis 
White matter structure and diffusion-weighted MRI 
The white matter is organized as a complex network of connected fibers, which is responsible for 
efficient information exchange between brain regions (22). Alterations in one region may affect the 
function of other regions to which they are connected via white matter fiber tracts. Diffusion weighted 
MRI (dMRI) can probe the white matter fiber architecture, based on the diffusion characteritics of 
water molecules. This technique yields quantitative measures that reflect microstructural properties 
related to preferences in diffusion direction relative to the fiber trajectories. 
The structure and efficiency of the constellation of the white matter fiber tracts, the so-called 
structural network, can be investigated by applying graph theory analysis (Intermezzo 2). In short, 
structural connectivity refers to the amount and integrity of white matter tracts between brain areas, 
thus in general, a lower structural connectivity is a marker of brain pathology. The use of dMRI-derived 
white matter tracts, in combination with graph theoretical analysis, addresses both the regional 
volumes, and their connections to other regions. 
Resting-state functional MRI 
To measure brain activity one can make use of the coupling between neuronal activity and 
microvascular blood supply that is expressed as spontaneous brain fluctuations (23). Functional MRI 
(fMRI) is sensitive to changes in blood oxygenation through the blood oxygen level dependent (BOLD) 
signal, which is related to brain function; more oxygenation consumption (indirectly) reflects higher 
brain activity. Neuronal activity can be measured during brain activation (task-based or stimulus-
induced) and in rest (resting-state). Resting-state fMRI is used to determine the so-called resting-state 
networks, consisting of functionally connected regions with comparable spontaneous fluctuation 
signatures, which show a high level of correlated BOLD time-signal activity such as the default mode 
network (Intermezzo 2). In task-based fMRI, a cognitive or behavioral task is performed while sensory 
stimuli (e.g., auditory or visual) are presented during scanning to visualize the brain regions that are 
involved in the specific tasks.  
The temporal correlations between the measured time signals of neuronal activity is used to assess 
collaborations between brain regions, which is termed as the so-called functional connectivity. The 
spatial organization of functional connectivity throughout the brain can also be expressed in terms of 
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Intermezzo 2: Graph theory 
In graph theory the brain is represented as a graph, which is a network of gray matter regions (nodes) 
connected by white matter connections (edges). A simple representation of such a white matter 
network is depicted below; with in the red square an enlarged node connected with edges to five 
other nodes. The organization of such a graph can be quantitatively characterized by using graph 
measures that describe the efficiency and integrity of the white matter network. 
These connections can either be represented by streamlines or temporal correlations between dMRI 
of fMRI measurements, respectively. 
 
 
Node = Gray matter region 
 
Edge = Connection between brain regions  
 
Node degree = # edges connected to a node 
 
Sparsity = 1 –
number of edges
number of possible edges
 
 
Path = sequence of connections in the network  
which represent potential routes for  
communication between brain regions.   
 
Graph = network of nodes connected by edges.  
Calculation of graph measures 
In structural connectivity analysis, connectivity matrices are based on tractography. As a result, 
not all pairs of nodes will have white matter connections, which leads to ‘sparse’ connectivity 
matrices. The measure sparsity reflects the extent of a graph’s deviation from the corresponding 
fully connected graph. However, this differs between subjects and is also influenced by scan 
quality. Therefore, thresholding is applied, which ensures that each subject has the same number 
of nodes and edges. This is needed, because otherwise the differences in graph measures found 
are not due to differences in topological organization, but caused by differences in number of 
edges. The reference network was calculated from all individual binarized connectivity matrices, 










Step 1: Sum all individual binarized connectivity matrices. 
Step 2: Proportional thresholding to a selected sparsity, e.g., 0.8. This means selection of the 20% 
connections that are present in most of the participants, in other words, the 20% of the nodes with 
the highest sum score. 
Step 3: Creation of a binary mask containing the 20% nodes from step 2. 
Step 4: Application of the binary mask to select for each participant a weighted, undirected network 
with a sparsity close to the sparsity of the reference network. The actual sparsity in the individuals is 
a bit higher than 0.80, because not each individual has a white matter tract at each connection in the 
reference network.  
To describe network organization, measures indicative of network segregation, to assess the 
presence of local densely interconnected groups of brain regions, and indicative of integration, to 
assess large-scale communication between nodes, can be calculated: 
 Graph measures of segregation: local connectivity properties 
- Clustering coefficient = number of connections between nearest neighbors of a node as a 
proportion of the maximum number of possible connections. 
- Local efficiency = inverse shortest path length of connections to neighbors of a specific 
node. 
 Graph measures of integration: global connectivity properties 
- Characteristic path length = minimum number of connections that must be traversed on 
average to go from one region to another. 
- Global efficiency = average inverse shortest path length in the network. 
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Intermezzo 3: Wavelet Transformation in resting-state fMRI. 
fMRI data consists of measured time signals of neuronal activity. A commonly used method to obtain 
insightful information from these time-series, by separating the signals related neuronal activity from 
nuisance, is to obtain a power spectrum by performing a Fourier transform. This power spectrum is 
usually dominated by nuisance signals, including the low frequency noise arising from physical 
sources (e.g., scanner drift, i.e., slowly varying changes in ambient temperature) and the high-
frequency physiological sources, such as respiratory and cardiac signals. By applying a band pass filter 
these “noise signals” can be removed to some extent. Unfortunately, by taking a Fourier transform 
from a time signal, all time information is lost in return for frequency information. As the BOLD signal 
is not purely harmonic but contains frequencies that vary over time, the use of the frequency 
components is far from ideal (24). The technique of wavelet transformation (WT) can offer a solution 
here, because it has a high resolution in both the frequency and time domain, and therefore provides 
information about at which frequency and time the signal oscillates. Moreover, it preserves the low 
frequencies, which can be used as a sensitive measure of a variety of physiological signals. WT splits 
the time signal in frequency subbands, which can be matched with the frequencies of physiological 
signals. Typical physiological signals and their frequency ranges are cardiac activity (0.6-2.0 Hz), 
respiration (0.145-0.6 Hz), myogenic activity (0.052-0.145 Hz), neurogenic activity (0.021-0.052 Hz), 
and endothelial activity (0.0095-0.021 Hz). In the figure below, we illustrate how the frequency 
subbands acquired with WT relate to the physiological measures. 
 
 
Brain imaging in population-based cohort studies 
Large population-based cohort studies play a key role in revealing pathways and underlying mechanisms 
of chronic diseases like type 2 diabetes, cardiovascular disease, brain dysfunction, and dementia. 
Particularly, the combination of advanced phenotyping, obtained by functional measurements, 
questionnaires, and medical history, in such studies with brain imaging is a major strength of population-
based cohort studies. Table 1.1 gives an overview of ongoing European population-based cohort studies 
with brain MRI scans available. The main goal of these studies is to find imaging biomarkers in order to 




1 Table 1.1: European population imaging studies with brain MRI scans available. Cohort and target Population Number* and age MRI scans: measures 
The Maastricht Study 
Maastricht, Netherlands 
Etiology, complications, and 






N=5323, age 40-75 
2012-ongoing 
Structural: volumes, cSVD; 
DWI: tractography, SC; 
Rs-fMRI: FC 
Rotterdam Scan Study 
Rotterdam, Netherlands 
Causes of neurological disease. 
General 
population 
N=5886, age 45+ 
2005-ongoing 
Structural: volumes, cSVD; 
DWI: diffusion metrics, SC; 
Rs-fMRI: FC 
RUN DMC Study 
Nijmegen, Netherlands 
Risk factors and clinical consequences of 
brain changes during aging. 
cSVD 
N=503, age 50-85 
2006: baseline; 
2012: follow-up 
Structural: volumes, cSVD; 
DWI: diffusion metrics 
SMART-MR Study 
Utrecht, Netherlands 
Examine risk factors and consequences 
of brain MRI abnormalities in patients 
with manifest arterial disease. 
Arterial 
disease 
N=1300, age 18-79 
2001-2005 
Structural: volumes, cSVD; 
Lothian Birth Cohort 1936 
Scottland 
Genetic contributions to individual 
differences in normal cognitive ageing. 
General 
population 
N=729, age 65-75 
2004-2007 
Structural: volumes, cSVD; 




Improving prevention, diagnosis and 







Structural: volumes, cSVD; 
DWI: diffusion metrics, 
tractography; 




Detect influence of lifetime 
genetic/environmental/ 




N=555, age 60+ 
2001-2003 
2004-2019 every 6 
years follow-up 
Structural: volumes, cSVD 
Ages-Reykjavik Study 
Reykjavik, Iceland 
Examine risk factors in relation to 
disease and disability in old age. 
General 
population 
N=5764, age 67+ 
2002-2006 
Structural: volumes, cSVD 
SHIP 
Northeast Germany 
Estimate prevalence/incidence of risk 
factors, subclinical disorders, and 




N=2500, age 20-90 
1997-2013 












Structural: volumes, cSVD 
*Number is based on availability in June 2020. T2DM indicates type 2 diabetes mellitus; cSVD, cerebral small 
vessel disease; DWI, diffusion-weighted imaging; SC, structural connectivity; Rs-fMRI, resting-state functional 
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The Maastricht Study 
In this thesis, we use population data from The Maastricht Study. The Maastricht Study is an ongoing 
observational prospective population‐based cohort study that focuses on the etiology, pathophysiology, 
complications, and comorbidities of type 2 diabetes and other chronic diseases (25). Its extensive 
phenotyping approach is certainly suitable to study the mechanisms and determinants of brain 
alterations in a population‐based setting. Eligible for participation were all individuals aged between 40 
and 75 years and living in the southern part of the Netherlands. Participants were recruited through mass 
media campaigns and from the municipal registries and the regional Diabetes Patient Registry via 
mailings. Recruitment was stratified according to known type 2 diabetes status, with an oversampling of 
individuals with type 2 diabetes. This thesis includes cross-sectional data from the first 5083 participants, 
who completed the baseline survey between November 2010 and December 2017, and with complete 
MRI data without artifacts (Figure 1.2).  
 




The main objectives of this thesis are twofold. 
1. To unveil novel neuronal imaging associations of cardiometabolic risk factors beyond visible 
brain lesions or abnormalities.  
2. To evaluate the value of structural and functional brain network measures for this purpose.  
Outline of thesis 
This thesis first summarizes the existing evidence on associations between cardiometabolic risk factors 
and subtle brain changes as assessed by structural and advanced imaging methods. Subsequently, we 
investigate in The Maastricht Study the associations of specific cardiometabolic and lifestyle factors with 
advanced MRI techniques, as these are thought to uncover more subtle tissue and vascular alterations 
than macroscopically visible lesions displayed by structural MRI. Finally, we unravel to what extent 
various systemic physiological influences are associated with the measured BOLD signal. Additionally, we 
investigate to what extent the BOLD signal components, particularly the neurogenic component, are 
altered in participants with cardiometabolic risk factors. Figure 1.3 gives a schematic overview of the 
associations investigated in this thesis. The next section describes the aims of each individual chapter. 
 
Figure 1.3: Schematic outline of the associations investigated in this thesis 
 
After the general introduction, a narrative review is conducted in Chapter 2 to summarize the existing 
evidence on associations between cardiometabolic risk factors and subtle brain changes as assessed by 
structural and advanced MRI. First, we introduce the different MRI techniques. Then we discuss the 
associations of the cardiometabolic risk factors hyperglycemia, physical inactivity, sedentary behavior, 
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central obesity, hypertension, and dyslipidemia, with changes on brain MRI. Finally, we discuss the 
findings and their currently available level of evidence. 
In Chapter 3, we investigate the association of prediabetes and type 2 diabetes, with white 
matter network characteristics, in terms of the number (node degree) and organization (graph measures) 
of the white matter connections. 
In Chapter 4, we investigate the association of objectively measured low- and high-intensity 
physical activity (LPA and HPA) and sedentary time (ST) with white matter connectivity, both throughout 
the whole brain, and in brain regions involved in motor function, as a measure of white matter integrity. 
In Chapter 5, we investigate if and, if so how, cSVD lesions, measures of the white matter tracts 
and network, and cognitive function are associated, and whether these associations dependent on 
cardiometabolic risk factors.  
In Chapter 6, we decompose the dynamic resting-state fMRI brain signal into wavelet 
components and explore whether the various frequency subbands are associated with physiological 
measures in the physiological frequency subbands cardiac activity, respiration, myogenic activity, 
neurogenic activity, and endothelial activity. 
Finally, in Chapter 7, we combine and discuss the key findings of this thesis. In addition, we 
address methodological considerations and directions for future research. 
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2 Abstract  
Cardiometabolic risk factors may be of key importance in the development of future brain diseases like 
dementia or depression. However, it remains unclear how these risk factors exactly affect the brain. 
Advanced MR imaging methods such as, diffusion weighted and functional MRI, can provide detailed 
insights into subtle brain changes, and potentially into early development of disease. In this narrative 
review, we summarize the available evidence on the associations of cardiometabolic risk factors with 
subtle changes in brain MRI measures. We found clear evidence that hyperglycemia, physical inactivity, 
central obesity, and hypertension are associated with both structural and functional brain alterations, 
while the role of dyslipidemia is far less clear. However, longitudinal evidence that assesses temporality 
of the associations with more advanced and thus more precise brain imaging methods is needed to 




   2 Introduction 
Cardiometabolic risk factors may be of key importance in the development of brain diseases like 
dementia and depression. However, it remains unclear how these risk factors exactly affect the brain. 
Advanced MR imaging methods can provide detailed insights into subtle brain changes, and thus early 
development of brain diseases, enhancing our understanding of disease pathology. Subtle brain changes 
are likely to precede brain dysfunction, and in a later stage, brain diseases (1). Cardiometabolic risk 
factors, like hyperglycemia, physical inactivity and sedentary behavior, central obesity, hypertension, and 
dyslipidemia, have been identified as risk factors of dementia and depression (2, 3), and their 
associations have been discussed in previous review articles (4, 5). However, no such summary is 
available on the cardiometabolic determinants of subtle brain alterations as visualized with advanced 
imaging methods. Therefore, in this narrative review, we summarize the existing evidence on 
associations between cardiometabolic risk factors and subtle brain changes as assessed by structural and 
advanced imaging modalities, such as, diffusion weighted MRI (dMRI) and functional MRI (fMRI). These 
advanced  techniques are thought to reflect more subtle tissue and vascular alterations than 
macroscopically visible lesions displayed by structural MRI.  
First, we will introduce the MRI techniques that are presented in literature. Second, we will 
discuss the association of well-known cardiometabolic risk factors, including hyperglycemia, physical 
inactivity, sedentary behavior, central obesity, hypertension and dyslipidemia, with structural changes on 
brain MRI, e.g., with measures of brain atrophy and cerebral small vessel disease (cSVD). Third, their 
associations with more advanced brain MRI measures, such as diffusion measures and brain connectivity 
derived from dMRI and fMRI, will be summarized. Finally, we will discuss the findings and their currently 
available level of evidence.  
Methods  
Literature search and study selection 
We performed an literature search by use of the search terms ‘brain’ and ‘MRI’, combined with specific 
search terms for each category of risk factors, as shown in Supplementary Figure 2.1. The inclusion 
criteria were: full-article research papers and English-written publications, published from inception to 
May 1, 2019. The following articles were excluded: animal studies, studies on subjects with a specific 
disease, with a small sample size (case-control N<10 per group; population-based N<100), focused on 
determinant(s) or outcome measures other than cardiometabolic risk factors or brain MRI, conference 
abstracts without a full text publication, and research protocols. In case of multiple studies on the same 
study population, the most recent or largest study was included in this review. When possible, we 
focused on studies performed in large observational population-based cohort studies to maximize 
generalizability. 




Figure 2.1: Schematic overview of the associations between cardiometabolic risk factors, early brain 
alterations, brain dysfunction, and brain diseases.  
Conventional MRI techniques to detect macrostructural brain changes 
Structural brain MRI techniques can detect macroscopically visible morphological brain abnormalities, of 
which atrophy and features of cSVD are highly relevant for this review. These macrostructural changes 
are presumably irreversible, but nonetheless important for understanding development of brain 
diseases.  
Brain atrophy 
Brain atrophy is a decrease in total or regional brain volume, not caused by a specific macroscopic focal 
injury such as an infarction or trauma. In general, this loss of volume is thought to be the result of 
neurodegeneration, e.g., the loss of neurons or other brain cells due to cell death and/or apoptosis (6, 7). 
Cerebral small vessel disease 
cSVD refers to lesions in the brain, such as white matter hyperintensities, microbleeds, and lacunar 
infarcts. According to previous studies, presence of lacunes, white matter hyperintensities, and 
microbleeds are jointly indicative of an underlying cSVD state, and each measure has been associated 
with lower general cognitive ability (8). 
White matter hyperintensities 
White matter hyperintensities (WMH) are hyper-intense loci on T2-weighted (TSE and FLAIR) MRI scans 
(6). Larger WMH volumes are associated with worse cognitive function (9). Like brain atrophy, WMH 
occur more often in older individuals and are strongly associated with cerebrovascular disease and 
cognitive decline (10). Wardlaw et al. (11) previously discussed the pathogenesis of cSVD features. The 
main mechanism underling cSVD-related brain injury, especially WMH, is usually assumed to be ischemia, 
which results from narrowed or occluded (perforating) arteries. However arterial occlusion might already 
be a late-stage phenomenon. Currently, earlier phenomena of cSVD pathology are considered to be 
represented by, systemic endothelium dysfunction (12). For WMH this may be accompanied by 
demyelinisation and even axonal loss.  
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Lacunar infarcts, or in short lacunes, are round or oval, subcortical, fluid-filled cavities (3-15 mm in 
diameter) (6) and occur frequently in asymptomatic elderly individuals (13).  
Microbleeds 
Microbleeds are small, mostly 2-5 mm in diameter, hypo-intense lesions seen on T2*- or susceptibility-
weighted (gradient-echo) MRI (14). Microbleeds are generally located in the cortico-subcortical junction 
and deep gray or white matter in the cerebral hemispheres, brainstem, and cerebellum (6).  
Advanced MRI techniques to detect microstructural brain changes 
Diffusion MRI 
The white matter is organized as a complex network of connected fibers, responsible for efficient 
information exchange between various brain regions. Alterations in one region may thus affect the 
function of other regions via the connecting white matter tracts. Therefore, it is important to assess the 
microstructure of the white matter, which can be visualized by use of dMRI. dMRI can probe white 
matter fiber architecture, based on the diffusion of water molecules, and yields quantitative measures 
such as the fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity 
(RD). All these measures reflect microstructural changes related to preferences in diffusion direction 
relative to the fiber trajectories. It is recommended to analyze a combination of these diffusion metrics, 
due to their complicated mutual dependence (15).  
Fractional anisotropy 
With respect to the detection of brain changes, the FA is a highly sensitive measure for microstructural 
changes, however, not very specific to the type of change. FA indicates the directionality of a diffusion 
process (e.g., due to the orientation of white matter fibers). However, alterations in FA are not 
unambiguous, as reductions in FA can be either due to decreases in AD and increases in RD or vice versa; 
FA is furthermore highly influenced by the many crossings of fibers and alterations thereof.  
Mean diffusivity 
MD indicates the motility of the water molecules. To measure the locally preferred directionality of 
water diffusion, diffusion-motion sensitized field gradients in multiple angular directions is used, so 
called High-Angular-Resolution-Diffusion-Imaging (HARDI). The MD represents an inverse measure of 
membrane or border density, is independent of direction, and sensitive to cellularity, edema, and 
necrosis.  
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AD reflects diffusion along the (long) fiber axis, and gives information about axonal injury and thus 
decreases when there is axonal damage. RD reflects the diffusion perpendicular to the fiber orientation, 
and is often most sensitive to impairment of the fiber structure. The RD is often suggested as a surrogate 
myelin marker and changes when there is myelin damage, and it can be influenced by the geometric 
properties of the axons (e.g., diameter and density). An increased RD is consistently found in many white 
matter pathologies, the AD tends to be more variable (16).  
Structural connectivity 
dMRI can be used to analyze the structure and efficiency of the constellation of white matter fiber tracts, 
the so-called structural network, by applying graph theory analysis. In graph theory, the brain is 
represented as a graph, which is a network of nodes (i.e., gray matter brain regions) connected by edges 
(i.e., white matter tracts between brain regions). The sequence of connections in the network which 
represent potential routes for communication between brain regions is called a path. The number of 
connections to one node is called the node degree. The organization of a graph can be characterized by 
use of graph measures, e.g., clustering coefficient, characteristic path length, global efficiency, and local 
efficiency. These graph measures describe the efficiency of the white matter network architecture (for an 
overview, see Table 1). In short, structural connectivity refers to the amount and integrity of white 
matter tracts between brain areas, thus in general, a lower structural connectivity is a marker of brain 
pathology. 
Functional MRI 
fMRI is sensitive to changes in blood oxygenation through the blood oxygen level-dependent (BOLD) 
signal, which is related to brain function; more oxygenation (indirectly) reflects higher brain activity. fMRI 
brain activity is thought to locally reflect the coupling between neuronal activity and microvascular blood 
supply (17). In contrast to structural connectivity, functional connectivity relies on statistical dependence 
of the time signals from different brain regions (which may not be structurally connected). Therefore, a 
lower functional connectivity is suggested to be a marker of brain dysfunction. fMRI can be used to 
analyze the temporal correlations between measured time-signals of neuronal activity, to assess 
collaborations between brain regions, the so-called functional connectivity. Functional connectivity can 
also expressed in terms of graph measures (Table 2.1). Neuronal activity can be measured during brain 
activation (task-based or stimulus-induced) and in rest (resting-state). The latter is used to determine the 
so-called resting-state networks, consisting of functionally connected regions, which show a high level of 
correlated BOLD time-signal activity, such as the default mode network (DMN). In task-based fMRI, a 
cognitive or behavioral task is performed while sensory stimuli (e.g., auditory or visual) are presented 





   2 Table 2.1: Glossary – Most used terms and measures in graph theory. 




Number of connections between nearest neighbors of a node as a 
proportion of the maximum number of possible connections. 
Local efficiency Inverse shortest path length of connections to neighbors of a specific node; 




The minimum number of connections that must be traversed on average to 
go from one region to another. 
Global efficiency Average inverse shortest path length in the network; inversely related to 
characteristic path length. 
Perfusion MRI 
Perfusion weighted MRI can be used to investigate the blood perfusion of tissues, including ischemic 
conditions. Lower brain perfusion is a marker for brain diseases, and is associated with cognitive decline. 
The most used perfusion weigthed MRI techniques are dynamic susceptibility contrast (DSC), dynamic 
contrast enhanced (DCE), and arterial spin labeling (ASL) MR perfusion. Both DSC and DCE require 
administration of the contrast medium gadolinium, while ASL does not need exogenous contrast. ASL 
imaging is based on signal loss due to magnetization exchange of labeled water molecules in the blood 
vessels (18).  
Results  
Type 2 diabetes and hyperglycemia as risk factor for early brain alterations 
Several large cross-sectional and longitudinal observational cohort studies investigated the association of 
type 2 diabetes mellitus (T2DM) with brain atrophy. T2DM was found to be consistently associated with 
global brain atrophy in cross-sectional data of the Utrecht Diabetic Encephalopathy Study (19-22), The 
Framingham Heart Study (23, 24), The SMART MR study (25), The CARDIA Brain MRI study (26), The 
Mayo Clinic Study of Aging (27), UK Biobank (28), and The ARIC study (29). This has been confirmed in 
longitudinal analyses of the Utrecht Diabetic Encephalopathy Study (30), the SMART MR study (31), and 
in the PROSPER study, over 3 to 4 years of follow-up (32).  
More specific, T2DM has been associated with smaller gray matter (24, 28, 31, 33-36) and 
white matter volumes (36, 37), larger CSF volumes (31, 34), global cortical thinning (31, 38, 39), and also 
smaller hippocampus volumes (23, 24, 27, 36, 40-43) as compared to normal glucose metabolism (NGM) 
inthese, (some population-based) cohort studies. These associations have also been confirmed in 
longitudinal analyses for decreased gray matter volumes (31, 33); increased CSF volumes (31), and with 
global cortical thinning (31, 39). The follow-up duration of these studies ranged from 40 months (31) up 
to 12 years (39).  
T2DM has also been associated with cSVD characteristics. In multiple large cross-sectional 
cohort studies an association of T2DM with larger WMH (19-22, 24, 28, 29, 31, 37, 38) and ischemic 
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2 lesion volumes (34, 44), and more lacunar infarcts (29) has been established. In longitudinal analyses, 
T2DM has been associated with increased WMH (31), and ischemic lesion volumes (34). Surprisingly, 
T2DM has not (yet) been associated with microbleeds (36, 45, 46). 
A minority of studies used advanced MRI techniques to investigate the association of T2DM 
with white matter microstructure and (both structural and functional) brain connectivity. By use of dMRI, 
several case-control studies observed lower FA (24, 28, 37, 47-53), and higher MD (28, 37, 47, 49-51), 
which indicate altered or impaired fiber microstructure in T2DM. Furthermore, two case-control studies 
found higher AD (47, 51), and higher RD (47, 51), similarly indicative of injured white matter by axonal 
injury and disruption of fibre structure. 
Van Bussel et al., reported lower structural connectivity, in terms of lower tract volumes 
between the hippocampi and the frontal lobe, temporal lobe and subcortical gray matter in T2DM 
compared to NGM as measured by dMRI (50). fMRI findings in subjects with T2DM included altered 
neuronal activity (54), lower functional connectivity (51, 55-57) (mainly in frontal and parietal lobes) and 
lower degree centrality (DC) (56) compared to NGM. However, in contradiction to expectations, T2DM 
was associated with lower characteristic path length (58), higher normalized clustering coefficient (CC) 
(58, 59), and higher local efficiency (Elocal) (59) as compared to NGM. A possible explanation for those 
findings is a compensatory mechanism to counteract (subtle or even subconsciuous) cognitive 
impairment. The authors hypothesized that this compensation is achieved by mobilizing additional neural 
resources, such as excessive activation of the network and the efficient networking of multiple brain 
regions. Furthermore, one study found a weaker FC of the posterior cingulate cortex (PCC) and stronger 
FC to several brain regions in T2DM compared to controls (60). Finally, T2DM has been associated with 
lower blood perfusion (61-64) measured by use of perfusion and flow MRI techniques. 
Very few studies investigated the association of prediabetes, defined as a disturbed fasting or 
non-fasting glucose metabolism, but not yet full-blown diabetes, with structural or functional brain MRI 
measures. In the large cross-sectional ARIC Neurocognitive Study, no association of prediabetes with 
smaller brain volumes or larger burden of brain vascular pathology was found (29). Meanwhile, in the 
large cross-sectional population-based Maastricht Study, prediabetes was associated with smaller WM 
volumes, but not with differences in GM volumes (46). In one case-control study, patients with 
prediabetes and those with T2DM showed lower GM volumes in the hippocampus, amygdala, and the 
putamen compared with controls, while no significant differences were found between participants with 
T2DM and prediabetes (65). This indicates that brain changes in T2DM compared to normal glucose 
metabolism were already present in prediabetes. Only one study reported an association of prediabetes 
with larger WMH volumes and presence of lacunar infarcts, but found no significant association with 
cerebral microbleeds (46). In the case-control study of Liang et al., a lower FA was found in prediabetes 
compared to controls (53). Using resting-state fMRI, higher normalized local efficiency was found in 
participants with prediabetes compared to NGM, hinting at reorganization of the functional networks as 
compensation for potential cognitive decrements (59). 
Furthermore, some studies investigated also the association of blood glucose levels on a 
continuous scale with MRI brain measures. A cross-sectional study reported that higher HbA1c levels 
were associated with smaller brain volumes and a higher burden of WMH and lacunar infarctions (29). 
Additionally, elevated glucose levels were associated with lower FA in the right inferior and bilateral 
superior longitudinal fasciculi (66). In large population-based studies, higher fasting blood glucose levels 
were associated with lower cortical thickness (39, 46, 67, 68) and lower GM density and FA (24). One of 
these was a 12-year follow-up study (39). 
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   2 In summary, several large cross-sectional and longitudinal population-based studies 
investigated the association of T2DM with brain changes, and found more atrophy both in gray and white 
matter, and more severe characteristics of cSVD in T2DM compared to NGM. Fewer studies investigated 
the association of T2DM with white matter microstructure and connectivity, and found impaired white 
matter microstructure, and lower structural and functional connectivity in T2DM compared to NGM, 
which may already be present in prediabetes. Unfortunately, only a few studies investigated continuous 
glucose measures in relation to brain changes, and most had a cross-sectional design, but did find clear 
associations. Allthough these results suggest a causal role for hyperglycemia in early brain changes, 
longitudinal population-based studies using continuous measures of hyperglycemia are needed to 
confirm a temporal, and thus potential causal, association of hyperglycemia with early brain damage.  
Physical inactivity and sedentary behavior as risk factor for early brain 
alterations 
The association of physical inactivity with structural MRI brain measures has been investigated in large 
cross-sectional population-based studies, e.g., the AGES-Reykjavik (69), SMART-MR (70), Framingham 
(71, 72), LADIS (73, 74), SHIP (75), MAP (76), and NOMAS (77) study. These studies found clear 
associations between physical inactivity and lower cortical thickness (78, 79), specifically in the left 
prefrontal lobe (78), more brain atrophy (70, 72, 80-85), and smaller white matter (69, 86) and gray 
matter volumes (69, 75, 76, 84, 87-91). Most of these studies used self-reported physical activity 
measures, while some used objective data as measured by accelerometric devices (69, 72, 76, 79, 80, 
82). PA questionnaires only collect subjetive information and may therefore over- or underestimate PA 
levels. Especially light- to moderate-intensity PA are difficult to measures with questionnaires. The 
longitudinal population-based AGES-Reykjavik study showed that objectively measured physical inactivity 
was associated with more 5-year GM and WM atrophy (69). Comparable results were found in the 
Cardiovascular Health Study, namely, a longitudinal association of lower self-reported physical activity 
intensity with more loss of total brain volume over a 9-year period (83). The longitudinal Korean Genome 
and Epidemiology study found that physical inactivity is associated with brain atrophy (92).  
Considering cerebral small vessel disease, more physical inactivity has been associated with the 
presence of silent brain infarcts (77), and larger WMH volumes (82, 88, 93) in cross-sectional cohort 
studies. However, others did not find any association of physical activity with WMH (70, 77, 84). None of 
these studies on cerebral small vessel disease used objectively measured data on physical activity. 
Physical inactivity has also been associated with diffusion MRI metrics, e.g. a significantly higher 
FA, and lower MD, AD and RD (80, 91, 93, 94). Only one study investigated the association of physical 
inactivity on structural connectivity measures. Kim et al. (95) found in a cross-sectional study that 
subjects with a lower level of self-reported physical activity showed significantly lower regional nodal 
strength in the bilateral middle frontal, bilateral inferior parietal, medial orbitofrontal,  and superior and 
middle temporal gyri, compared to subjects with high levels of self-reported physical activity. In addition, 
this study found that physical inactivity was associated with lower local efficiency. Using functional MRI 
measurements, an association of physical inactivity with less fMRI activation was found in a study on 
obese women after a six-month hypo caloric Mediterranean diet and increased physical activity program 
(96). In the 1-year, single-blinded, multicenter randomized controlled LIFE-p trial, an intervention to 
improve physical activity was compared to health education in sedentary elderly. The intervention on PA 
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2 was associated with higher fMRI signal only in the inferior frontal gyrus as compared to sedentary groups 
with health education, 2 years after the intervention ended (97). 
Recently, sedentary time has been proposed as an independent risk factor for health outcomes 
(98, 99). Evidence on the association of sedentary behavior and MRI measures is still scarce; however, 
results from the AGEs Reykjavik study indicate that objectively measured PA and sedentary behavior late 
in life are associated with current and prior cross-sectional measures of white and gray matter atrophy, 
and that these brain changes over time are associated with PA and sedentary behavior in expected 
directions (69). 
In summary, physical inactivity has been associated with more atrophy, the manifestation of 
cerebral small vessel disease, and lower structural connectivity. Information on sedentary behavior is 
scarce, but indicates an association with more brain atrophy. Furthermore, longitudinal studies are 
needed, to further investigate the brain changes over time, and whether lifestyle changes could improve 
the condition of the brain. 
Central adiposity as risk factor for early brain alterations 
A number of large population-based studies have investigated the association between central adiposity 
and structural brain changes. The studies included in this section focus on both simple, anthropometric 
methods, such as waist circumference (WC), and waist-hip-ratio (WHR), and on more advanced, direct 
measures of central obesity, such as visceral fat accumulation (VFA) as measured with dual-energy X-ray 
absorptiometry (DXA), computed tomography (CT), and abdominal MRI scans, all in combination with 
brain MRI measures. In large cross-sectional (100-102) and longitudinal (103-106) population-based 
cohort studies, larger WC and WHR have been associated with lower total brain volume and lower gray 
matter volume. The Framingham Heart Study Offspring assessed VFA by use of CT, and found an 
association of more visceral adipose tissue with lower total brain volumes (100). Higher VFA measured 
with abdominal MRI was also associated with global cortical thinning in large cross-sectional population-
based studies (107, 108). Visceral adiposity has also been associated with lower white matter volumes. 
More specifically, larger WC and WHR were associated with less frontal lobe volume in cross-sectional 
studies (101, 102) , and with lower frontal and temporal lobe volume in one longitudinal study (104). 
More visceral adipose tissue measured with abdominal MRI was associated with lower hippocampal and 
larger ventricular volume in a large cross-sectional population-based study (108). Larger WHR was also 
associated with lower hippocampal volume according to another cross-sectional population-based study 
(108, 109).  
Furthermore, several large cross-sectional population-based cohort studies found an 
association of VFA with markers of cSVD. In these studies, larger WHR, waist circumference, and VFA 
have been associated with larger WMH volumes (102, 109-112) and lacunar infarcts (110, 112-114). 
Higher BMI and WHR were associated with larger deep WMH volumes, and to a lower extend with 
periventricular WMH volumes in the population-based LIFE study (115). A higher visceral-to-
subcutaneous fat ratio measured with abdominal CT was associated with cerebral microbleeds (116) in 
neurologically healthy people. The longitudinal ARIC study found an association of higher WC and WHR 
with more incident lacunar infarcts after 10-year follow-up, but not with WMH progression (117). 
Evidence on the association of VFA with more advanced measures of brain function is scarce, 
only associations with diffusion metrics were reported. Higher WC has been associated with lower FA in 
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   2 cross-sectional population-based (48, 118-122) and case-control studies (118); with higher apparent 
diffusion coefficient (ADC) in one case-control study (48); lower AD in one cross-sectional population-
based study (122); and higher RD in another cross-sectional population-based study (123). In contrast, 
Birdsill et al. found different results, i.e., an association of higher WC with higher FA, and lower MD, AD, 
and RD (124). 
In short, several large cross-sectional population-based studies assessed the association of 
central obesity with brain alterations, and found that central obesity was associated with atrophy and 
markers of cSVD. Only a few longitudinal studies on these associations were conducted, which indicated 
that central obesity precedes the development of brain atrophy, cSVD, and changes in white matter 
microstructure. These longitudinal associations need to be investigated further, because this could be a 
potential target for prevention of brain deterioration. No studies were found that investigated the 
association of central obesity with structural and functional connectivity, and other functional MRI 
measures. 
Hypertension and high blood pressure as risk factor for early brain 
alterations 
The brain is known to be more vulnerable to elevated blood pressure or hypertension than other organs, 
because its microcirculation is characterized by low impedance, which allows the pressure load to 
penetrate deeply into its microvascular bed (125, 126). This (pulsatile) pressure load may cause damage 
to the smallest blood vessels and thereby cause ischemia and neurodegeneration. Hypertension has 
been cross-sectionally associated with smaller gray matter volumes (127), left hemisphere (128) and 
total brain atrophy (129-131), thinner cortex(132, 133) and larger ventricles (128, 130, 131, 134) in 
population-based cohort studies. Furthermore, both population-based cohort studies (134-141), case-
control studies (142, 143), and studies on hypertensive patients (144-148) found an association between 
hypertension and larger WMH volumes. Only two of these studies had a longitudinal population-based 
design, and could assess temporality. One study found an association of higher mean arterial pressure 
with increased WMH volumes after a 28-year follow-up period (135), while the other reported 
progression of periventricular WMHs in participants with hypertension over 4 years of follow-up (146). 
Hypertension has also been associated with silent cerebral infarctions (134, 143, 149, 150), lacunar 
infarctions (134, 151), and larger perivascular spaces (151) in both cross-sectional (134) and longitudinal 
(151)  population-based studies (134), and large cross-sectional studies including hypertensive patients 
(149), in addition to smaller case-control studies (143, 150). 
Evidence on the association of hypertension or blood pressure with more advanced measures 
of brain function is scarce, only associations with diffusion metrics and changes in cerebral blood flow 
have been reported. Associations of hypertension with impaired white matter microstructure (152-154), 
higher MD (152) and lower FA in normal appearing white matter (152, 154, 155) have been observed. All 
these studies had a cross-sectional design, three of these had a large sample size (153, 155, 156), and 
two were smaller (n<100) (152, 154). The study by Gons et al. found a lower FA in both normal appearing 
white matter and white matter hyperintensities, and higher MD in white matter hyperintensities for both 
categorical (i.e., based on hypertensive status), and continuous blood pressure measures (i.e., systolic 
and diastolic)(156). The study by Fennema-Notestine et al., also had data on hypertension status at an 
earlier time-point (approximately 5.5 years earlier), and used this information to categorize participants 
Cardiometabolic determinants of early and advanced brain alterations: Insights from MRI 
27 
2 in groups of recent or longer duration of hypertension (153). However, no differences between these 
two groups were observed. Furthermore, an association of hypertension with lower FA (152, 156), and 
hypertension and higher systolic and diastolic blood pressure with lower FA and higher MD in WMH 
(156) was found. Finally, in three case-control studies, hypertension has been associated with lower 
cerebral blood flow (63, 157-159). 
Taken together, hypertension and elevated blood pressure have been associated with brain 
atrophy, lower cortical thickness, and cSVD characteristics mostly in cross-sectional studies. Longitudinal 
population-based analyses are scarce, but do indicate that higher mean arterial pressure is associated 
with increased WMH volume over time. Furthermore, hypertension has been associated with impaired 
white microstructure, and functional changes in cross-sectional studies. No large population-based 
studies have investigated the association of hypertension with white matter microstructural impairment 
yet. To increase knowledge about the temporal, and potentially causal aspects of the association 
between elevated blood pressure and brain changes, longitudinal population-based studies are needed. 
Dyslipidemia as risk factor for early brain alterations 
A number of population-based, case-control, and case studies investigated the association of an adverse 
lipid profile with early brain changes. In most studies, lipid profiles included information on total, LDL and 
HDL cholesterol levels, and triglycerides, and for brain outcome measures cortical thickness and markers 
of cSVD, while studies on atrophy were scarce. We here first summarize findings on total and LDL 
cholesterol, second on HDL cholesterol and finally on triglycerides. The Strong Heart Study investigated 
the cross-sectional association of LDL cholesterol levels with brain volumes in a population of American 
Indians, but found no significant association of LDL cholesterol with total brain and hippocampus volume 
(134). In contrast to what one might expect, lower LDL cholesterol levels have been associated with GM 
atrophy in the precentral gyrus and insula cortex in a cross-sectional study (160). In agreement with this, 
in other cross-sectional studies lower LDL cholesterol was associated with cortical thinning in fronto-
parietal and occipital areas (161), within the (left) caudal-middle frontal cortex (66), and for the total 
cortex (133). Higher total cholesterol (162-165) was reported to be associated with larger WMH volume, 
in three large population-based and one smaller cross-sectional study. However, another study found no 
association of LDL cholesterol with WHH volumes, but the majority of their study population used lipid-
modifying medication, which might decrease their cholesterol level-associated risk for cSVD (166). Less 
information is available on the association of cholesterol profile with lacunar infarctions. However, 
Bezerra et al. (167) found an association of higher LDL cholesterol with larger lacunes in the cross-
sectional population-based ARIC study. Several longitudinal studies have investigated the association of 
levels of LDL cholesterol with the prevalence of microbleeds, but not all found significant associations. In 
the population-based Rotterdam Study (168), a borderline association of high LDL cholesterol levels with 
prevalence of lobar microbleeds was found. In addition, Lee et al. (169) found lower concentrations of 
LDL cholesterol in patients with a severe degree of microbleeds compared to those without, in a 
longitudinal study with a follow-up period of 1-5 years. However, in the Strong Heart Study, high serum 
LDL was not significantly associated with WMH volume, (lacunar) infarcts, and microbleeds (134). 
In case-control studies by Cohen et al. (170) and Lou et al. (118), obesity-related abnormal 
plasma cholesterols (both high LDL and low HDL) with lower FA in prefrontal brain regions was found. 
This might indicate that elevated LDL levels contribute to obesity-associated impairment of white matter 
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   2 microstructure. Information on the association of cholesterol levels with functional connectivity is scarce. 
Only one small cross-sectional study reported a stronger functional connectivity in the DMN in a high 
total cholesterol group compared to a low cholesterol group, and lower functional connectivity was 
found in the salience network (SN) (171). With regard to HDL cholesterol, Coutinho et al. (161) reported 
that lower HDL cholesterol levels were associated with decreased cortical thickness in various brain 
regions in middle-aged and older adults (40-86 years), which was expected. Lower HDL cholesterol levels 
were reported to be associated with higher WMH volume, in one large longitudinal and three large cross-
sectional population-based studies and two smaller cross-sectional studies (111, 172-176). Lower HDL 
cholesterol was found to be associated with lacunar infarctions, in one large 3-year follow-up population-
based (177), and one smaller cross-sectional study (178). In the longitudinal AGES-Reykjavik Study (179) 
an association of higher levels of HDL cholesterol with increased risk for lobar, but not deep, microbleeds 
was found after 5 years. With regard to triglyceride levels, two cross-sectional studies (161, 180) found 
that higher triglyceride levels were associated with thinner cortex in multiple  brain regions. Three 
longitudinal studies investigated the association of triglyceride levels with cerebral small vessel disease. 
In the population-based Rotterdam Study, lower triglyceride levels were associated with an increased 9-
year incidence of microbleeds (168, 181). This longitudinal association was confirmed in the AGES-
Reykjavik Study (179) over 5-years of follow-up. Furthermore, the multicenter LADIS study reported that 
higher triglyceride levels could predict the occurrence of new lacunes over a three-year period (177). 
These differential results for lacunar infarcts and microbleeds may fit with the hypothesis that 
microbleeds and lacunes have distinct etiologies.   
Studies using advanced MRI techniques were scarce. Only one small cross-sectional study found that 
lower levels of triglycerides were associated with higher levels of cerebral blood flow as measured with 
ASL (182). 
In conclusion, high LDL cholesterol has been associated with thinner cortex, but higher incidence of 
lacunar infarcts and microbleeds. On the contrary, high HDL cholesterol was associated with thicker 
cortex and less white matter hyperintensities, but also with incidence of lacunar infarcts and potentially a 
higher risk for lobar microbleeds. Studies on diffusion or functional MRI measures are scarce. One study 
found an association of higher total cholesterol with lower functional connectivity, and one study found 
an association of higher triglyceride levels with lower cerebral blood flow. 
Discussion 
Overview and in-depth analysis of the findings  
Table 2.2 provides a condensed systematic overview of the findings in literature about cardiometabolic 
risk factors in relation to brain volumes and cSVD. The many omissions in the table indicate that not all 
risk factors have been studied in relation to brain alterations. In general, higher levels of cardiometabolic 
risk factors considered in this review have been associated to markers of brain atrophy, i.e., smaller total, 
gray matter and white matter, and larger CSF volumes. Although, the association of altered lipid profile 
and sedentary behavior with WM, GM, and CSF volumes has been studied too little and needs further 
investigation. Furthermore, all cardiometabolic risk factors were associated with globally thinner cortex, 
except for an altered lipid profile. Higher LDL and total cholesterol levels were associated to thicker 
cortex in some brain regions. With respect to the cSVD characteristics, all cardiometabolic risk factors 
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2 were associated with larger WMH volumes and the presence of lacunar infarctions. Visceral fat 
accumulation, altered lipid profile, and hypertension were associated with the presence of microbleeds, 
while hyperglycemia was not, and for PA and sedentary time, no information was found. These results 
suggest that all cardiometabolic risk factors are associated with early pathological changes in the brain, in 
particular with brain volumes and the presence of particular cSVD features. This fits with the notion that 
all risk factors that are harmful for heart and vasculature, are also harmful for the brain. 
 
Table 2.2: Overview of evidence on the associations between cardiometabolic risk factors and markers of 
brain atrophy and small vessel disease.  
 
 
Table 2.3 provides an overview of the main findings for diffusion measures, structural connectivity, and 
functional connectivity. All cardiometabolic risk factors were associated with lower FA and MD, indicating 
microstructural changes. For an adverse lipid profile, an association with lower FA was found, but no 
information was available on MD. Hyperglycemia, less PA and more sedentary behavior were also 
associated with higher AD and RD, indicating impaired white matter microstructure; and visceral fat 
accumulation was associated with lower AD and higher RD, indicating axonal and myelin damage. 
Regarding structural connectivity, limited data were available, as only studies on hyperglycemia and PA 
were found. Hyperglycemia has been associated with lower overall structural connectivity. In addition, 
less physical activity and sedentary behavior have been associated to lower nodal strength and local 
efficiency, indicating less efficient networks. For fMRI, several associations of hyperglycemia with 
functional MRI measures were found, e.g., lower overall functional connectivity, higher clustering 
coefficient, higher local efficiency, lower degree centrality, all indications of network alterations, and 
lower cerebral blood flow. Furthermore, less physical activity and sedentary behavior have been 
associated to lower fMRI activation, and a higher functional connectivity in the default mode network 
(DMN). In addition, an adverse lipid profile was associated to a lower decreased functional connectivity 
in the salience network (SN). Finally, hypertension was associated with lower functional connectivity. 
Most omissions in Table 2.3 are in the field of structural connectivity. Studies on associations of risk 
factors with white matter structure could probably lead to more insights in microstructural changes.  
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   2 Table 2.3: Overview of evidence on the associations between cardiometabolic risk factors and diffusion 
measures and structural and functional connectivity.  
 
 
In addition to the overviews in Table 2.2 and 2.3, we visualised the level of evidence of the observed 
associations by depicting the study designs found in litereature by risk factors in Figure 2.2. This figure 
shows that despite to what we may think, the evidence that cardiometabolic risk factors have a temporal 
association with brain atrophy. This has been evaluated in longitudinal data for diabetes and physical 
inactivity, but not for obesity, hypertension, and dyslipidemia. In addition, the association of physical 
inactivity with cSVD needs to be investigated in larger longitudinal studies, to investigate temporal 
associations. Assessing the associations of cardiometabolic risk factors with more advanced MRI 
measures as diffusion metrics, structural or function connectivity are in their infancy but coming.  
 
  




Figure 2.2: Highest level of evidence in the available literature on the associations between 
cardiometabolic risk factors and conventional (white symbols) and advanced (gray symbols) MRI 
measures. Large indicates N>100; small, N<100. The size of the symbols indicates the amount of studies in 
that category: small indicates 1-4; medium, 5-10; large: >10 studies. 
Future outlook and clinical relevance 
As we observe several lacunes in this review, there are a number of opportunities for future studies. 
First, advanced MRI techniques, including microstructural, functional, and perfusion MRI, may provide 
more detailed insight into underlying mechanisms that lead from cardiometabolic risk factors to brain 
dysfunction and disease. These insights may help to develop better treatment strategies to delay or even 
prevent brain alterations and eventual disease. In addition, the longitudinal association of obesity, 
hypertension and dyslipidemia with volumetric data needs investigation in order to find support for 
potential causality. Second, reduction of residual confounding is of key importance to interpret the 
results of studies. The studies included in this review did this to some extent, at least by matching or 
adjustments for age and sex. However, cardiometabolic risk factors are interrelated, therefore, an 
integrated approach where cardiometabolic risk factors are taken into account jointly, would advance 
this field of research. Third, most advanced MRI outcome measures may represent early changes prior to 
end-organ damage, which makes them potentially more useful as response markers for intervention 
studies than volumetic data. This is of particular interest, because cardiometabolic risk factors are 
modifiable. Fourth, early biomarkers for brain disease may enable us to identify people at risk, to prevent 
further escalation to functional decrements and eventual disease. Thus, future longitudinal studies are 
needed to address the usefulness of these novel biomarkers in relation to disease outcomes and risk 
prediction. Finaly, other novel MRI approaches, such as dynamic contrast enhanced (DCE) MRI, to 
investigate blood-brain-barrier leakage; magnetic resonance spectroscopy (MRS), to investigate the 
metabolic characteristics of brain alterations; or ultra-high field MRI (>3Tesla) might provide alternative 
ways to elucidate the early signs and complex pathophysiology of brain diseases. 
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   2 Conclusions 
This narrative review indicates clear evidence on the associations of hyperglycemia, central obesity, 
hypertension, and physical inactivity on brain atrophy, cSVD, and white matter microstructure 
alterations, although longitudinal data is often lacking. The associations of an adverse lipid profile with 
MRI markers of the brain are far less clear, as well as the association of relatively novel risk factors as 
physical inactivity and sedentary behavior. In particular, the evidence from more advanced MRI 
measures, such as microstructural, functional, and perfusion MRI needs to be applied in longitudinal 
studies, as insight into more subtle brain alterations, development over time, and subsequent brain 
dysfunction and disease is needed. 
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Prediabetes and type 2 diabetes are associated with structural brain abnormalities, often observed in 
cognitive disorders. Besides visible lesions, (pre)diabetes might also be associated with alterations of the 
intrinsic organization of the white matter. In this population-based cohort-study, the association of 
prediabetes and type 2 diabetes with white matter network organization was assessed. 
Research Design and Methods 
In The Maastricht Study, a type 2 diabetes-enriched population-based cohort-study (1361 normal glucose 
metabolism, 348 prediabetes, 510 type 2 diabetes assessed by OGTT, 52% men, aged 59±8 years) 3 Tesla 
structural and diffusion MRI was performed. Whole brain white matter tractography was used to assess 
the number of connections (node degree) between 94 brain regions and the topology (graph measures). 
Multivariable linear regression analyses were employed to investigate the associations of glucose 
metabolism status with network measures. Associations were adjusted for age, sex, education, and 
cardiovascular risk factors.  
Results  
Prediabetes and type 2 diabetes were associated with lower node degree after full adjustment 
(standardized [st]βPrediabetes[95%CI]=-0.055[-0.172,-0.062], stβType2diabetes[95%CI]=-0.256[-0.379,-
0.133],Ptrend<0.001). Prediabetes was associated with lower local efficiency (stβ[95%CI]=-0.084[-0.159,-
0.008],P=0.033) and lower clustering coefficient (stβ[95%CI]=-0.097[-0.189,-0.005],P =0.049), while type 
2 diabetes was not. Type 2 diabetes was associated with higher communicability 
(stβ[95%CI]=0.148[0.042,0.253], P=0.008). 
Conclusions  
These findings indicate that prediabetes and type 2 diabetes are associated with fewer white matter 
connections, and weaker organization of white matter networks. Type 2 diabetes was associated with 
higher communicability, which was not yet observed in prediabetes, which may reflect the use of 




   3 Introduction 
Type 2 diabetes is associated with cognitive decline (1-3) and poses an increased risk for brain diseases, 
such as Alzheimer’s disease and depression (4; 5). As type 2 diabetes is associated with abundant macro- 
and microvascular disease, it may also affect brain vessels leading to cerebral small vessel disease (e.g., 
white matter lesions (WML)) and neurodegeneration (brain atrophy)(6; 7), which represent early 
features in the pathophysiology of cognitive decline and dementia (8), and can be measured by brain 
MRI. Some studies even show that prediabetes is already associated with alterations in the brain (9; 10), 
more specifically with presence of lacunar infarcts, larger WML volumes, and smaller white matter 
volumes, with further deterioration in type 2 diabetes, as previously reported (7). The white matter is 
organized as a complex network of connected fibers, which is responsible for efficient information 
exchange between brain regions. Alterations in one region may affect the function of other regions to 
which they are connected via white matter tracts. Thus, to understand the organization of white matter 
networks entirely, assessment of regional brain volumes is insufficient. The use of diffusion MRI-derived 
white matter tracts, in combination with graph theoretical analysis, does address both the regional 
volumes, and its connections to other regions. 
Type 2 diabetes might also be associated with alterations in the intrinsic organization of the white matter 
(11-14). However, whether changes in the intrinsic network organization of the white matter already 
occur in prediabetes is currently unknown (15-17). We hypothesize that brain abnormalities comparable 
to those found in type 2 diabetes are, to a lesser extent, already present in prediabetes, possibly already 
before onset of cognitive decline. The main objective of this study is to assess the association of 
prediabetes and type 2 diabetes, with white matter network characteristics, in terms of the number 
(node degree) and organization (graph measures) of the white matter connections. 
Research Design and Methods 
The Maastricht Study: population and design 
We used data from The Maastricht Study, an observational prospective population-based cohort study. 
The rationale and methodology have been described previously (18). In brief, the study focuses on the 
etiology, pathophysiology, complications, and comorbidities of type 2 diabetes and is characterized by an 
extensive phenotyping approach. Eligible for participation were all individuals aged between 40 and 75 
years and living in the southern part of the Netherlands. Participants were recruited through mass media 
campaigns and from the municipal registries and the regional Diabetes Patient Registry via mailings. 
Recruitment was stratified according to known type 2 diabetes status, with an oversampling of 
individuals with type 2 diabetes, for reasons of efficiency. Participants with type 1 diabetes or other 
types of diabetes were excluded from the analysis. The present report includes cross-sectional data from 
the first 3451 participants, who completed the baseline survey between November 2010 and September 
2013. The examinations of each participant were performed within a time window of three months. MRI 
measurements were implemented from December 2013 onwards until February 2017 and were available 
in 2318 out of 3451 participants. Of the 2318 participants with MRI measurements available, 2302 
subjects had complete data without artifacts [Flowchart in Supplementary material Figure 3.1]. The study 
has been approved by the institutional medical ethical committee (NL31329.068.10) and the Dutch 
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3 Ministry of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). All participants 
gave written informed consent. 
Glucose metabolism status 
To determine glucose metabolism status, all participants, except those who used insulin, underwent a 
standardized 2-h 75g oral glucose tolerance test (OGTT) after an overnight fast. For safety reasons, 
participants with a fasting blood glucose (FBG) level above 11.0 mmol/L, as determined by a finger prick, 
did not undergo the OGTT. For these individuals, fasting glucose level and information about diabetes 
medication were used to determine glucose metabolism status. Glucose metabolism status was defined 
according to the WHO 2006 criteria into NGM, prediabetes, and type 2 diabetes (19). Participants were 
considered to have type 2 diabetes if they had a fasting blood glucose ≥7.0 mmol/l, or a 2-h post-load 
blood glucose ≥11.1 mmol/l or used oral glucose-lowering medication or insulin, prediabetes if they had 
a FBG ≥6.1 mmol/l and/or a 2-h post-load blood glucose ≥7.8 mmol/l, and NGM if they had a FBG <6.1 
mmol/l, and a 2-h post-load blood glucose <7.8 mmol/l and no use of diabetes medication. 
Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) was performed on a 3T MRI scanner (MAGNETOM Prisma-fit Syngo 
MR D13D; Siemens Healthcare, Erlangen, Germany) using a 64-element head/neck coil for parallel 
imaging with an acceleration factor of two. A 3D T1-weighted magnetization prepared rapid acquisition 
gradient echo (MPRAGE) sequence (TR/TI/TE 2300/900/2.98 ms, 176 slices, 256x240 matrix size and 1.00 
mm cubic voxel size) was acquired for anatomic reference. Diffusion-weighted MRI (dMRI) data were 
acquired using a diffusion sensitized echo-planar imaging (EPI) sequence (TR/TE 6100/57 ms, 65 slices, 
100×100 matrix size, 2.00 mm cubic voxel size, and 64 diffusion sensitizing gradient directions (b=1200 
s/mm2)). In addition, three minimally-diffusion-weighted images (b=0 s/mm2) were acquired. 
Image preprocessing 
To define N=94 regions, the automatic anatomical labeling 2 (AAL2) atlas (20) was used. The AAL2 
volumes of interest were transformed to diffusion space for each individual subject. First, affine 
registrations of the dMRI image to the T1 image and of the T1 image to T1 MNI-152 standard space (21) 
were performed. These two transformations were combined and the inverse transformation matrix was 
applied to the AAL2 template. T1-weighted and Fluid Attenuated Inversion Recovery (FLAIR) images were 
segmented by use of an ISO13485:2012 certified, automated method (which included visual 
inspection)(22; 23) into white matter, gray matter, cerebrospinal fluid, and WML. Detailed methods are 
described in (7). dMRI data analysis was performed with the diffusion MR Toolbox ExploreDTI version 
4.8.6. (24) The main preprocessing steps were eddy current induced geometric distortions and head 
motion correction, and estimation of the diffusion tensor. After preprocessing, fiber orientation 
distributions (FOD) were estimated using constrained spherical deconvolution with a maximum harmonic 
degree of 8 (25), which allows fiber tracking through regions with crossing fibers. Whole brain 
deterministic tractography was performed using FOD sampling (26) with a seed point resolution of 2 
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   3 mm3, a step size of 1 mm, and an FOD and maximum deflection angle threshold of 0.1 and 30°, 
respectively. The next step was performing connectivity analysis to obtain white matter tracts from and 
to all the segmented regions. A previous study of our group confirmed the robustness of tract volume as 
a measure for the edge weighting (27), therefore, for each connection, the tract volume was calculated 
as the number of voxels visited by at least one tract between concerned areas multiplied by the voxel 
volume (in mm3). The obtained connectivity matrix with tract volumes was normalized to intracranial 
volume to reduce inter-subject variation (28). When regions were connected by only one or two 
streamlines, the corresponding tract volumes were removed from the connectivity matrix, as an 
additional noise filter. 
White matter networks 
Network analysis was performed using the Brain Connectivity Toolbox (version 2017-15-01)(29) in 
MATLAB (Release 2016a; The MathWorks, Inc., Natick, MA). In this method (for an overview, see Figure 
3. 1), the brain is represented as a graph, which is a network of nodes (i.e., gray matter brain regions) 
connected by edges (i.e., white matter connections between brain regions). The organization of such a 
graph can be characterized by use of graph measures, e.g., clustering coefficient, local efficiency, 
communicability, and global efficiency. These graph measures describe the efficiency and integrity of the 
white matter networks.  
The node degree is calculated for each AAL2 region and the mean value is defined as the 
average node degree, which is a measure for the average number of edges connected to a region (node). 
In a network with a high average node degree, nodes are connected to many other nodes in the network 
(i.e., strong innervation). The sparsity of a network is the ratio of the number of missing connections in a 
network to the possible number of connections and is closely, but inversely, related to the node degree. 
The sparsity ranges from 0 to 1, the higher the sparsity, the lower the density of the network (29). 
Graph measures 
To describe network organization, measures indicative of network segregation, to assess the presence of 
local densely interconnected groups of brain regions, and indicative of integration, to assess large-scale 
communication between nodes, were calculated [see Figure 3.1]. Measures of segregation describe the 
local connectivity properties of a network and comprise clustering and local efficiency. The clustering 
coefficient quantifies the number of connections between the nearest neighbors of a region as a 
proportion of the maximum number of possible connections (15). The local efficiency of a region is the 
inverse of the average shortest path connecting all neighbors of that region (30). Paths are sequences of 
connections in the network, which represent potential routes for communication between brain regions. 
Measures of integration describe the ease with which brain regions communicate in terms of 
paths and include global efficiency and communicability. The global efficiency is the inverse of the 
average shortest path length calculated over the entire brain, thus a high global efficiency reflects long 
paths between regions (30). However, neural communication does not necessarily follow the shortest 
paths only, but slightly longer paths might also be used (e.g., to bypass affected paths). Therefore an 
alternative measure of communication, the communicability, was calculated, which includes all possible 
paths between brain regions, weighted according to their length (31). 




Figure 3.1: Glossary. 
White matter structural connectivity 
The node degree was first calculated for the full connectivity matrices of the groups, NGM, prediabetes, 
and type 2 diabetes, for comparison of the basic network architecture between them. Subsequently, a 
standard group averaged network was calculated for each group separately (32). Note that these 
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   3 standard networks may differ per group comparison. This standard network was proportionally 
thresholded to a sparsity of 0.80 (only the connections that were present in at least 80% of the 
participants in that group will be taken into account in the individual connectivity matrices), resulting in a 
weighted, undirected network with a sparsity close to the sparsity of the standard network. The standard 
networks were also thresholded for a range of sparsity values (0.65-0.9, step size 0.05) to assess the 
robustness over different sparsity values. Additionally, connections were identified with a significantly 
increased or decreased tract volume. First, we applied thresholding by a network based on only the NGM 
subjects, to check whether differences in basic network architecture were also present after exclusion of 
connections formed due to noise as opposed to pathology. As the networks of the type 2 diabetes group 
appeared to be most sparse, subsequently, the organization of this remaining (sub)network was 
analyzed. Hence, the resulting network contains only the connections of the sparser type 2 diabetes 
network of which the connections are also present in the other two groups. Otherwise the ‘true sparsity’ 
of the subjects with type 2 diabetes would be lower than for the NGM and prediabetes subjects, which 
again leads to different results in graph measures due to differences in sparsity. To investigate whether 
prediabetes is already associated with a structural reorganization, for the comparison of prediabetes and 
NGM, the average prediabetes derived network was applied.  
To investigate the structural organization in the white matter networks in type 2 diabetes and 
prediabetes, graph measures of segregation (i.e., clustering coefficient and local efficiency) and 
integration (i.e., global efficiency and communicability)(16; 17; 33) were calculated from the brain 
graphs. Graph measures were normalized to comparable values from randomly generated networks of 
equal size and similar connectivity distribution (N = 100) (34), and calculated over a range of six sparsity 
values, 0.65-0.9 (step size 0.05). 
General characteristics and covariates 
Educational level (low, intermediate, high), smoking status (never, current, former) and history of 
cardiovascular disease were assessed by questionnaires (18). Medication use was assessed in a 
medication interview where generic name, dose, and frequency were registered. We measured weight, 
height, BMI, waist circumference, blood pressure (measured in office [705IT; Omron, Kyoto, Japan]), and 
plasma lipid profile (18). 
Statistical analysis 
All statistical analyses were performed by use of the Statistical Package for Social Sciences (SPSS Statistics 
23.0; IBM, Chicago, IL). Clinical characteristics of the participants within the three groups of glucose 
metabolism status were compared using ANOVA and Pearson χ^2 tests, where appropriate. 
Multivariable linear regression was used to investigate the association of glucose metabolism status, with 
average node degree, and graph measures. For linear trend analyses, the categorical variable glucose 
metabolism status (NGM=0, prediabetes=1, and type 2 diabetes=2) was used in the regression models. 
To assess regression coefficients per glucose metabolism group, analysis with dummy variables for 
prediabetes and type 2 diabetes with NGM as reference group were used. Analyses were adjusted for 
potential confounders, notably age, sex, education level and MRI date (Model 1), and additionally 
adjusted for cardiovascular disease risk factors: BMI, total cholesterol-to-HDL-ratio, lipid-modifying 
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3 medication, office systolic blood pressure, antihypertensive medication, and prior cardiovascular disease 
(Model 2). Regression coefficients for normal aging (i.e., in participants with normal compared to 
abnormal glucose metabolism) were determined in the NGM group. Multiple linear regression with false-
discovery-rate (FDR) correction (q-value=0.05) was used to correct for multiple comparisons to 
determine which connections had significantly different tract volumes between groups, and were 
adjusted for age, sex, education level, and MRI lag time. In the type 2 diabetes-based standard networks, 
the associations of glucose metabolism groups and continuous measures of blood glucose with graph 
measures were analyzed by use of multiple regression analyses. Analyses on graph measures were 
adjusted for age, sex, education level, MRI date, and average node degree (Model 1), and additionally for 
cardiovascular disease risk factors (Model 2). Furthermore, we investigated the association of HbA1c, 
FBG, and 2-h post-load glucose levels, with average node degree and graph measures; and adjusted in an 
additional model for life style factors. Skewed variables (WML volumes) were log10 transformed. P-
values <0.05 were considered statistically significant. 
Results  
General characteristics of the study population 
Table 3.1 shows the general characteristics of the study population for subjects with NGM, prediabetes, 
and type 2 diabetes. The study population consisted of 2219 individuals; 1361 had NGM, 348 had 
prediabetes, and 510 had type 2 diabetes. Mean age was 59±8 years, and 48% were women. Individuals 
with prediabetes and type 2 diabetes were older, less often female, more often had an adverse 
cardiovascular risk profile, and more often had a low educational level [Table 3.1]. Individuals who 
underwent MRI were younger, less likely to have type 2 diabetes, less often current smokers, and less 
often had a low education level compared to those that did not undergo MRI [Supplementary Table 3.1]. 
Structural network characteristics 
After full adjustment, the average node degree for the full connectivity matrices (i.e., before 
thresholding) was significantly lower for type 2 diabetes subjects compared to NGM (1.3% lower, 
standardized [st]β[95% CI]=-0.111[-0.220,-0.002], Ptrend=0.047, Supplementary Table 3.2). Subsequent 
analysis using the standard network based on only NGM subjects, showed significantly different results 
for type 2 diabetes compared to prediabetes (0.7% lower, stβ[95% CI]=-0.256[-0.379,-0.133], 
Ptrend<0.001). Higher HbA1c, FBG, and 2-h post-load glucose levels were also associated with lower node 





   3 Table 3.1: Clinical characteristics of participants according to glucose metabolism status. 
Characteristic  NGM Prediabetes Type 2 diabetes Ptrend 
 (n = 1361) (n = 348) (n = 510)  
Demographics     
Age (years) 57.6±8.1 61.2±7.5 62.5±7.6 <0.001 
Sex, male (%) 44.2 55.2 68.6 <0.001 
Education level (%), 
Low/Middle/High 
25.4/28.1/46.4 33.0/31.0/36.0 41.3/30.2/28.5 <0.001 
Glucose metabolism     
Fasting blood glucose (mmol/l) 5.2±0.4 5.9±0.6 7.8±1.9 <0.001 
2h post-load glucose* (mmol/l) 5.4±1.1 8.1±1.8 14.2±4.1 <0.001 
HbA1c (%) 5.4±0.3 5.7±0.4 6.9±1.0 <0.001 
HbA1c (mmol/mol) 36.0±3.7 38.6±4.4 51.4±11.0 <0.001 
Diabetes duration† (years) – – 6.9±7.2 – 
Cardiovascular risk factors     
BMI (kg/m2) 25.5±3.5 27.3±4.0 29.3±4.6 <0.001 
Waist circumference (cm) 90.2±10.9 96.8±11.3 104.3±12.9 <0.001 
Office systolic blood pressure 
(mmHg) 
131±17 136±16 141±17 <0.001 
Office diastolic blood pressure 
(mmHg)  
75±10 78±10 77±9 <0.001 
Hypertension, yes (%) 39.1 59.4 82.0 <0.001 
Ratio of total cholesterol to HDL 3.6±1.2 3.9±1.2 3.6±1.1 0.152 
History of cardiovascular disease, 
yes (%) 
8.9 11.3 21.3 <0.001 
History of CVA, yes (%)‡ 1.1 2.3 3.9 <0.001 
Medication use     
Insulin use, yes (%)† – – 19.6 – 
Antihypertensive medication, yes 
(%) 
20.6 38.8 70.2 <0.001 
Lipid-modifying medication, yes 
(%) 
14.8 29.0 72.5 <0.001 
Lifestyle factors     
Alcohol consumption (%), 
None/Low/High 
13.9/57.5/28.6 16.3/53.5/30.2 26.4/53.1/20.5 <0.001 
Smoking status (%), 
Never/Former/Current 
40.9/47.9/11.1 30.4/58.0/11.6 32.7/53.7/13.5 0.001 
Cognitive score     
MMSE total score§ 29.2±1.1 28.9±1.1 28.7±1.3 <0.001 
Data are presented as means ± standard deviation or percentage, and stratified for glucose metabolism status: 
normal glucose metabolism (NGM), prediabetes, and type 2 diabetes. P-values indicate trend analysis over 
glucose metabolism status. HbA1c indicates hemoglobin A1c; BP, blood pressure; HDL, high-density lipoprotein; 
LDL, low-density lipoprotein; CVA, cerebrovascular accident; MMSE, Mini-Mental State Examination. *2h post-
load glucose values were available in n=2098. †Available in 344 type 2 diabetes individuals. ‡History of CVA data 
was available is n=2191.§Five participants had a MMSE score of 22 or 23 (mild cognitive impairment) and none 
had dementia. Detailed protocols of the general measurements are presented in the supplementary material. 
Characteristics of variables used in the additional models (Supplementary Table 3.6-3.11) are given in 
Supplementary Table 3.12. 
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3 In Figure 3.2A, the standard network for the NGM group is schematically shown. Figure 3.2B 
and 3.2C indicate for which connections the tract volumes were significantly different in prediabetes 
compared to NGM, and in type 2 diabetes compared to NGM, respectively. These results indicate that in 
prediabetes, only intra-hemispheric connections had significantly smaller tract volumes. In type 2 
diabetes, both inter- and intra-hemispheric connections (of which 66% were inter-hemispheric) had 




Figure 3.2: Schematic representation of connections between the atlas regions present in the NGM-based 
standard network (A), and those connections which had a significantly different tract volume in (B) 
prediabetes or (C) type 2 diabetes compared to NGM subjects. Blue connection lines indicate connections 
with significantly smaller tract volumes (unstandardized β<0), and red lines with significantly larger tract 
volumes (unstandardized β>0). P<0.05, FDR corrected. Darker blue or red connection lines indicate lower 
p-values. (D) Brain regions that represent the color-coded brain regions. 
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   3 As an additional analysis, the association between WML volume and node degree was 
determined over all subjects. After full adjustment, relative WML volume (in % of intracranial volume) 
was negatively associated with the node degree of the NGM-based standard network (stβ[95%CI]=-
0.059[-0.101,-0.018], p=0.001). This association was not present for the smaller type 2 diabetes-based 
standard network (stβ[95%CI]=-0.010[-0.035,0.018], p=0.714). 
Graph measures of the type 2 diabetes-based standard network 
After thresholding all individual networks by use of the prediabetes-, or type 2 diabetes-based networks, 
graph analysis was performed. In Table 3.2, the associations of these graph measures at a sparsity of 0.8 
are shown. In the prediabetes-based standard network, prediabetes was significantly associated with a 
lower normalized clustering coefficient compared to NGM, which indicates a lower local connectivity. 
Prediabetes was also associated with a lower normalized average local efficiency. No association was 
found between prediabetes and the normalized global efficiency and communicability. In addition, type 2 
diabetes was associated with higher communicability as compared to NGM, despite the lower node 
degree. The other three graph measures were not significantly associated with type 2 diabetes. Graph 
measures for a range of sparsity thresholds are shown in Supplementary Figure 3.2. After full 
adjustment, only the association with higher communicability in type 2 diabetes remained significant. No 
associations remained significant for prediabetes. A higher communicability was also found for higher 
continuous glucose measures and this remained significant after full adjustment (Supplementary Table 
3.4). 
 
Table 3.2: Associations of prediabetes and type 2 diabetes with graph network measures at a sparsity 
value of 0.8. 
 Prediabetes* P Type 2 diabetes† P 
Normalized graph measures, β (95% CI) 
Clustering coefficient     
Model 1 -0.097 (-0.189, -0.005) 0.049 -0.026 (-0.111, 0.059) 0.562 
Model 2 -0.066 (-0.161, 0.028) 0.169 0.027 (-0.074, 0.128) 0.603 
Global efficiency     
Model 1 0.034 (-0.086, 0.151) 0.625 -0.056 (-0.164, 0.052) 0.212 
Model 2 0.032 (-0.092, 0.156) 0.615 -0.051 (-0.180, 0.077) 0.434 
Local efficiency     
Model 1 -0.084 (-0.159, -0.008) 0.033 -0.043 (-0.113, 0.027) 0.208 
Model 2 -0.060 (-0.137, 0.017) 0.128 0.010 (-0.073, 0.093) 0.816 
Communicability     
Model 1 0.026 (-0.092, 0.144) 0.475 0.148 (0.042, 0.253) 0.008 
Model 2 0.043 (-0.079, 0.165) 0.491 0.163 (0.037, 0.290) 0.011 
*Prediabetes-based standard network. †Type 2 diabetes-based standard network. Associations of prediabetes 
and type 2 diabetes with graph measures. Regression coefficients and 95% CI indicate the mean difference in 
clustering coefficient, global efficiency, local efficiency, and communicability of participants with prediabetes or 
type 2 diabetes compared with NGM. Model 1: Adjusted for age, sex, education, average node degree, and MRI 
date. Model 2: Model 1 + additionally adjusted for BMI, office systolic blood pressure, total cholesterol-to-HDL-
ratio, antihypertensive medication, lipid-lowering medication, history of cardiovascular disease. Bold values = 
p<0.05. 
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3 Diabetes and aging 
Multiple linear regression analysis was employed to determine the relative association of prediabetes 
and type 2 diabetes with node degree as compared to aging. Node degree was significantly lower in 
subjects with prediabetes or type 2 diabetes compared to NGM and corresponded to 2.3 or 10.4 years of 
aging, respectively (Supplementary Table 3.5). Adjustment for potential confounders (i.e., BMI, systolic 
blood pressure, total cholesterol-to-HDL-ratio, prior cardiovascular disease, and antihypertensive and 
lipid-lowering medication) did not substantially change these results.  
There were also connections where tract volumes were significantly associated with age 
[Supplementary Figure 3.3A]. Please note the large similarities between connection tract volumes 
associated with age and type 2 diabetes. However, in type 2 diabetes, the connections between the left 
and right hippocampus and between right frontal and temporal regions, had significantly smaller tract 
volumes compared to NGM, but these connections were not associated with age [Supplementary Figure 
3.3B]. 
Discussion  
In this study, we found that both prediabetes and type 2 diabetes were associated with a lower node 
degree, and thus fewer white matter connections, as compared to NGM. Continuous measures of 
hyperglycemia (HbA1c, FBG, and 2-h post-load glucose levels) were also associated with lower node 
degree. Moreover, prediabetes and type 2 diabetes were associated with smaller tract volumes of 
several connections between cortical regions, which were comparable to those associated with aging. 
The lower node degree of 0.4 and 1.3% in subjects with prediabetes and type 2 diabetes, respectively, 
compared to NGM, was equivalent to 2 and 9 years of aging, which fits with the idea that (pre)diabetes is 
accompanied by accelerated aging. We also investigated the association between prediabetes and type 2 
diabetes with structural organization. In prediabetes compared to NGM, the local efficiency and 
clustering coefficient were lower, which indicates that there was a weaker local connectivity. In type 2 
diabetes compared to NGM, a higher communicability was found, indicating that in type 2 diabetes more 
alternative white matter connections are used to facilitate structural connectivity between brain regions. 
In prediabetes, the clustering coefficient and local efficiency were lower compared to NGM, 
indicating that structural alterations can be observed already in prediabetes. These findings indicate that 
brain changes already occur, in prediabetes, before the clinical diagnosis of type 2 diabetes. Therefore, 
treatment of prediabetes should be considered as a potential target of intervention, for the prevention 
of complications of type 2 diabetes, including structural brain changes. In type 2 diabetes compared to 
NGM, a higher communicability was found. Communicability is a measure, which indicates the ease of 
communication between two brain regions, taking into account not only the shortest path, but also all 
other possible paths connecting them. A potential explanation for the higher communicability in type 2 
diabetes compared to NGM involves the increased WML load in type 2 diabetes and prediabetes (7).  The 
brain might be able to adapt to changing circumstances (to a small extent), and staying physically and 
mentally fit can possibly promote this effect (35; 36). However, the precise pathophysiological basis of 
white matter alterations in patients with (pre)diabetes remains to be elucidated, and a complex interplay 
of endocrinological, metabolic, and vascular mechanisms is likely involved (5; 7). 
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   3 Our findings are in line with previous studies that assessed the association between type 2 
diabetes and white matter connectivity. Previous reports showed lower white matter connectivity 
between the hippocampus and the frontal lobe (13), and microstructural abnormalities in four major 
white matter tracts connecting the frontal, parietal and temporal lobe (12) in type 2 diabetes compared 
to a control group. In contrast, a study comparing 55 age-, sex- and education-matched individuals with 
type 2 diabetes with 50 non-diabetes individuals (11), found that the mean clustering coefficients and 
global efficiency were lower in type 2 diabetes compared to controls. However, the total number of 
connections in the network did not differ between the groups, and these between-group differences 
were independent of vascular lesion load. This difference in observations may be due to the much 
smaller sample size and the differences in the specific networks, which were analyzed in that study. 
Interestingly, altered functional connectivity, in terms of a higher clustering coefficient and high local 
efficiency, was found in type 2 diabetes and at a lower level in prediabetes (37), which was interpreted as 
a compensatory mechanism in the form of functional reorganization to counteract a decrease in 
cognitive performance. This is in agreement with the altered structural connectivity observed in the 
present study, which is indicative of alternative white matter connections in type 2 diabetes. 
Study considerations 
Strengths of this study are the sample size and population-based design with an oversampling of 
participants with type 2 diabetes, which enables an accurate comparison between the three glucose 
metabolism groups. The large amount of diffusion MRI scans available, were semi-automatically 
processed blinded to group status, which ensures an objective analysis. Other strengths were the use of 
HbA1c levels and a 2-hr OGTT to accurately characterize glucose metabolism; and the extensive 
assessment of potential confounders. In this study, most findings were robust over a large sparsity range 
and remained statistically significant after adjustment for potential confounders.  
There are also some limitations. First, the time between baseline measurements and MRI scan 
might have influenced the associations observed. However, when we additionally adjusted for this, 
associations did not significantly change. Second, we used a single OGTT to assess (pre)diabetes status, 
which may result in misclassification of long-term glucose tolerance status (38). When group sizes and 
misclassification estimates (38) are taken into account, the net result of this misclassification is likely to 
be underestimation of brain abnormalities in the prediabetes group. Furthermore, individuals who 
underwent MRI were younger, were less likely to have type 2 diabetes, were less often current smokers 
and less often had a low educational level, as compared to the study population which did not undergo 
MRI. However, as included individuals with MRI data were relatively more healthy compared to those 
without MRI, our current selection may have caused us to underestimate any of the associations 
between glucose metabolism status with network measures. And finally, due to the cross-sectional 
design of the study we cannot infer any conclusion about the causality of this association. Therefore, 
future longitudinal studies are needed to address if hyperglycemia precedes the development of the 
observed brain abnormalities, which may infer causality. 
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3 Conclusion  
We showed, in a population-based study, that prediabetes, type 2 diabetes and continuous measures of 
hyperglycemia are associated with fewer white matter connections, and weaker organization of white 
matter networks. In addition, type 2 diabetes was associated with higher communicability, which was 
not yet observed in prediabetes, and which may reflect the use of alternative white matter connections. 
These findings support the concept that hyperglycemia, even in the prediabetes phase, may be harmful 
to the brain, and that type 2 diabetes affects the global and local organization of brain structures.   
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   3 Supplementary Material 
Detailed protocols of the measurements performed within The 
Maastricht Study: 
Questionnaires. As described elsewhere (1), we used web-based questionnaires to obtain information 
regarding smoking status (never/former/current), alcohol consumption, educational level, physical 
activity, diet, prior CVD and cognitive impairment. Alcohol consumption was classified as none, low (1– 7 
glasses/wk for women and 1–14 glasses/wk for men) and high (> 7 glasses/wk for women and >14 
glasses/wk for men). Educational level was classified as low (no education, primary education, lower 
vocational education), intermediate (intermediate general secondary education, intermediate vocational 
education, higher general secondary education), or high (higher vocational education or university). 
Physical activity was assessed by means of a modified version of the Champs questionnaire. Diet was 
assessed by a tailor-made FFQ developed by use of the National FFQ Tool. Prior CVD was defined as a 
history of myocardial infarction; stroke; or vascular surgery (including angioplasty) on coronary, carotid, 
abdominal aortic, or peripheral arteries, and prior CVA as history of cerebrovascular accident (stroke, or 
TIA), both based on the Rose questionnaire. Cognitive impairment was measured using the Mini-Mental 
State Examination (MMSE). Five participants had a MMSE score of 22 or 23 (MCI) and none had 
dementia Medication use was assessed in a medication interview where generic name, dose, and 
frequency were registered. 
 
Laboratory assessments. Plasma glucose is measured with a standard enzymatic hexokinase reference 
method, and serum total cholesterol, HDL cholesterol, and triglycerides are measured with standard 
(enzymatic and/or colorimetric) methods by an automatic analyzer (until 9 May 2012: Beckman Synchron 
LX20, Beckman Coulter Inc., Brea, USA; after 9 May 2012: Cobas 6000, Roche diagnostics, Mannheim, 
Germany). When appropriate LDL cholesterol is calculated according to the Friedewald formula (2). 
HbA1c is measured with ion-exchange high performance liquid chromatography (HPLC) (Variant tm II, 
Bio-Rad, Hercules, California, USA).  
 
Physical examination. Weight and height are measured without shoes and wearing light clothing using a 
scale and stadiometer to the nearest 0.5 kg or 0.1 cm (Seca, Hamburg, Germany). Waist circumference is 
measured with a flexible plastic tape measure (Seca, Hamburg, Germany) in a duplicate midway between 
the lower rib margin and the iliac crest at the end of expiration, to the nearest 0.5 cm. 
 
Blood pressure. Office blood pressure is determined three times on the right arm after a 10-minute rest 
period, using a non-invasive blood pressure monitor (Omron 705IT, Japan). When the difference 
between measurement two and three is more than 10mmHg, a fourth measurement is performed. All 
available measurements are used to calculate the average blood pressure. Ambulatory 24-h blood 
pressure (WatchBP O3, Microlife, Switzerland, respectively) is measured at the non-dominant arm, using 
an ambulatory device that is programmed to take blood pressure readings every 15 minutes from 8.00 – 
23.00 and every 30 minutes from 23.00 – 8.00. 
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3 Additional analyses 
With regard to the node degree analyses, the associations of prediabetes and type 2 diabetes, remained 
unchanged when substituting office systolic blood pressure for 24- hour ambulatory systolic blood 
pressure (24-hour ambulatory blood pressure was available in n=1888 individuals; Supplementary Table 
6) or substituting BMI for waist circumference (Supplementary Table 7), or further adjustment for 
lifestyle factors, i.e., smoking status, alcohol use, physical activity, and diet score (data available for 
n=1825, Supplementary Table 8). Furthermore, in the analyses of graph measures, the association of 
prediabetes and type 2 diabetes remained also unchanged when substituting office systolic blood 
pressure for 24- hour ambulatory systolic blood pressure (24-hour ambulatory blood pressure was 
available in n=1888 individuals; Supplementary Table 9) or substituting BMI for waist circumference 
(Supplementary Table 10), or further adjustment for lifestyle factors (data available for n=1825, 
Supplementary Table 10).  
Commentary on Supplementary Figure 2 
We want to emphasize that we depicted the normalized graph measures in the figure. These normalized 
graph measured show a different behavior with varying sparsity values compared to the not normalized 
graph measures, and are more different to interpret. However, normalization is necessary for 
comparisons between groups (3). In more detail: Normalized clustering coefficient increased with 
sparsity, with the removal of connections at increasing sparsity, the proportion of connections between 
the nodes within its neighborhood divided by the number of connections that theoretically could exist 
between them, will decrease. However, since the clustering coefficient is normalized to a random 
network, for which the proportional decrease is larger, the normalized clustering coefficient thus 
increases at increasing sparsity (this was also found in the study of van Wijk et al. (4)). The normalized 
local efficiency is related to the normalized clustering coefficient, and will therefore show the same 
behavior. Since the connection-weights represent tract volumes, and since the structural connections 
taken into account are mostly short (intra-hemispheric) tracts with a small volume, the structural global 
efficiency is calculated using low connection strengths that increases with sparsity. 
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   3 Supplementary Figures 
 
Supplementary Figure 3.1: Flowchart of the study population. The time lag between baseline assessment 
and MRI was 2.3±1.3 years (mean ± standard deviation). 




Supplementary Figure 3.2: Normalized graph measures over a range a sparsity values for participants 
with type 2 diabetes, prediabetes, and NGM. SEM = standard error of mean.= sparsity values analyzed. 
All graph measures were normalized to random networks (see additional comment in the Supplementary 
Material on page 3). * = p-value<0.05, red for type 2 diabetes compared to NGM and green for 
prediabetes compared to NGM. (A) Clustering coefficient. (B) Communicability. (C) Global efficiency, and 
(D) Local efficiency. 
 
 
Supplementary Figure 3.3: Schematic representation of connections between the atlas regions which had 
a significantly different tract volume for (A) higher age, and (B) in type 2 diabetes compared to NGM. 
Blue lines indicate connections with significantly lower tract volumes (unstandardized β<0), and red lines 
with significantly higher tract volumes (unstandardized β>0). For the comparison of type 2 diabetes with 
normal aging only the 100 connections with the lowest p-values (all p-values were<0.05) were visualized. 
Darker blue or red lines indicate lower p-values.  
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   3 Supplementary Tables 
Supplementary Table 3.1: General characteristics of the study population with and without brain MRI 
data. 
Characteristic  Study population 
(n=2219) 




Demographics    
Age (years) 59.3±8.2 60.6±8.3 <0.001 
Sex, male (%) 51.5 51.3 0.905 
Education level (%), Low/Middle/High 30.2/29.0/40.7 39.7/26.8/33.5 <0.001 
Glucose metabolism    
Type 2 diabetes (%) 23.0 37.7 <0.001 
Fasting blood glucose (mmol/l) 5.9±1.5 6.5±2.2 <0.001 
2h post-load glucose (mmol/l) 7.5±4.0 8.8±4.6 <0.001 
HbA1c (%) 5.8±0.8 6.2±1.1 <0.001 
HbA1c (mmol/mol) 40.0±8.9 43.9±12.0 <0.001 
Diabetes duration* (years) 6.9±7.2 7.3±1.1 0.449 
Cardiovascular risk factors    
BMI (kg/m2) 26.6±4.2 27.9±5.1 <0.001 
Waist circumference (cm) 94.5±12.8 98.5±15.1 <0.001 
Office systolic blood pressure (mmHg) 133±17 137±20 <0.001 
Office diastolic blood pressure (mmHg)  76±10 76±10 0.320 
Hypertension, yes (%) 52.1 61.0 <0.001 
Total cholesterol (mmol/L)  5.3±1.1 5.0±1.2 <0.001 
HDL cholesterol (mmol/L) 1.6±0.5 1.5±0.5 <0.001 
LDL cholesterol (mmol/L) 3.2±1.0 2.9±1.0 <0.001 
Triglyceride levels (mmol/L) 1.4±0.8 1.5±0.9 <0.001 
Total cholesterol-to-HDL-ratio  3.7±1.2 3.7±1.2 0.283 
History of cardiovascular disease, yes (%) 12.1 25.1 <0.001 
Medication use    
Insulin use, yes (%)* 19.6 33.8 <0.001 
Antihypertensive medication, yes (%) 34.9 49.2 <0.001 
Lipid-modifying medication, yes (%) 30.7 47.0 <0.001 
Lifestyle factors    
Alcohol consumption (%), None/Low/High 17.1/55.9/27.9 21.3/54.6/24.1 0.003 
<0.001 Smoking status (%), Never/Former/Current 37.4/50.8/11.8 29.3/53.1/17.7 
Cognitive score    
MMSE total score 29.0±1.2 28.7±1.4 <0.001 
Data are presented as means ± standard deviation or percentage, and stratified for availability of MRI data. 
HbA1c indicates hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MMSE, Mini-
Mental State Examination. *Available in type 2 diabetes individuals. 
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3 Supplementary Table 3.2: Associations of prediabetes and type 2 diabetes with node degree. 
 Prediabetes Type 2 diabetes Ptrend 
Node degree  standardized β (95% CI) standardized β (95% CI)  
Unthresholded network    
Model 1 -0.044 (-0.164, 0.076) -0.111 (-0.220, -0.002) 0.047 
Model 2 -0.060 (-0.183, 0.063) -0.151 (-0.280, -0.022) 0.022 
NGM-based network    
Model 1 -0.066 (-0.181, 0.048) -0.296 (-0.400, -0.191) <0.001 
Model 2 -0.055 (-0.172, 0.062) -0.256 (-0.379, -0.133) <0.001 
Type 2 diabetes-based network    
Model 1 -0.055 (-0.174, 0.064) -0.135 (-0.243, -0.027) 0.015 
Model 2 -0.071 (-0.193, 0.050) -0.168 (-0.296, -0.040) 0.010 
Associations of prediabetes and type 2 diabetes with node degree, with NGM as reference. Regression 
coefficients and 95% CI indicate the mean difference in node degree of participants with prediabetes or type 2 
diabetes compared with NGM. Model 1: Adjusted for age, sex, education, and MRI date. Model 2: Model 1 + 
additionally adjusted for BMI, office systolic blood pressure, total cholesterol-to-HDL-ratio, antihypertensive 
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3 Supplementary Table 3.5: Relative change for (pre)diabetes and age in node degree. 
  Node degree*  
  standardized β (95%) p-value 
Model 1† Prediabetes -0.024 (-0.065, 0.017) 0.258 
 Type 2 diabetes -0.134 (-0.181, -0.086) <0.001 













  10.4 years  
Model 2‡ Prediabetes -0.020 (-0.061, 0.022) 0.357 
 Type 2 diabetes -0.116 (-0.171, -0.060) <0.001 













  9.7 years  
*Node degree for entire dataset (n=2219), calculated in NGM-based standard network. 
 †Additionally adjusted for sex, education, and MRI date. ‡Model 1 + additionally adjusted  
for BMI, office systolic blood pressure, total-cholesterol-to-HDL-ratio, antihypertensive  
medication, lipid-lowering medication, history of cardiovascular disease. Bold values = p<0.05. 
 
Supplementary Table 3.6: Associations of prediabetes and type 2 diabetes with node degree, with 
replacement of office by 24-h systolic ambulatory blood pressure in regression models. 
 Prediabetes Type 2 diabetes Ptrend 
Node degree  standardized β (95% CI) standardized β (95% CI)  
Unthresholded network    
Model 1 -0.058 (-0.189, 0.072) -0.169 (-0.287, -0.051) 0.005 
Model 2 -0.078 (-0.211, 0.055) -0.234 (-0.371, -0.097) 0.001 
NGM-based network    
Model 1 -0.068 (-0.194, 0.058) -0.279 (-0.393, -0.166) <0.001 
Model 2 -0.063 (-0.192, 0.065) -0.259 (-0.392, -0.127) <0.001 
Type 2 diabetes-based network    
Model 1 -0.057 (-0.189, 0.074) -0.150 (-0.269, -0.032) 0.013 
Model 2 -0.077 (-0.211, 0.057) -0.201 (-0.340, -0.063) 0.004 
Associations of prediabetes and type 2 diabetes with node degree, with NGM as reference. Regression 
coefficients and 95% CI indicate the mean difference in node degree of participants with prediabetes or type 2 
diabetes compared with NGM. Model 1: Adjusted for age, sex, education, and MRI date. Model 2: Model 1 + 
additionally adjusted for BMI, 24-h systolic ambulatory blood pressure, total cholesterol-to-HDL-ratio, 
antihypertensive medication, lipid-lowering medication, history of cardiovascular disease. Data were available 




   3 Supplementary Table 3.7: Associations of prediabetes and type 2 diabetes with node degree, with 
replacement of BMI by waist circumference in regression models. 
 Prediabetes Type 2 diabetes Ptrend 
Node degree  standardized β (95% CI) standardized β (95% CI)  
Unthresholded network    
Model 1 -0.043 (-0.163, 0.077) -0.111 (-0.220, -0.002) 0.047 
Model 2 -0.054 (-0.177, 0.069) -0.139 (-0.270, -0.009) 0.037 
NGM-based network    
Model 1 -0.066 (-0.181, 0.049) -0.296 (-0.400, -0.191) <0.001 
Model 2 -0.055 (-0.172, 0.062) -0.256 (-0.380, -0.131) <0.001 
Type 2 diabetes-based network    
Model 1 -0.054 (-0.173, 0.065) -0.135 (-0.243, -0.027) 0.015 
Model 2 -0.070 (-0.192, 0.052) -0.168 (-0.295, -0.037) 0.012 
Associations of prediabetes and type 2 diabetes with node degree, with NGM as reference. Regression 
coefficients and 95% CI indicate the mean difference in node degree of participants with prediabetes or type 2 
diabetes compared with NGM. Model 1: Adjusted for age, sex, education, and MRI date. Model 2: Model 1 + 
additionally adjusted for waist circumference, office systolic blood pressure, total cholesterol-to-HDL-ratio, 
antihypertensive medication, lipid-lowering medication, history of cardiovascular disease. Data were available 
in n=2218 individuals (type 2 diabetes/prediabetes/NGM, 510/348/1360, respectively). Bold values = p<0.05. 
 
Supplementary Table 3.8: Associations of prediabetes and type 2 diabetes with node degree, additionally 
adjusted for lifestyle factors. 
 Prediabetes Type 2 diabetes Ptrend 
Node degree  standardized β (95% CI) standardized β (95% CI)  
Unthresholded network    
Model 1 -0.009 (-0.139, 0.120) -0.126 (-0.246, -0.006) 0.054 
Model 2 -0.030 (-0.162, 0.103) -0.179 (-0.321, -0.037) 0.020 
Model 3 -0.027 (-0.160, 0.106) -0.174 (-0.318, -0.031) 0.026 
NGM-based network    
Model 1 -0.066 (-0.188, 0.055) -0.320 (-0.433, -0.207) <0.001 
Model 2 -0.047 (-0.171, 0.078) -0.264 (-0.397, -0.130) <0.001 
Model 3 -0.041 (-0.165, 0.084) -0.253 (-0.388, -0.118) 0.001 
Type 2 diabetes-based network    
Model 1 -0.035 (-0.163, 0.093) -0.168 (-0.287, -0.049) 0.008 
Model 2 -0.048 (-0.179, 0.083) -0.188 (-0.329, -0.047) 0.012 
Model 3 -0.044 (-0.175, 0.087) -0.176 (-0.318, -0.034) 0.020 
Associations of prediabetes and type 2 diabetes with node degree, with NGM as reference. Regression 
coefficients and 95% CI indicate the mean difference in node degree of participants with prediabetes or type 2 
diabetes compared with NGM. Model 1: Adjusted for age, sex, education, and MRI date. Model 2: Model 1 + 
additionally adjusted for BMI, office systolic blood pressure, total cholesterol-to-HDL-ratio, antihypertensive 
medication, lipid-lowering medication, history of cardiovascular disease. Model 3: Model 2 + additionally 
adjusted for smoking status, alcohol use, physical activity and diet score. Bold values = p<0.05. Physical activity 
and diet score data were available in n=1825 individuals (388/294/1143 for type 2 diabetes/prediabetes/NGM, 
respectively). 
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3 Supplementary Table 3.9: Associations of prediabetes and type 2 diabetes with graph network measures 
at a sparsity value of 0.8, with replacement of office by 24-h systolic ambulatory blood pressure in 
regression models. 
 Prediabetes* P Type 2 diabetes† P 
Normalized graph measures, β (95% CI) 
Clustering coefficient     
Model 1 -0.110 (-0.210, -0.009) 0.032 -0.036 (-0.128, 0.056) 0.448 
Model 2 -0.085 (-0.188, 0.017) 0.103 0.024 (-0.083, 0.131) 0.665 
Global efficiency     
Model 1 0.015 (-0.117, 0.147) 0.820 -0.071 (-0.188, 0.046) 0.235 
Model 2 0.028 (-0.107, 0.163) 0.683 -0.021 (-0.158, 0.116) 0.762 
Local efficiency     
Model 1 -0.093 (-0.175, -0.011) 0.027 -0.050 (-0.126, 0.025) 0.191 
Model 2 -0.073 (-0.157, 0.011) 0.087 0.012 (-0.076, 0.099) 0.794 
Communicability     
Model 1 0.032 (-0.097, 0.162) 0.622 0.165 (0.048, 0.282) 0.006 
Model 2 0.047 (-0.086, 0.179) 0.490 0.173 (0.037, 0.310) 0.013 
*Prediabetes-based standard network. †Type 2 diabetes-based standard network. Associations of prediabetes and type 
2 diabetes with graph measures. Regression coefficients and 95% CI indicate mean difference in clustering coefficient, 
global efficiency, local efficiency, and communicability of participants with prediabetes or type 2 diabetes compared 
with NGM. Model 1: Adjusted for age, sex, education, node degree, and MRI date. Model 2: additionally adjusted for 
BMI, 24-h systolic ambulatory blood pressure, total cholesterol-to-HDL-ratio, antihypertensive medication, lipid-
lowering medication, history of cardiovascular disease. Data were available in n=1888 individuals (type 2 
diabetes/prediabetes/NGM, 437/293/1158, respectively). Bold values p<0.05. 
 
Supplementary Table 3.10: Associations of prediabetes and type 2 diabetes with graph network 
measures at a sparsity value of 0.8, with replacement of BMI by waist circumference in regression 
models. 
 Prediabetes* P Type 2 diabetes† P 
Normalized graph measures, β (95% CI) 
Clustering coefficient     
Model 1 -0.092 (-0.185, 0.000) 0.050 -0.025(-0.112, 0.061) 0.562 
Model 2 -0.067 (-0.162, 0.028) 0.168 0.035 (-0.067, 0.137) 0.500 
Global efficiency     
Model 1 0.030 (-0.091, 0.151) 0.624 -0.069 (-0.178, 0.040) 0.212 
Model 2 0.049 (-0.076, 0.173) 0.445 -0.014 (-0.144, 0.116) 0.836 
Local efficiency     
Model 1 -0.082 (-0.157, -0.006) 0.034 -0.045 (-0.116, 0.025) 0.208 
Model 2 -0.057 (-0.135, 0.020) 0.148 0.022 (-0.062, 0.105) 0.615 
Communicability     
Model 1 0.029 (-0.090, 0.147) 0.475 0.146 (0.039, 0.253) 0.008 
Model 2 0.035 (-0.087, 0.157) 0.577 0.154 (0.026, 0.282) 0.018 
*Prediabetes-based standard network. †Type 2 diabetes-based standard network. Associations of prediabetes and type 
2 diabetes with graph measures. Regression coefficients and 95% CI indicate mean difference in clustering coefficient, 
global efficiency, local efficiency, and communicability of participants with prediabetes or type 2 diabetes compared 
with NGM. Model 1: Adjusted for age, sex, education, node degree, MRI date. Model 2: additionally adjusted for waist 
circumference, office systolic blood pressure, total cholesterol-to-HDL-ratio, antihypertensive medication, lipid-
lowering medication, history of cardiovascular disease. Data were available in n=2218 individuals (type 2 




   3 Supplementary Table 3.11: Associations of prediabetes and type 2 diabetes with graph network 
measures at a sparsity value of 0.8, additionally adjusted for lifestyle factors. 
 Prediabetes* P Type 2 diabetes† P 
Normalized graph measures, β (95% CI) 
Clustering coefficient     
Model 1 -0.077 (-0.177, 0.023) 0.130 -0.014 (-0.109, 0.081) 0.771 
Model 2 -0.047 (-0.150, 0.056) 0.371 0.046 (-0.066, 0.158) 0.425 
Model 3 -0.049 (-0.152, 0.054) 0.349 0.034 (-0.079, 0.146) 0.560 
Global efficiency     
Model 1 0.023 (-0.107, 0.152) 0.733 -0.042 (-0.161, 0.077) 0.490 
Model 2 0.021 (-0.113, 0.155) 0.755 -0.014 (-0.155, 0.128) 0.847 
Model 3 0.023 (-0.111, 0.157) 0.737 -0.015 (-0.157, 0.128) 0.839 
Local efficiency     
Model 1 -0.072 (-0.154, 0.009) 0.083 -0.039 (-0.117, 0.039) 0.326 
Model 2 -0.048 (-0.132, 0.036) 0.259 0.017 (-0.075, 0.109) 0.712 
Model 3 -0.049 (-0.133, 0.035) 0.252 0.010 (-0.082, 0.103) 0.828 
Communicability     
Model 1 0.082 (-0.046, 0.211) 0.208 0.171 (0.052, 0.290) 0.005 
Model 2 0.103 (-0.030, 0.235) 0.128 0.199 (0.059, 0.340) 0.005 
Model 3 0.097 (-0.036, 0.229) 0.154 0.184 (0.042, 0.326) 0.011 
*Prediabetes-based standard network. †Type 2 diabetes-based standard network. Associations of prediabetes and type 
2 diabetes with graph measures. Regression coefficients and 95% CI indicate the mean difference in clustering 
coefficient, global efficiency, local efficiency, and communicability of participants with prediabetes or type 2 diabetes 
compared with NGM. Model 1: Adjusted for age, sex, education, node degree, and MRI date. Model 2: Model 1 + 
additionally adjusted for BMI, office systolic blood pressure, total cholesterol-to-HDL-ratio, antihypertensive 
medication, lipid-lowering medication, history of cardiovascular disease. Model 3: Model 2 + additionally adjusted for 
smoking status, alcohol use, physical activity, and diet score. Bold values = p<0.05. Physical activity and diet score data 
were available in n=1825 individuals (388/294/1143 for type 2 diabetes/prediabetes/NGM, respectively). 
 
Supplementary Table 3.12: Additional clinical characteristics of participants according to glucose 
metabolism status. 
Characteristic  NGM Prediabetes Type 2 diabetes Ptrend 
 (n = 1361) (n = 348) (n = 510)  
Cardiovascular risk factors     
24-h ambulatory systolic BP (mmHg)* 118±11 121±12 123±11 <0.001 
24-h ambulatory diastolic BP (mmHg)* 75±7 76±7 74±7 0.114 
Total cholesterol (mmol/L)  5.6±1.0 5.5±1.1 4.5±1.0 <0.001 
HDL cholesterol (mmol/L) 1.7±0.5 1.5±0.4 1.3±0.4 <0.001 
LDL cholesterol (mmol/L) 3.4±0.9 3.3±1.0 2.4±0.9 <0.001 
Triglyceride levels (mmol/L) 1.2±0.7 1.6±1.0 1.7±1.0 <0.001 
Lifestyle factors     
Physical activity (hours/week)† 15.2±8.1 14.4±7.7 12.1±7.1 <0.001 
Diet (Greek Mediterranean diet score, 1-9)‡ 4.6±1.7 4.5±1.7 4.1±1.6 <0.001 
Data are presented as means ± standard deviation or percentage, and stratified for glucose metabolism status: normal 
glucose metabolism (NGM), prediabetes, and type 2 diabetes. P-values indicate trend analysis over glucose 
metabolism status. BP indicates blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein. *24-h 
ambulatory blood pressure data was available in n=1888. †Physical activity data was available in n=1969. ‡Diet score 
was available in n=2104. Detailed protocols of the general measurements are presented in the supplementary 
material. 
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We assessed whether objectively measured low- and high-intensity physical activity (LPA and HPA) and 
sedentary time (ST) were associated with white matter connectivity, both throughout the whole brain, 
and in brain regions involved in motor function. 
Methods 
In the large population-based Maastricht Study (n=1715, age 59.6±8.1 (mean ± standard deviation) years, 
and 48% woman), the amounts of LPA, HPA, and ST were objectively measured during 7 days by an 
activPAL accelerometer. In addition, using 3T structural and diffusion MRI, we calculated whole brain 
node degree, and node degree of the basal ganglia and primary motor cortex. Multivariable linear 
regression analysis was performed and we report standardized regression coefficients (stβ) adjusted for 
age, sex, education level, wake time, diabetes status, BMI, office systolic blood pressure, 
antihypertensive medication, total-cholesterol-to-HDL-cholesterol ratio, and lipid-modifying medication, 
alcohol use, smoking status, and history of cardiovascular disease. 
Results  
Lower HPA was associated with lower whole brain node degree after full adjustment (stβ [95%CI]=-0.062 
[-0.101, -0.013]; p=0.014), whereas lower LPA (stβ [95%CI]=-0.013 [-0.061, 0.034]; p=0.580) and higher ST 
(stβ [95%CI]=-0.030 [-0.081, 0.021]; p=0.250) were not. In addition, lower HPA was associated with lower 
node degree of the basal ganglia after full adjustment (stβ [95%CI]=-0.070 [-0.121, -0.018]; p=0.009).  
Conclusions  
Objectively measured lower HPA, but not lower LPA and higher ST, were associated with lower whole 
brain node degree and node degree in specific brain regions highly specialized in motor function. Further 
research is needed to establish whether more HPA may preserve structural brain connectivity.  
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   4 Introduction  
It is increasingly acknowledged that low physical activity is not only harmful for general health (1), but 
also for the brain (2-4). In addition, sedentary behavior, which is a risk factor independent of physical 
activity, may also be associated with cognitive decline (5, 6). However, how both physical activity and 
sedentary behavior exactly affect early changes in brain function is not yet clear. 
A growing body of evidence shows a clear association between low physical activity and 
sedentary behavior and structural brain changes, such as brain atrophy (7-10) and cerebral small vessel 
disease (cSVD) (11) at the population level. However, both atrophy and cSVD are likely to represent 
irreversible damage, while novel markers of early reversible brain changes may be available. Previous 
studies have indicated that the structural organization of brain networks, also named connectivity, may 
represent such a marker, which is also affected in dementia (12). However, data on the association 
between physical activity and structural brain networks are scarce (13), while the association of 
sedentary behavior and structural brain networks have not been reported yet.  
In this study, we hypothesize that both whole brain structural organization of brain networks 
and the organization of specific regions involved in motor function, as the basal ganglia and the primary 
motor cortex (14), are affected by low physical activity and high levels of sedentary time. Therefore, we 
assessed the association of objectively measured low- and high-intensity physical activity and sedentary 
time with both whole brain and regional white matter structural connectivity within the population-
based Maastricht Study. 
Research Design and Methods 
The Maastricht Study: population and design 
We used data from The Maastricht Study, an observational prospective population-based cohort study. 
The rationale and methodology have been described previously (15). In brief, the study focuses on the 
etiology, pathophysiology, complications, and comorbidities of type 2 diabetes mellitus (T2DM), and is 
characterized by an extensive phenotyping approach. Eligible for participation were all individuals aged 
between 40 and 75 years and living in the southern part of the Netherlands. Participants were recruited 
through mass media campaigns and from the municipal registries and the regional Diabetes Patient 
Registry via mailings. Recruitment was stratified according to known T2DM status, with an oversampling 
of individuals with T2DM, for reasons of efficiency. The present report considered cross-sectional data 
from the first 3451 participants, who completed the baseline survey between November 2010 and 
September 2013. The examinations of each participant were performed within a time window of three 
months [Supplementary Figure 4.1]. MRI measurements were implemented from December 2013 
onwards until February 2017 and were available in 2318 out of 3451 participants. Of the 2318 
participants with MRI measurements available, 2302 participants had complete data without artifacts, 
and 1715 participants of those also had objectively measured physical activity data available [Flowchart 
in Supplementary material Figure 4.2]. The study has been approved by the institutional medical ethical 
committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 
131088-105234-PG). All participants gave written informed consent.  
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4 Physical activity and sedentary time measures 
Daily activity levels were measured using the activPAL3™ physical activity monitor (PAL Technologies, 
Glasgow, UK). This device is a small (53 × 35 × 7 mm), lightweight (15 g) triaxial accelerometer that 
records movement in the vertical, anterio-posterior and mediolateral axes, and also determines posture 
(sitting or lying, standing and stepping) based on acceleration information. The device was attached 
directly to the skin on the front of the right thigh with (transparent 3M Tegaderm™) tape, after the 
device had been waterproofed using a nitrile sleeve. Participants were asked to wear the accelerometer 
for 8 consecutive days, without removing it at any time. To avoid inaccurately identifying non-wear time, 
participants were asked not to replace the device once removed. The method for determining the 
waking time has been described elsewhere (16). Data were uploaded using the activPAL software and 
processed using customized software (MATLAB R2013b, MathWorks, Natick, MA, USA). Data from the 
first day were excluded from the analysis because participants performed physical function tests at the 
research center after the device was attached. In addition, data from the final wear day providing ≤14 
waking hours of data were excluded from the analysis. Participants were included if they provided at 
least one valid day (≥10 h of waking data). 
The total amount of stepping time was based on the stepping posture, and calculated as the 
mean time spent in that position during waking time per day (17). The total stepping time was further 
classified into high-intensity physical activity (HPA, minutes with a step frequency >110 steps/min during 
waking time) (18) and low-intensity physical activity (LPA, minutes with a step frequency ≤110 steps/min 
during waking time). In this study, we aimed to identify risk factors for brain alterations. As physical 
activity may be protective and sedentary time a risk, we choose to consider high physical inactivity (low 
physical activity) and high sedentary time as risk factors. Therefore we inversed the physical activity data 
(e.g., multiplied by -1, and used the inverse of total, low-intensity, and high-intensity physical activity was 
used in statistical analyses, to represent low physical activity levels. The total amount of sedentary time 
(ST) was based on the sedentary posture (sitting or lying), and calculated as the mean time spent in a 
sedentary position during waking time per day. 
For descriptive purposes, we present the data in Table 4.1 according to the recently published 
physical activity guidelines (19, 20). These guidelines both recommend at least 150 minutes of high-
intensity physical activity per week for considerable health benefits, including brain health. Participants 
that were compliant with these guidelines were indicated as the high HPA group, and those that were 
not compliant as the low HPA group. We used these categories to assess the reference networks for 
white matter integrity, to address potential differences in connectivity between active and inactive 
participants. 
Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) was performed on a 3T MRI scanner (MAGNETOM Prisma-fit Syngo 
MR D13D, Siemens Healthcare, Erlangen, Germany) by use of a 64-element head/neck coil for parallel 
imaging with an acceleration factor of two. A 3D T1-weighted magnetization prepared rapid acquisition 
gradient echo (MPRAGE) sequence (TR/TI/TE 2300/900/2.98 ms, 176 slices, 256x240 matrix size and 1.00 
mm cubic voxel size) was acquired for anatomic reference. Diffusion-weighted MRI (dMRI) data were 
acquired with a diffusion sensitized echo-planar imaging (EPI) sequence (TR/TE 6100/57 ms, 65 slices, 
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   4 100×100 matrix size, 2.00 mm cubic voxel size, and 64 diffusion sensitizing gradient directions (b=1200 
s/mm2)). In addition, three minimally-diffusion-weighted images (b=0 s/mm2) were acquired. 
Image preprocessing 
To define N=120 brain regions, the Automatic Anatomical Labeling (AAL2) atlas (21) was used. The atlas 
volumes of interest were transformed to diffusion image space for each individual subject. First, affine 
registrations of the dMRI image to the T1 image and of the T1 image to T1 Montreal Neurological 
Institute-152 standard space (22) were performed. These two transformations were combined and the 
inverse transformation matrix was applied to the AAL2 template. T1-weighted images were segmented 
by use of a certified (ISO13485:2012), automated method (which included visual inspection) (23, 24). T1-
weighted images were segmented into gray matter, white matter and cerebrospinal fluid volumes (1 
voxel = 1.00 mm3 = 0.001 ml) (23). Intracranial volume was calculated as the sum of gray matter, white 
and cerebrospinal fluid volumes. Total brain parenchyma volume was calculated as the sum of gray and 
white matter volumes. dMRI (pre)processing was performed with the diffusion MR Toolbox ExploreDTI 
version 4.8.6 (25). The main preprocessing steps were eddy current induced geometric distortions and 
head motion correction, and estimation of the diffusion tensor. After preprocessing, fiber orientation 
distributions (FOD) were estimated using constrained spherical deconvolution with a maximum harmonic 
degree of 8, which allows fiber tracking through regions with crossing fibers (26). Whole brain 
deterministic tractography was performed using FOD sampling (27) with a seed point resolution of 2 
mm3, a step size of 1 mm, and FOD and maximum deflection angle threshold of 0.1 and 30°, respectively. 
The next step was to perform connectivity analysis to obtain white matter tracts from and to all the AAL2 
brain regions. A previous study of our group confirmed the robustness of tract volume as a measure for 
the edge weighting (28), therefore, for each connection, the tract volume was calculated as the number 
of voxels visited by at least one tract between the areas concerned multiplied by the voxel volume (in 
mm3) (as previously described (29)). The obtained connectivity matrix with tract volumes was normalized 
to intracranial volume to reduce inter-subject variation (30). When regions were connected by only one 
or two streamlines, the corresponding tract volumes were removed from the connectivity matrix, as an 
additional noise filter.  
White matter networks 
Network analysis was performed using the Brain Connectivity Toolbox (version 2017-15-01) (31) in 
MATLAB (Release 2016a, The MathWorks, Inc., Natick, Massachusetts, United States). In this method, the 
brain was represented as a graph, which is a network of nodes (i.e., gray matter brain regions) connected 
by edges (i.e., white matter connections between brain regions). The node degree was calculated for 
each atlas region and the mean value was defined as the whole brain node degree, which is a measure 
for the average number of edges connected to a node. In a network with a high whole brain node 
degree, brain regions are connected to many other brain regions in the network (i.e., strong innervation). 
The sparsity of a network is the ratio of the number of missing connections in a network to the possible 
number of connections and is closely, but inversely, related to the node degree. The sparsity ranges from 
0 to 1, the higher the sparsity, the lower the density of the network (31). 
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activity and sedentary time. Note that these reference networks may differ per group comparison. The 
reference networks were proportionally thresholded to a sparsity of 0.80 (only the 20% connections with 
the highest occurrence in the individual connectivity matrices of the participants in that group), resulting 
in a weighted, undirected network with a sparsity close to the sparsity of the standard network (more 
detailed information can be found in the Supplementary Material). 
The first reference network was based on the high HPA group (participants who met the 
physical activity guidelines (19, 20), i.e., at least 150 minutes of high-intensity physical activity per week 
(21.4 minutes per day)). With regard to sedentary behavior, as mentioned above, the guidelines only 
advise reducing sitting without providing numbers. Therefore, the sedentary behavior reference network 
was based on the tertile of the participants with the lowest sedentary time (i.e., less than 512 minutes of 
sedentary time per day). Thereafter, we calculated the whole brain node degree for both reference 
networks. To investigate local connectivity changes we calculated the node degree for brain regions 
important for physical activity and motor functions (i.e., the basal ganglia (i.e., caudate nucleus, 
putamen, pallidum, and thalamus as defined by the AAL2 atlas) (Figure 4.1A)) and the primary motor 
cortex (Figure 4.1B), and for the four brain lobes (i.e., the frontal (without primary motor cortex), 
temporal, parietal, and occipital lobe). 
 
 
Figure 4.1: White matter tracts crossing the basal ganglia and primary motor cortex. Tracts crossing the 
basal ganglia (A1) are mainly projection fibers, and crossing the primary motor cortex (A2) pyramidal 
tracts (e.g., the cortico-spinal tract). Blue and red volumes indicate the locations of the basal ganglia (B1) 
and primary motor cortex (B2), respectively. The gray dots represent the centers of 120 atlas regions. 
Lines indicate connections from a subset of brain regions to these two volumes; the number of lines is 
equal to the node degree. 
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   4 General characteristics and covariates 
Educational level (low, intermediate, high), smoking status (never, current, former) and history of 
cardiovascular disease were assessed by questionnaires (33). Medication use was assessed in an 
interview where generic name, dose, and frequency were registered. We measured weight, height, BMI, 
waist circumference, blood pressure (measured in office [Omron 705IT, Japan]), and plasma lipid 
profile(33). 
Statistical analysis 
All statistical analyses were performed by use of the Statistical Package for Social Sciences (SPSS Statistics 
23.0, IBM, Chicago, IL, USA). Multivariable linear regression analysis was used to investigate the 
association of physical activity and sedentary behavior, with whole brain node degree, node degree of 
the basal ganglia (BG), and the primary motor cortex (PMC). Analyses were adjusted for potential 
confounders, notably age, sex, education level, MRI lag time, and wake time (model 1), additionally 
adjusted for diabetes status (model 2), and additionally adjusted for cardiovascular risk factors: BMI, 
office systolic blood pressure, antihypertensive medication, total-cholesterol-to-HDL-cholesterol ratio, 
and lipid-modifying medication, alcohol use, smoking status, and history of CVD (model 3). P-values <0.05 
were considered statistically significant. Interaction terms (e.g., HPA time*sex, and HPA time*diabetes) 
were incorporated in the regression models to test for interaction among, on the one hand, physical 
activity and sedentary time, and on the other hand, sex and diabetes status, on node degree. For 
interaction terms a P value ≤0.10 was considered statistically significant. 
Results 
General characteristics of the study population 
Table 4.1 shows the general characteristics of the study population stratified for low or high HPA. The 
study population consisted of 1715 participants, mean age was 59.6±8.1 years, and 48% were woman. 
The low HPA groups was older, had a higher BMI and waist circumference, more often had an adverse 
cardiovascular risk profile, and were more often smoker. Education levels did not differ significantly for 
individuals with different levels of physical activity [Table 4.1].  
 
  
Association of physical activity and sedentary time with structural brain networks 
85 
4 Table 4.1: General characteristics of participants stratified by low or high HPA measured by the ActivPAL.  







Demographics     
Age (years) 59.6±8.1 58.0±7.9 60.9±8.0 <0.001 
Sex, female (No. [%]) 830 [48.4] 447 [57.3] 383 [41.0] <0.001 









Cardiovascular risk factors     
BMI (kg/m2) 26.6±4.2 25.5±3.7 27.6±4.4 <0.001 
Waist circumference (cm) 94.4±12.7 89.8±11.0 98.2±12.8 <0.001 
Systolic blood pressure (mmHg) 134.0±17.3 131.8±16.9 135.8±17.4 <0.001 
Diastolic blood pressure (mmHg)  76.1±9.7 75.3±9.8 76.7±9.6 0.003 
T2DM (No. [% of T2DM]) 400 [23.6] 99 [12.9] 301 [32.6] <0.001 
Hypertension, yes (No. [%]) 914 [53.3] 345 [44.2] 569 [60.8] <0.001 
Total-to-HDL-cholesterol-ratio  3.6±1.1 3.3±1.0 3.7±1.2 <0.001 
History of CVD, yes (No. [%]) 218 [12.7] 57 [7.3] 161 [17.2] <0.001 
Medication use     
Diabetes medication, yes (No. [%]) 308 [18.0] 72 [9.2] 236 [25.2] <0.001 
Antihypertensive medication, yes (No. 
[%]) 
619 [36.1] 199 [25.6] 420 [44.9] 
<0.001 
Lipid-modifying medication, yes (No. 
[%]) 
540 [31.5] 178 [22.9] 362 [38.7] 
<0.001 
Lifestyle factors     


















Diet (Dutch Healthy Diet, 0-100)‡ 85.6±14.3 83.1±14.8 82.3±14.0 <0.001 
Total PA (min/day) 124±41 145±37 106±35 <0.001 
LPA (min/day) 100±33 106±31 95±34 <0.001 
HPA (min/day) 24±19 39±18 11±6 <0.001 
Sedentary time (min/day) 558±99 530±93 581±99 <0.001 
Wake time (min/day) 945±53 951±50 940±54 <0.001 
Cognitive score     
MMSE total score 29.0±1.2 29.2±1.1 28.9±1.2 <0.001 
Node degree     
Whole brain 20.9±0.8 21.1±0.7 20.8±0.8 <0.001 
Frontal lobe 17.8±0.9 17.9±0.9 17.7±1.0 <0.001 
Temporal lobe 19.8±0.9 19.9±0.8 19.7±0.9 <0.001 
Parietal lobe 20.3±0.8 20.3±0.8 20.4±0.9 0.150 
Occipital lobe 24.4±1.3 24.4±1.3 24.3±1.3 0.354 
Basal ganglia 42.0±2.0 42.3±2.0 41.8±2.0 <0.001 
Primary motor cortex 25.0±2.7 25.3±2.6 24.8±2.8 0.001 
Other     
MRI lag time (years) 2.0±1.2 2.0±1.2 2.1±1.2 0.097 
General characteristics of the study population were evaluated by ANOVA (continuous variables with a normal 
distribution) or χ2 tests (categorical variables). Data are presented as means ± standard deviation, or percentages for 
categorical variables. No. indicates number; PA. physical activity; T2DM, type 2 diabetes mellitus; HDL, high-density  
lipoprotein; CVD, cardiovascular disease; MMSE, Mini-Mental State Examination. High HPA was defined as at least 150 




   4 Table 4.2 shows the associations of physical activity and sedentary time with total brain volume 
and white matter volume. None of these associations remained significant after adjustment for 
demographics and cardiovascular risk factors. Participants without MRI or accelerometry data (N=1736) 
had a higher BMI, more often had T2DM, a history of CVD and mobility (Supplementary Table 4.1), 
compared with the study population.  
 
Table 4.2: Associations of subtypes of PA and ST with volumes of the total brain, and white matter. 
 Total brain volume  White matter volume  
LPA time (high to low) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.019 (-0.033, -0.006) 0.005 0.003 (-0.019, 0.025) 0.784 
Model 2 -0.012 (-0.025, 0.002) 0.092 0.011 (-0.012, 0.033) 0.353 
Model 3 -0.008 (-0.022, 0.005) 0.230 0.010 (-0.013, 0.033) 0.395 
HPA time (high to low) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.013 (-0.027, 0.001) 0.065 0.003 (-0.020, 0.026) 0.821 
Model 2 -0.005 (-0.019, 0.009) 0.506 0.011 (-0.013, 0.034) 0.365 
Model 3 -0.003 (-0.017, 0.011) 0.687 0.010 (-0.014, 0.034) 0.423 
     
Sedentary time (low to high) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.022 (-0.037, -0.008) 0.002 -0.008 (-0.032, 0.016) 0.492 
Model 2 -0.013 (-0.028, 0.001) 0.073 0.001 (-0.024, 0.025) 0.963 
Model 3 -0.010 (-0.024, 0.005) 0.200 0.001 (-0.024, 0.026) 0.944 
Associations between physical activity measures (minutes/day) with brain volumes.  
Regression coefficients and 95% CI indicate the mean difference in volume per SD  
Higher LPA, HPA or lower sedentary time. Model 1: Adjusted for age, sex,   
education level, MRI lag time, wake time, and ICV. Model 2: additionally adjusted for  
diabetes status. Model 3: additionally adjusted for BMI, systolic blood pressure,  
antihypertensive medication, total-to-HDL-cholesterol-ratio, lipid-modifying medication,  
smoking status, alcohol use, and history of cardiovascular disease. 
Figure 4.2 shows the node degree of the four lobes and specific motor regions for participants 
with high and low HPA. The low HPA group had a slightly, but significantly lower node degree of the 
frontal lobe (1.1%), temporal lobe (1.0%), basal ganglia (1.2%), and primary motor cortex (2.0%),  
compared to the high HPA group. The highest node degree was found in the basal ganglia, because these 
structures are centrally located in the brain and therefore connected to many other regions (Figure 4.1A 
and 4.1B).  




Figure 4.2: Boxplot for the node degree of the whole brain, the four lobes, and the motor regions of the 
brain for participants with high (dashed) and low HPA time. Note the different scale for the node degree 
of the basal ganglia (BG). 
Physical activity, sedentary behavior and whole brain node degree 
Table 4.3 shows the associations of physical activity and sedentary time with whole brain node degree. 
Lower levels of HPA and higher amount of sedentary time were associated with lower whole brain node 
degree in model 1. After adjustment for diabetes status, the association between sedentary time and 
whole brain node degree was attenuated (model 2). After full adjustment for cardiovascular risk factors, 




   4 Table 4.3: Associations of low and high-intensity physical activity time, and high sedentary time with 
whole brain node degree. 
 Whole brain node degree  
LPA time (high to low) stβ (95% CI) P-value 
Model 1 -0.035 (-0.081, 0.011) 0.137 
Model 2 -0.022 (-0.069, 0.025) 0.356 
Model 3 -0.013 (-0.061, 0.034) 0.580 
HPA time (high to low) stβ (95% CI) P-value 
Model 1 -0.081 (-0.128, -0.033) 0.001 
Model 2 -0.068 (-0.116, -0.021) 0.005 
Model 3 -0.062 (-0.112, -0.013) 0.014 
   
Sedentary time (low to high) stβ (95% CI) P-value 
Model 1 -0.052 (-0.101, -0.002) 0.039 
Model 2 -0.037 (-0.087, 0.013) 0.152 
Model 3 -0.030 (-0.081, 0.021) 0.250 
Associations of physical activity measures with whole brain node degree. 
Standardized regression coefficients and 95% CI indicate the mean difference in node 
degree per SD lower physical activity and higher sedentary time. Model 1: Adjusted for  
age, sex, education level, MRI lag time, and wake time. Model 2: additionally adjusted  
for diabetes status. Model 3: additionally adjusted for BMI, systolic blood pressure,  
antihypertensive medication, total-to-HDL-cholesterol-ratio, lipid-modifying 
medication, smoking status, alcohol use, and history of cardiovascular disease.  
Lower HPA was also associated with lower node degree of the temporal and frontal lobe in 
fully adjusted analyses, but not with node degree of the parietal and occipital lobe (Table 4.4). 
To put this into perspective, the difference in whole brain node degree associated with lower 
HPA time equivalent to one year of aging was 5.0 minutes less HPA time per day (Supplementary Table 
4.6). 
Physical activity, sedentary behavior and regional node degree 
Table 4.5 shows the associations of physical activity and sedentary time with specific node degree of the 
motor regions, i.e., the basal ganglia, and the primary motor cortex. Lower LPA and HPA, and higher 
sedentary time were associated with lower node degree of the basal ganglia (model 1). These 
associations remained statistically significant after adjustment for diabetes status, except for higher 
sedentary time (model 2). Lower HPA remained statistically significantly associated with lower node 
degree of the basal ganglia after additional adjustment for cardiovascular risk factors (model 3). Lower 
HPA was also associated with a lower node degree of the primary motor cortex in model 1, but this 
association attenuated after adjustment for diabetes status and other cardiovascular risk factors (model 
2 and 3). LPA and sedentary time were not associated with node degree of the primary motor cortex.  
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   4 Table 4.5: Associations of low- and high-intensity physical activity time, and high sedentary time with 




Primary Motor Cortex 
 
LPA time (high to low) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.067 (-0.116, -0.019) 0.006 -0.038 (-0.085, 0.010) 0.118 
Model 2 -0.053 (-0.102, -0.004) 0.032 -0.017 (-0.065, 0.031) 0.487 
Model 3 -0.049 (-0.098, 0.001) 0.056 -0.017 (-0.066, 0.032) 0.489 
HPA time (high to low) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.085 (-0.134, -0.035) 0.001 -0.052 (-0.101, -0.003) 0.037 
Model 2 -0.070 (-0.121, -0.020) 0.006 -0.030 (-0.079, 0.019) 0.232 
Model 3 -0.070 (-0.121, -0.018) 0.009 -0.035 (-0.086, 0.016) 0.178 
     
Sedentary time (low to high) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.052 (-0.103, 0.000) 0.049 -0.033 (-0.084, 0.017) 0.197 
Model 2 -0.034 (-0.087, 0.018) 0.203 -0.008 (-0.060, 0.044) 0.761 
Model 3 -0.029 (-0.082, 0.025) 0.295 -0.008 (-0.061, 0.045) 0.759 
Associations of physical activity measures with node degree of the basal ganglia and primary motor cortex. 
Regression coefficients and95% CI indicate the mean difference in node degree per SD lower physical activity 
and higher sedentary time. Model 1: Adjusted for wake time, age, sex, education level, MRI lag time. Model 2: 
additionally adjusted for diabetes status. Model 3: additionally adjusted for BMI, systolic blood pressure, 
antihypertensive medication, total-to-HDL-cholesterol-ratio, lipid-modifying medication, smoking status, 
alcohol use, and history of cardiovascular disease. 
Additional analyses 
Qualitatively similar associations of physical activity and sedentary time with node degree were observed 
in a range of additional analyses; when we used total PA (Supplementary Table 4.2), when we used PA 
data measured with questionnaires instead of accelerometry (Supplementary Table 4.3), when model 3 
was additionally adjusted for MRI quality, diet, (available in a smaller sample size), MMSE score , or white 
matter hyperintensity volume, and when we replaced BMI with waist circumference, or replaced office 
with 24h ambulatory blood pressure (available in a smaller sample size; Supplementary Table 4.4 and 
4.5). No interactions were observed with sex and diabetes status (Pinteraction>0.10 for all analyses). 
Discussion 
In this study, we found an association of lower HPA with lower whole brain node degree, independent of 
major demographic, cardiovascular and lifestyle risk factors. In other words, the difference in whole brain 
node degree associated with lower HPA time equivalent to one year of aging was 5.0 minutes less HPA 
time per day. LPA and ST were not significantly associated with whole brain node degree. In analyses on 
regional node degree, we found that lower HPA was associated with low node degree of the basal 
ganglia, but not of the primary motor cortex, independent of major demographic, cardiovascular and 
lifestyle risk factors. LPA and sedentary time were not associated with markers of regional node degree.  
We found that objectively measured lower HPA was associated with lower whole brain node 
degree. Our finding is in agreement with, and extends a prior cross-sectional study, which observed an 
association between lower levels of self-reported physical activity and lower regional connectivity (nodal 
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organization (local efficiency). We also found an association of lower physical activity with lower node 
degree in the primary motor cortex (which is located in the frontal lobe), other motor regions (i.e., the 
basal ganglia), and in the frontal and temporal lobe (Table 4.4). However, we did not find such an 
association for the parietal lobe. Our findings are also in line with a study, where lower aerobic fitness 
has been associated with lower structural connectivity in multiple cortical areas involving frontal, 
temporal, and motor regions (34).  
We found no association of sedentary time with whole brain or regional node degree after 
adjustment for cardiovascular and lifestyle risk factors. This may mean that the association between 
sedentary time and regional connectivity is mediated by up or down stream factors like BMI, blood 
pressure, lipid profile, prior cardiovascular disease and/or lifestyle risk factors. In addition, our findings 
may indicate that potential prevention strategies for preservation of brain function on increasing physical 
activity, in particular HPA, may be more beneficial to the brain, as opposed to reduction of sedentary 
time. However, standardized regression coefficient were very similar for HPA and ST in model 1, which 
may indicate that the association between ST and connectivity is more strongly affected by mediating 
factors. Furthermore, reducing sedentary time might be easier to achieve, than engaging in HPA. 
Therefore, studies on sedentary time remain of high relevance for the development of easy applicable 
prevention strategies. In addition, our study population consists of relatively healthy participants, with 
adequate cognitive function and relatively low cerebral small vessel disease load (35). Therefore, 
analyses in more diseased populations may yield differential results.  
In general, physical activity periodically increases blood flow to the brain, resulting in increased 
vascularization of the brain, improved supply of nutrients and removal of metabolic waste. More 
specifically, higher levels of physical activity or cardiorespiratory fitness have been associated with an 
increase in cerebral perfusion and cerebral oxygen supply to the prefrontal cortex (36), which is an area 
involved in motor function (37). Higher levels of physical activity stimulate processes of neurogenesis 
(formation of new neurons) and angiogenesis (formation of blood vessels), and reduce inflammation 
(38). Furthermore, being physically active has been shown to reduce cardiovascular risk factors such as 
type 2 diabetes and hypertension through increasing neurotrophic factors, reducing oxidative stress, 
and/or reducing beta-amyloid formation (39). These mechanisms may reduce the incidence of mild 
cognitive impairment and dementia (2, 3).  
Strengths of this study are the large sample size, the population-based design, the objective 
measurement of physical activity and sedentary behavior, the extensive assessment of potential 
confounders which enabled us to substantially reduce potential residual confounding, and the broad 
array of additional analyses, which all gave consistent results. Furthermore, the use of diffusion MRI 
scans to study structural connectivity measures, enabled us to find more subtle brain alterations, as we 
did not find associations with brain volumes in this population. The large number of diffusion MRI scans, 
were semi-automatically processed blinded to group status, which ensures an objective analysis.  
There are also some limitations. First, the cross-sectional design of the study implies that any 
conclusion about causality should be made with caution. Further longitudinal studies and intervention 
trials may be prompted to investigate whether specific connectivity loss can be reversed or prevented by 
increasing high-intensity physical activity. Second, the study population was oversampled for type 2 
diabetes. However, analyses were adjusted for diabetes status, and no consistent interaction with 
diabetes status was observed. Third, participants with missing data had a more adverse cardiovascular 
risk profile, which might have led to an underestimation of our findings. Fourth, although we cannot 
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   4 exclude the possibility of residual confounding by variables not included in this study, we have adjusted 
for many known confounding factors, which may have resulted in overadjustment, and thus 
underestimate the association of physical activity and sedentary time with node degree.  
We showed that objectively measured lower HPA, but not LPA and ST, were associated with 
lower whole brain node degree and node degree in specific brain regions highly specialized in motor 
function. Further research is needed to establish whether more HPA may preserve structural brain 
connectivity. 
References  
1. Scherder EJA, Van Paasschen J, Deijen JB, Van Der Knokke S, Orlebeke JFK, Burgers I, Devriese PP, Swaab DF, 
Sergeant JA. Physical activity and executive functions in the elderly with mild cognitive impairment. Aging & 
Mental Health 2005;9(3):272-280. doi: 10.1080/13607860500089930 
2. Kennedy G, Hardman RJ, Macpherson H, Scholey AB, Pipingas A. How Does Exercise Reduce the Rate of Age-
Associated Cognitive Decline? A Review of Potential Mechanisms. Journal of Alzheimer's disease : JAD 
2017;55(1):1-18. doi: 10.3233/jad-160665 
3. Gallaway PJ, Miyake H, Buchowski MS, Shimada M, Yoshitake Y, Kim AS, Hongu N. Physical Activity: A Viable Way 
to Reduce the Risks of Mild Cognitive Impairment, Alzheimer's Disease, and Vascular Dementia in Older Adults. 
Brain Sci 2017;7(2). doi: 10.3390/brainsci7020022 
4. Mekari S, Dupuy O, Martins R, Evans K, Kimmerly DS, Fraser S, Neyedli HF. The effects of cardiorespiratory fitness 
on executive function and prefrontal oxygenation in older adults. GeroScience 2019;41(5):681-690. doi: 
10.1007/s11357-019-00128-5 
5. Wheeler MJ, Dempsey PC, Grace MS, Ellis KA, Gardiner PA, Green DJ, Dunstan DW. Sedentary behavior as a risk 
factor for cognitive decline? A focus on the influence of glycemic control in brain health. Alzheimer's & 
Dementia: Translational Research & Clinical Interventions 2017;3(3):291-300. doi: 
https://doi.org/10.1016/j.trci.2017.04.001 
6. Falck RS, Davis JC, Liu-Ambrose T. What is the association between sedentary behaviour and cognitive function? 
A systematic review. British journal of sports medicine 2017;51(10):800-811. doi: 10.1136/bjsports-2015-095551 
7. Doi T, Makizako H, Shimada H, Tsutsumimoto K, Hotta R, Nakakubo S, Park H, Suzuki T. Objectively measured 
physical activity, brain atrophy, and white matter lesions in older adults with mild cognitive impairment. 
Experimental gerontology 2015;62:1-6. doi: 10.1016/j.exger.2014.12.011 
8. Spartano NL, Davis-Plourde KL, Himali JJ, Andersson C, Pase MP, Maillard P, DeCarli C, Murabito JM, Beiser AS, 
Vasan RS, Seshadri S. Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain 
Volume: The Framingham Heart StudyAssociation of Accelerometer-Measured Light-Intensity Physical Activity 
With Brain VolumeAssociation of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume. 
JAMA Network Open 2019;2(4):e192745-e192745. doi: 10.1001/jamanetworkopen.2019.2745 
9. Hamer M, Sharma N, Batty GD. Association of objectively measured physical activity with brain structure: UK 
Biobank study. Journal of internal medicine 2018;284(4):439-443. doi: 10.1111/joim.12772 
10. Arnardottir NY, Koster A, Domelen DR, Brychta RJ, Caserotti P, Eiriksdottir G, Sverrisdottir JE, Sigurdsson S, 
Johannsson E, Chen KY, Gudnason V, Harris TB, Launer LJ, Sveinsson T. Association of change in brain structure to 
objectively measured physical activity and sedentary behavior in older adults: Age, Gene/Environment 
Susceptibility-Reykjavik Study. Behavioural brain research 2016;296:118-124. doi: 10.1016/j.bbr.2015.09.005 
11. Willey JZ, Moon YP, Paik MC, Yoshita M, Decarli C, Sacco RL, Elkind MS, Wright CB. Lower prevalence of silent 
brain infarcts in the physically active: the Northern Manhattan Study. Neurology 2011;76(24):2112-2118. doi: 
10.1212/WNL.0b013e31821f4472 
12. Tucholka A, Grau-Rivera O, Falcon C, Rami L, Sánchez-Valle R, Lladó A, Gispert JD, Molinuevo JL, Alzheimer’s 
Disease Neuroimaging I. Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: 
Association of physical activity and sedentary time with structural brain networks 
93 
4 Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau. Journal of Alzheimer's disease : JAD 2018;61(4):1575-1587. doi: 10.3233/JAD-170553 
13. Kim GH, Im K, Kwon H, Seo SW, Ye BS, Cho H, Noh Y, Lee JM, Kim ST, Park SE, Kim H, Hwang JW, Kang SJ, Jeong 
JH, Na DL. Higher Physical Activity Is Associated with Increased Attentional Network Connectivity in the Healthy 
Elderly. Frontiers in aging neuroscience 2016;8:198. doi: 10.3389/fnagi.2016.00198 
14. Brooks DJ. The role of the basal ganglia in motor control: contributions from PET. Journal of the neurological 
sciences 1995;128(1):1-13. doi: 10.1016/0022-510x(94)00206-4 
15. Schram MT, Sep SJ, van der Kallen CJ, Dagnelie PC, Koster A, Schaper N, Henry RM, Stehouwer CD. The 
Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its 
comorbidities. Eur J Epidemiol 2014;29(6):439-451. doi: 10.1007/s10654-014-9889-0 
16. van der Berg JD, Willems PJ, van der Velde JH, Savelberg HH, Schaper NC, Schram MT, Sep SJ, Dagnelie PC, Bosma 
H, Stehouwer CD, Koster A. Identifying waking time in 24-h accelerometry data in adults using an automated 
algorithm. Journal of sports sciences 2016;34(19):1867-1873. doi: 10.1080/02640414.2016.1140908 
17. van der Berg JD, Stehouwer CDA, Bosma H, van der Velde JHPM, Willems PJB, Savelberg HHCM, Schram MT, Sep 
SJS, van der Kallen CJH, Henry RMA, Dagnelie PC, Schaper NC, Koster A. Associations of total amount and 
patterns of sedentary behaviour with type 2 diabetes and the metabolic syndrome: The Maastricht Study. 
Diabetologia 2016;59(4):709-718. doi: 10.1007/s00125-015-3861-8 
18. Tudor-Locke C, Rowe DA. Using cadence to study free-living ambulatory behaviour. Sports medicine (Auckland, 
NZ) 2012;42(5):381-398. doi: 10.2165/11599170-000000000-00000 
19. Weggemans RM, Backx FJG, Borghouts L, Chinapaw M, Hopman MTE, Koster A, Kremers S, van Loon LJC, May A, 
Mosterd A, van der Ploeg HP, Takken T, Visser M, Wendel-Vos GCW, de Geus EJC. The 2017 Dutch Physical 
Activity Guidelines. The international journal of behavioral nutrition and physical activity 2018;15(1):58. doi: 
10.1186/s12966-018-0661-9 
20. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The Physical Activity 
Guidelines for Americans. Jama 2018;320(19):2020-2028. doi: 10.1001/jama.2018.14854 
21. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. 
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI 
MRI single-subject brain. Neuroimage 2002;15(1):273-289. doi: 10.1006/nimg.2001.0978 
22. Fonov V, Evans AC, Botteron K, Almli CR, McKinstry RC, Collins DL. Unbiased average age-appropriate atlases for 
pediatric studies. NeuroImage 2011;54(1):313-327. doi: https://doi.org/10.1016/j.neuroimage.2010.07.033 
23. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, Breteler MM, Niessen WJ. Multi-
spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification. NeuroImage 
2007;37(1):71-81. doi: 10.1016/j.neuroimage.2007.05.018 
24. de Boer R, Vrooman HA, van der Lijn F, Vernooij MW, Ikram MA, van der Lugt A, Breteler MM, Niessen WJ. White 
matter lesion extension to automatic brain tissue segmentation on MRI. NeuroImage 2009;45(4):1151-1161. doi: 
10.1016/j.neuroimage.2009.01.011 
25. Leemans A, Jeurissen B, Sijbers J, Jones D. ExploreDTI: a graphical toolbox for processing, analyzing, and 
visualizing diffusion MR data.  ISMRM 17th Scientific Meeting & Exhibition2009; p. 3537. 
26. Tournier JD, Calamante F, Connelly A. Determination of the appropriate b value and number of gradient 
directions for high-angular-resolution diffusion-weighted imaging. NMR in Biomedicine 2013;26(12):1775-1786. 
doi: 10.1002/nbm.3017 
27. Jeurissen B, Leemans A, Jones DK, Tournier J-D, Sijbers J. Probabilistic fiber tracking using the residual bootstrap 
with constrained spherical deconvolution. Human Brain Mapping 2011;32(3):461-479. doi: 10.1002/hbm.21032 
28. Vaessen MJ, Jansen JFA, Vlooswijk MCG, Hofman PAM, Majoie HJM, Aldenkamp AP, Backes WH. White Matter 
Network Abnormalities Are Associated with Cognitive Decline in Chronic Epilepsy. Cerebral Cortex 
2011;22(9):2139-2147. doi: 10.1093/cercor/bhr298 
29. Vergoossen LW, Schram MT, de Jong JJ, Stehouwer CD, Schaper NC, Henry RM, van der Kallen CJ, Dagnelie PC, 
van Boxtel MP, Eussen SJ, Backes WH, Jansen JF. White Matter Connectivity Abnormalities in Prediabetes and 
Type 2 Diabetes: The Maastricht Study. Diabetes care 2019:dc190762. doi: 10.2337/dc19-0762 
CHAPTER 4 
94 
   4 30. Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001;22(8):1483-1489.  
31. Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. NeuroImage 
2010;52(3):1059-1069. doi: 10.1016/j.neuroimage.2009.10.003 
32. de Reus MA, van den Heuvel MP. Estimating false positives and negatives in brain networks. NeuroImage 
2013;70:402-409. doi: 10.1016/j.neuroimage.2012.12.066 
33. Schram MT, Sep SJS, van der Kallen CJ, Dagnelie PC, Koster A, Schaper N, Henry RMA, Stehouwer CDA. The 
Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its 
comorbidities. European Journal of Epidemiology 2014;29(6):439-451. doi: 10.1007/s10654-014-9889-0 
34. Voss MW, Heo S, Prakash RS, Erickson KI, Alves H, Chaddock L, Szabo AN, Mailey EL, Wójcicki TR, White SM, 
Gothe N, McAuley E, Sutton BP, Kramer AF. The influence of aerobic fitness on cerebral white matter integrity 
and cognitive function in older adults: results of a one-year exercise intervention. Human brain mapping 
2013;34(11):2972-2985. doi: 10.1002/hbm.22119 
35. van Agtmaal MJM, Houben A, de Wit V, Henry RMA, Schaper NC, Dagnelie PC, van der Kallen CJ, Koster A, Sep SJ, 
Kroon AA, Jansen JFA, Hofman PA, Backes WH, Schram MT, Stehouwer CDA. Prediabetes Is Associated With 
Structural Brain Abnormalities: The Maastricht Study. Diabetes care 2018;41(12):2535-2543. doi: 10.2337/dc18-
1132 
36. Dupuy O, Gauthier CJ, Fraser SA, Desjardins-Crèpeau L, Desjardins M, Mekary S, Lesage F, Hoge RD, Pouliot P, 
Bherer L. Higher levels of cardiovascular fitness are associated with better executive function and prefrontal 
oxygenation in younger and older women. Frontiers in human neuroscience 2015;9(66). doi: 
10.3389/fnhum.2015.00066 
37. Goldman-Rakic PS. Motor control function of the prefrontal cortex. Ciba Found Symp 1987;132:187-200. doi: 
10.1002/9780470513545.ch12 
38. Trigiani LJ, Hamel E. An endothelial link between the benefits of physical exercise in dementia. Journal of 
Cerebral Blood Flow & Metabolism 2017;37(8):2649-2664. doi: 10.1177/0271678x17714655 
39. Zimmerman B, Sutton B, Low K, Fletcher M, Tan CH, Schneider-Garces N, Li Y, Ouyang C, Maclin E, Gratton G, 
Fabiani M. Cardiorespiratory fitness mediates the effects of aging on cerebral blood flow. Frontiers in aging 




Association of physical activity and sedentary time with structural brain networks 
95 
4 Supplementary Material 
1. Detailed protocols of the measurements performed within The Maastricht 
Study: 
Questionnaires. As described elsewhere (1), we used web-based questionnaires to obtain information 
regarding smoking status (never/former/current), alcohol consumption, educational level, physical 
activity, diet, prior CVD and cognitive impairment. Alcohol consumption was classified as none, low (1– 7 
glasses/wk for women and 1–14 glasses/wk for men) and high (> 7 glasses/wk for women and >14 
glasses/wk for men). Educational level was classified as low (no education, primary education, lower 
vocational education), intermediate (intermediate general secondary education, intermediate vocational 
education, higher general secondary education), or high (higher vocational education or university). Diet 
was assessed by a tailor-made FFQ developed by use of the National FFQ Tool. Prior CVD was defined as 
a history of myocardial infarction; stroke; or vascular surgery (including angioplasty) on coronary, carotid, 
abdominal aortic, or peripheral arteries based on the Rose questionnaire. Cognitive impairment was 
measured using the Mini-Mental State Examination (MMSE). Medication use was assessed in a 
medication interview where generic name, dose, and frequency were registered. Subjective physical 
activity was assessed by means of a modified version of the Champs questionnaire. 
 
Laboratory assessments. Plasma glucose is measured with a standard enzymatic hexokinase reference 
method, and serum total cholesterol, HDL cholesterol, and triglycerides are measured with standard 
(enzymatic and/or colorimetric) methods by an automatic analyzer (until 9 May 2012: Beckman Synchron 
LX20, Beckman Coulter Inc., Brea, USA; after 9 May 2012: Cobas 6000, Roche diagnostics, Mannheim, 
Germany). When appropriate LDL cholesterol is calculated according to the Friedewald formula(2). 
HbA1c is measured with ion-exchange high performance liquid chromatography (HPLC) (Variant tm II, 
Bio-Rad, Hercules, California, USA).  
 
Glucose metabolism status. To determine glucose metabolism status, all participants, except those who 
used insulin, underwent a standardized 2-h 75g oral glucose tolerance test (OGTT) after an overnight 
fast. For safety reasons, participants with a fasting glucose level above 11·0 mmol/L, as determined by a 
finger prick, did not undergo the OGTT. For these individuals, fasting glucose level and information about 
diabetes medication were used to determine glucose metabolism status. Glucose metabolism status was 
defined according to the WHO 2006 criteria into NGM, prediabetes, and T2DM(3). Participants were 
considered to have T2DM if they had a fasting blood glucose (FBG) ≥7.0 mmol/l, or a 2hr post-load blood 
glucose ≥11.1 mmol/l or used oral glucose-lowering medication or insulin, prediabetes if they had a FBG 
≥6.1 mmol/l and/or a 2hr post-load blood glucose ≥7.8 mmol/l, and NGM if they had a FBG <6.1 mmol/l, 
and a 2hr post-load blood glucose <7.8 mmol/l and no use of diabetes medication. Participants with type 
1 diabetes or other types of diabetes were excluded from the analysis. 
 
Physical examination. Weight and height are measured without shoes and wearing light clothing using a 
scale and stadiometer to the nearest 0.5 kg or 0.1 cm (Seca, Hamburg, Germany). Waist circumference is 
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   4 measured with a flexible plastic tape measure (Seca, Hamburg, Germany) in a duplicate midway between 
the lower rib margin and the iliac crest at the end of expiration, to the nearest 0.5 cm. 
 
Blood pressure. Office blood pressure is determined three times on the right arm after a 10-minute rest 
period, using a non-invasive blood pressure monitor (Omron 705IT, Japan). When the difference between 
measurement two and three is more than 10 mmHg, a fourth measurement is performed. All available 
measurements are used to calculate the average blood pressure. Ambulatory 24-h blood pressure 
(WatchBP O3, Microlife, Switzerland, respectively) is measured at the non-dominant arm, using an 
ambulatory device that is programmed to take blood pressure readings every 15 minutes from 8.00 – 23.00 
and every 30 minutes from 23.00 – 8.00. 
2. Detailed methods for calculation of reference networks and sparsity: 
In structural connectivity analysis, connectivity matrices are based on tractography. As a result, not all 
pairs of nodes will have white matter connections, which leads to ‘sparse’ connectivity matrices. The 
measure sparsity reflects the extent of a graph’s deviation from the corresponding fully connected graph. 
However, this differs between subjects and is also influenced by scan quality. Therefore, thresholding is 
applied, which ensures that each subject has the same number of nodes and edges. The reference 
network was calculated from all individual binarized connectivity matrices, for a specific subset of 
participants (e.g., the physical activity network was based on the participants who met the physical 
activity guidelines). This is illustrated in a simplified example, not a real network (Supplementary Figure 
4.3). First, all individual binarized connectivity matrices were summed (Step 1 in Supplementary Figure 
4.3). This reference network was proportionally thresholded to a sparsity of 0.80 (Step 2 in 
Supplementary Figure 4.3). This means that the 20% connections that were present in most of the 
participants were selected, in other words, the 20% of the nodes with the highest sum score. These 20% 
nodes were used to create a binary mask (Step 3 in Supplementary Figure 4.3) that was used to select for 
each participant a weighted, undirected network with a sparsity, close to the sparsity of the reference 
network (Step 4 in Supplementary Figure 4.3). The actual sparsity in the individuals is a bit higher than 
0.80, because not each individual has a white matter tract at each connection in the reference network. 
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Supplementary Figure 4.2: Flowchart of the study population.  
  







   4 Supplementary Tables 
Supplementary Table 4.1: General characteristics of participants stratified by availability of physical 
activity and/or brain MRI data.  
Characteristic  Total 
(n=3451) 
Physical activity and 
MRI data available 
(n=1715) 
Physical activity and/or 
MRI data not available 
(n=1736) 
P 
Demographics     
Age (years) 59.8±8.3 59.6±8.1 60.0±8.5 0.183 
Sex, female (%) 48.6 48.4 48.7 0.843 
Education level (%), 
Low/Middle/High 
33.6/28.2/38.2 30.5/29.0/40.5 36.6/27.5/35.9 <0.001 
Cardiovascular risk factors     
BMI (kg/m2) 27.1±4.6 26.6±4.2 27.5±4.8 <0.001 
Waist circumference (cm) 95.9±13.8 94.4±12.7 97.5±14.6 <0.001 
Systolic blood pressure 
(mmHg) 
135.1±18.2 134.0±17.3 136.1±19.0 0.001 
Diastolic blood pressure 
(mmHg)  
76.1±9.9 76.1±9.7 76.2±10 0.634 
T2DM (%) 23.0 23.7 20.9 <0.001 
Hypertension, yes (%) 56.4 53.3 59.4 <0.001 
Total cholesterol-to-HDL-
ratio  
3.6±1.2 3.6±1.1 3.9±1.3 <0.001 
History of CVD, yes (%) 16.7 12.7 20.7 <0.001 
Medication use     
Diabetes medication, yes 
(%) 
19.7 18.0 60.6 <0.001 
Antihypertensive 
medication, yes (%) 
35.1 36.1 32.1 0.079 
Lipid-modifying medication, 
yes (%) 
31.1 31.5 30.1 0.546 
Lifestyle factors     
Alcohol (%), None/Low/High 18.6/55.4/26.0 
 
17.0/57.2/25.9 20.2/53.7/26.1 0.001 
Smoking (%), 
Never/Former/Current 
34.5/51.6/13.8 38.0/49.8/12.3 31.1/51.9/15.4 <0.001 
Cognitive score     
MMSE total score 28.9±1.3 29.0±1.2 28.9±1.4 <0.001 
Other     
MRI lag time 2.3±1.3 2.0±1.2 2.9±1.4* <0.001 
Data are presented as means ± standard deviation, or percentages for categorical variables. T2DM, 
indicates type 2 diabetes mellitus; HDL, high-density lipoprotein; CVD, cardiovascular disease; MMSE, 
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4 Supplementary Table 4.2a: Associations of total physical activity time with whole brain node degree and 
node degree of the basal ganglia and primary motor cortex. 





Primary Motor Cortex 
 
TPA time  
(high to low) stβ (95% CI) P stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.064 (-0.111, -0.018) 0.007 -0.093 (-0.142, -0.044) <0.001 -0.054 (-0.102, -0.006) 0.027 
Model 2 -0.049 (-0.097, -0.002) 0.042 -0.077 (-0.127, -0.027) 0.003 -0.028 (-0.077, 0.021) 0.265 
Model 3 -0.041 (-0.090, 0.009) 0.111 -0.075 (-0.127, -0.023) 0.005 -0.031 (-0.083, 0.020) 0.231 
Associations of total physical activity (minutes/day) with node degree. Regression coefficients and 95% CI indicate the  
mean difference in node degree per SD higher TPA. Model 1: Adjusted for age, sex, education level, MRI lag time, and  
wake time. Model 2: additionally adjusted for diabetes status. Model 3: additionally adjusted for BMI, systolic blood  
pressure, antihypertensive medication, total-to-HDL-cholesterol-ratio, lipid-modifying medication, smoking status,  
alcohol use, and history of cardiovascular disease. 
 
Supplementary Table 4.2b: Associations of total physical activity time with total brain and white matter 
volume. 
 Total brain volume  WM volume  
TPA time (high to low) stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.022 (-0.035, -0.008) 0.001 0.004 (-0.019, 0.026) 0.746 
Model 2 -0.012 (-0.026, 0.012) 0.092 0.014 (-0.009, 0.037) 0.241 
Model 3 -0.009 (-0.024, 0.005) 0.189 0.013 (-0.011, 0.037) 0.280 
Associations between physical activity measures (minutes/day) with brain volumes.  
Regression coefficients and 95% CI indicate the mean difference in volume per SD  
higher TPA time. Model 1: Adjusted for age, sex, education level, MRI lag time, wake time,  
and ICV. Model 2: additionally adjusted for diabetes status. Model 3: additionally  
adjusted for BMI, systolic blood pressure, antihypertensive medication,  
total-to-HDL-cholesterol-ratio, lipid-modifying medication, smoking status, alcohol use,  
and history of cardiovascular disease. 
 
Supplementary Table 4.2c: Associations of total physical activity time with node degree of the frontal, 










(high to low) stβ (95% CI) stβ (95% CI) stβ (95% CI) stβ (95% CI) 
Model 1 -0.050 (-0.098, -0.003) -0.056 (-0.105, -0.007) 0.031 (-0.017, 0.080) 0.013 (-0.036, 0.062) 
Model 2 -0.027 (-0.075, 0.022) -0.054 (-0.104, -0.003) 0.022 (-0.027, 0.072) 0.019 (-0.031, 0.069) 
Model 3 -0.019 (-0.070, 0.032) -0.054 (-0.106, -0.001) 0.014 (-0.038, 0.066) 0.016 (-0.037, 0.068) 
Associations of physical activity measures (minutes/day) with node degree. Regression coefficients and 95% CI indicate the mean 
difference in node degree per SD higher PA time. Model 1: Adjusted for age, sex, education level, MRI lag time, and wake time. Model 
2: additionally adjusted for diabetes status. Model 3: additionally adjusted for BMI, systolic blood pressure, antihypertensive 






   4 Supplementary Table 4.3: Associations of physical activity time determined with CHAMPS questionnaire 
with whole brain node degree and node degree of the basal ganglia and primary motor cortex. 





Primary Motor Cortex 
 
Total PA time (high to low) 
 stβ (95% CI) P stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.032 (-0.081, 0.016) 0.188 -0.055 (-0.106, -0.004) 0.033 -0.069 (-0.119, -0.020) 0.006 
Model 2 -0.023 (-0.072, 0.025) 0.343 -0.045 (-0.096, 0.006) 0.081 -0.056 (-0.106, -0.006) 0.027 
Model 3 -0.019 (-0.068, 0.029) 0.433 -0.041 (-0.092, 0.010) 0.113 -0.057 (-0.107, -0.007) 0.025 
MVPA time (high to low) 
 stβ (95% CI) P stβ (95% CI) P stβ (95% CI) P 
Model 1 -0.065 (-0.111, -0.018) 0.007 -0.104 (-0.153, -0.055) <0.001 -0.102 (-0.150, -0.054) <0.001 
Model 2 -0.054 (-0.101, -0.007) 0.026 -0.093 (-0.142, -0.044) <0.001 -0.087 (-0.135, -0.038) <0.001 
Model 3 -0.049 (-0.097, 0.001) 0.043 -0.075 (-0.140, -0.040) <0.001 -0.091 (-0.140, -0.041) <0.001 
Associations of physical activity (CHAMPS questionnaire) with node degree. Regression coefficients and 95% CI indicate the mean 
difference in node degree per SD higher PA. Model 1: Adjusted for age, sex, education level, and MRI lag time. Model 2: additionally 
adjusted for diabetes status. Model 3: additionally adjusted for BMI, systolic blood pressure, antihypertensive medication, total-to-
HDL-cholesterol-ratio, lipid-modifying medication, smoking status, alcohol use, and history of cardiovascular disease. MVPA indicates 
mild-to-vigorous physical activity (hours/week). CHAMPS questionnaire information available in n=1486.  
 
Supplementary Table 4.4: Associations of low and high-intensity physical activity time, and high 
sedentary time with whole brain node degree, additionally corrected for waist circumference, 24h blood 
pressure, MRI quality, diet, or white matter hyperintensity volume. 
 Whole brain node degree  
LPA time (high to low) stβ (95% CI) P-value 
Model 3 -0.013 (-0.061, 0.034) 0.580 
Model 3 + waist circ. for BMI -0.012 (-0.060, 0.036) 0.621 
Model 3 + 24h for office BP -0.010 (-0.062, 0.042) 0.705 
Model 3 + MRI quality -0.007 (-0.052, 0.038) 0.757 
Model 3 + DHD score -0.008 (-0.057, 0.041) 0.736 
Model 3 + WMH* + ICV -0.008 (-0.056, 0.039) 0.725 
HPA time (high to low) stβ (95% CI) P-value 
Model 3 -0.062 (-0.112, -0.013) 0.014 
Model 3 + waist circ. for BMI -0.056 (-0.107, -0.006) 0.027 
Model 3 + 24h for office BP -0.070 (-0.124, -0.015) 0.012 
Model 3 + MRI quality -0.054 (-0.102, -0.007) 0.023 
Model 3 + DHD score -0.064 (-0.115, -0.014) 0.013 
Model 3 + WMH* + ICV -0.061 (-0.110, -0.012) 0.015 
   
Sedentary time (low to high) stβ (95% CI) P-value 
Model 3 -0.030 (-0.081, 0.021) 0.250 
Model 3 + waist circ. for BMI -0.019 (-0.070, 0.033) 0.478 
Model 3 + 24h for office BP -0.026 (-0.083, 0.030) 0.362 
Model 3 + MRI quality -0.019 (-0.068, 0.030) 0.448 
Model 3 + DHD score -0.022 (-0.075, 0.031) 0.414 
Model 3 + WMH* + ICV -0.025 (-0.076, 0.026) 0.327 
Associations of physical activity measures (minutes/day) with whole brain node degree. Standardized regression coefficients and 95% 
CI indicate the mean difference in node degree per SD lower physical activity and higher sedentary time. Model 3: Adjusted for age, 
sex, education level, MRI lag time, wake time, diabetes status, BMI, systolic blood pressure, antihypertensive medication, total-to-HDL-
cholesterol-ratio, lipid-modifying medication, smoking status, alcohol use, and history of cardiovascular disease. Waist circ. Indicated 
waist circumference; 24h BP, 24-hour ambulatory blood pressure; DHD, Dutch Healthy Diet index; WMH, white matter hyperintensity 
volume; ICV, intracranial volume. 24h BP available in n=1408. MRI quality available in n=1657. DHD score available in n=1581. *log-
transformed WMH volume. 
 
Association of physical activity and sedentary time with structural brain networks 
103 
4 Supplementary Table 4.5: Associations of low- and high-intensity physical activity time, and high 




Primary Motor Cortex 
 
LPA time (high to low) stβ (95% CI)  stβ (95% CI)  
Model 3 -0.049 (-0.098, 0.001) 0.056 -0.017 (-0.066, 0.032) 0.489 
Model 3 + waist circ. for BMI -0.048 (-0.098, 0.002) 0.059 -0.017 (-0.066, 0.032) 0.490 
Model 3 + 24h for office BP -0.062 (-0.116, -0.009) 0.022 -0.015 (-0.068, 0.038) 0.574 
Model 3 + MRI quality -0.045 (-0.094, 0.004) 0.074 -0.018 (-0.067, 0.031) 0.475 
Model 3 + DHD score -0.044 (-0.096, 0.007) 0.092 -0.005 (-0.056, 0.046) 0.838 
HPA time (high to low) stβ (95% CI)  stβ (95% CI)  
Model 3 -0.070 (-0.121, -0.018) 0.009 -0.035 (-0.086, 0.016) 0.178 
Model 3 + waist circ. for BMI -0.066 (-0.119, -0.014) 0.014 -0.035 (-0.087, 0.016) 0.181 
Model 3 + 24h for office BP -0.080 (-0.136, -0.023) 0.006 -0.052 (-0.108, 0.004) 0.068 
Model 3 + MRI quality -0.066 (-0.117, -0.014) 0.012 -0.036 (-0.087, 0.015) 0.172 
Model 3 + DHD score -0.069 (-0.112, -0.016) 0.011 -0.033 (-0.086, 0.020) 0.219 
     
Sedentary time (low to high) stβ (95% CI)  stβ (95% CI)  
Model 3 -0.029 (-0.082, 0.025) 0.295 -0.008 (-0.061, 0.045) 0.759 
Model 3 + waist circ. for BMI -0.023 (-0.077, 0.031) 0.402 -0.008 (-0.061, 0.045) 0.766 
Model 3 + 24h for office BP -0.036 (-0.094, 0.023) 0.233 -0.019 (-0.076, 0.039) 0.531 
Model 3 + MRI quality -0.025 (-0.078, 0.028) 0.358 -0.009 (-0.062, 0.044) 0.738 
Model 3 + DHD score -0.020 (-0.075, 0.036) 0.482 0.002 (-0.052, 0.057) 0.930 
Associations of physical activity measures with node degree of the basal ganglia and primary motor cortex. 
Regression coefficients and95% CI indicate the mean difference in node degree per SD lower physical activity 
and higher sedentary time. Model 3: wake time, age, sex, education level, MRI lag time, diabetes status, BMI, 
systolic blood pressure, antihypertensive medication, total-to-HDL-cholesterol-ratio, lipid-modifying 
medication, smoking status, alcohol use, and history of cardiovascular disease. 24h BP available in n=1408. MRI 
quality available in n=1657. DHD score available in n=1581.  
 
 
Supplementary Table 4.6: Relative change for HPA time and age in whole brain node degree. 
 Node degree*  
 standardized β p-value 
HPA time 0.081 0.001 
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Lesions of cerebral small vessel disease in individuals with cardiometabolic risk factors, such as white 
matter hyperintensities (WMH), interfere with the trajectories of the white matter, and eventually 
contribute to cognitive decline. However, there is no consensus yet about the precise underlying 
topological mechanism. 
Purpose 
To examine whether WMH and cognitive function are associated, and whether any of such association is 
mediated or explained by structural connectivity measures in an adult population. Additionally, 
underlying local abnormalities in white matter are investigated, by assessing the tract-specific WMH 
volumes and their tract-specific association with cognitive function. 
Materials and methods 
In the prospective type-2 diabetes-enriched population-based Maastricht Study, structural and diffusion 
tensor MRI was performed (December 2013-February 2017). Total and tract-specific WMH volumes, 
network measures, cognition scores, and demographic, cardiovascular, and lifestyle characteristics were 
determined. Multivariable linear regression and mediation analyses were employed to investigate the 
association of WMH volume, tract-specific WMH volumes, and network measures with cognitive 
function. Associations were adjusted for age, sex, education, diabetes-status, and cardiovascular risk 
factors.  
Results 
A total of 5083 participants (59 ± 9 years, 2592 men, 1027 with diabetes) were evaluated. Larger WMH 
volumes were associated with stronger local (standardized beta [stβ], 0.065, p<0.001), but not global, 
network efficiency and lower information processing speed (stβ, −0.073, p<0.001). Moreover, lower local 
efficiency (stβ, −0.084, p<0.001) was associated with lower information processing speed. In particular, 
the relationship between WMHs and information processing speed was mediated (percentage mediated 
7.2% [95% CI: 3.5, 10.9], p<0.05) by the local network efficiency. Finally, WMH load was larger in the 
white matter tracts important for information processing speed. 
Conclusion 
White matter hyperintensity volume, local network efficiency, and information processing speed scores 
are interrelated, and local network properties explain lower cognitive performance due to white matter 
network alterations. 
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Cerebral small vessel disease (cSVD) is a major cause of vascular cognitive impairment (1). The 
characteristic lesions, of which white matter hyperintensities (WMHs) are the most prevalent, interfere 
with the trajectories of the white matter, and may disrupt the connections between distributed gray 
matter regions. Well-known risk factors for the occurrence of these lesions are of cardiometabolic origin 
and include diabetes, hypertension, abdominal obesity, dyslipidemia, physical inactivity, and ageing (2, 
3). The changes in white matter connectivity may contribute to general cognitive decline, and decline in 
various specific cognitive domains, including information processing speed, executive function and 
attention, and memory (3, 4). Cognitive function generally relies on the integrity and spatiotemporally 
orchestrated interplay of large-scale structural white matter connections of the underlying brain network 
(5).  
Previously it was shown in a population based study of elderly individuals that periventricular 
WMHs are related to worse cognitive function in contrast to more deeply located, subcortical WMHs (6). 
This finding is of interest because periventricular WMHs are located in areas with a high density of long-
association white matter tracts that connect various widely distributed cortical regions supporting 
multiple cognitive functions. Similarly, initially it was thought that only the extensive level of WMH load 
would impair cognitive function, while currently it is clear that cardiovascular risk factors are associated 
with cSVD and cognitive performance (7). 
Previous studies provided some insight in the mechanisms underlying cSVD-related cognitive 
decline (8-10). However, the precise topological manner in which white matter connectivity is disrupted, 
how cSVD contributes, and consequently how strong cognitive function is affected remains unknown. 
Similarly, it is unclear to what extent variations in locations of cSVD lesions in a population affect 
cognitive function. To unravel these interrelations, more information about the underlying local and 
tract-specific characteristics of the white matter network is needed. 
The Maastricht Study provides the opportunity to investigate the associations between cSVD 
MRI markers and cognitive function in a large population with extensive availability of cardiometabolic 
risk factors. Therefore, the aim of the present study was to investigate whether cSVD lesions and 
cognitive function are associated, and whether this association is mediated, or explained by structural 
connectivity measures (ie global and local network efficiency). To investigate underlying local changes in 
white matter, we assessed the tract-specific WMH volumes in the three types of white matter tracts (ie 
association, projection, and commissural tracts) and their tract-specific association with cognitive 
function.  
Materials and Methods 
The Maastricht Study 
We used data from The Maastricht Study, an observational prospective population-based cohort study. 
The rationale and methodology have been described previously (7). In brief, the study focuses on the 
etiology, pathophysiology, complications, and comorbidities of type 2 diabetes and is characterized by an 
extensive phenotyping approach. Eligible for participation were all individuals aged between 40 and 75 
years living in the southern part of the Netherlands. Participants were recruited through mass media 
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5 campaigns, from the municipal registries, and regional Diabetes Patient Registry by mail. Recruitment was stratified according to known type 2 diabetes status, with an oversampling of individuals with type 2 
diabetes, for reasons of efficiency. The present report includes cross-sectional data from the first 7689 
participants, who completed the baseline survey between November 2010 and December 2017. The 
examinations of each participant were performed within a time window of three months. MRI 
measurements were implemented from December 2013 onwards until February 2017. 5547 participants 
were invited for MRI, 464 were excluded due to contra-indications (Supplementary Material 2), and 5083 
participants had complete data without artifacts (Figure 5.1). The study was approved by the institutional 
medical ethical committee (NL31329.068.10) and the Dutch Ministry of Health, Welfare and Sports 




Figure 5.1: Flowchart of the study population. 
MRI Scans 
MRI was performed on a 3T scanner (MAGNETOM Prisma-fit Syngo MR D13D, Siemens Healthcare, 
Germany) using a 64-element head and neck coil. A three-dimensional T1-weighted magnetization-
prepared rapid acquisition gradient echo sequence (repetition time, 2300 ms; inversion time, 900 ms; 
echo time, 2.98 ms; 176 slices; 256 x 240 matrix; and 1.00 mm voxel size) was acquired for anatomic 
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   5 reference. Diffusion-weighted MRI comprised a diffusion sensitized echo-planar imaging sequence 
(repetition time, 6100 ms; echo time, 57 ms; 65 slices; 100 × 100 matrix; 2.00 mm voxel size; and 64 
diffusion sensitizing gradient directions [b = 1200 s/mm2]), with  three b=0 images. 
Image Preprocessing 
Ninety-four regions were defined by a standard (AAL2) atlas software (11). After transformation (12), 
images were segmented into gray and white matter, WMH volume and intracranial volume were 
calculated, and cSVD lesions were identified (13) (Supplementary Material 1). Periventricular WMHs 
were automatically defined as WMHs < 3 mm, and deep WMHs as WMHs ≥ 3 mm from the cerebrospinal 
fluid in the ventricles (14). We focused on WMH volume, as these are prominent in aging, and centrally 
and deeply located in the cerebrum (analyses for periventricular and deep WMHs separately are 
provided in Supplementary Table 5.1, 5.2, and 5.4)(15). Diffusion-weighted MRI analysis comprised 
tractography as described previously (12). 
White Matter Networks 
Graph measures served to describe the network topology (15-17) using specialized software (Brain 
Connectivity Toolbox, version 2017-15-01 (18)). Local efficiency was calculated as the inverse of the 
average shortest path connecting all neighbors of a region (excluding that region) and determines a 
network’s resistance to failure at small scale. Global efficiency was determined by the inverse of the 
average shortest path length calculated over the entire brain and quantifies the exchange of information 
on the whole network scale (19). Also, whole brain node degree was calculated as the average number of 
connections per region. Subsequent steps were calculation of a standard network frame by proportional 
sparsity thresholding (80%), and normalization of the network measures to random networks (12). 
White Matter Tract Segmentation 
We determined the spatial distribution of WMHs, and the WMH volumes of a number of well-known 
tracts with automated atlas-guided tract reconstruction (20) (Figure 5.2). Among the selected tracts are 
long association, projection, and commissural tracts (21). Volumes were merged for bilateral tracts. We 
transformed an atlas with 130 gray and white matter regions to diffusion-space (22), and selected for 
each tract a specific subset of streamlines (20). Individual WMH maps transformed to diffusion-space 
were used to determine the WMH volume traversed by the selected tracts (Flowchart with processing 
steps in Supplementary Figure 5.1). 




Figure 5.2: Three orthogonal views of the 13 preselected white matter tracts acquired with automated 
atlas-guided tract reconstruction. (A) Long association tracts shown for cingulum of cingulate gyrus 
(CGC), hippocampal part of cingulate gyrus (CGH), fronto-occipital fasciculus (IFO), inferior-longitudinal 
fasciculus (ILF), parietal part of the superior-longitudinal fasciculus (SLFPT), temporal part of the superior-
longitudinal fasciculus (SLFT), and the uncinate fasciculus (UNC). (B) Projection tracts shown for cortico-
spinal tract (CST), anterior thalamic radiation (ATR), posterior thalamic radiation (PTR), and the superior 
thalamic radiation (STR). (C) Commissural tracts shown for the forceps major (Fmaj) and the forceps 
minor (Fmin). 
Cognitive Performance 
Cognitive performance was assessed using a concise neuropsychological test-battery (23). Information 
processing speed was primarily reported as it is captures complex cognitive functioning (24), affects 
various major tracts simultaneously (25), and is strongly impaired in cSVD (10). Detailed descriptions of 
the tests and other cognitive domain scores are provided in Supplementary Material 3. 
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Multivariable Linear Regression 
Multivariable linear regression was used to investigate the association of (tract-specific) WMH volume 
and structural connectivity with cognitive function. Analyses were adjusted for age, sex, education level, 
MRI patch update, and intracranial volume (the latter only in models with WMH volume, as network 
measures were already adjusted for intracranial volume) (Model 1). Subsequent analyses were adjusted 
for diabetes-status (Model 2), and body-mass index, total cholesterol-to-high-density lipoprotein-ratio, 
systolic blood pressure, lipid-modifying and antihypertensive medication, and prior cardiovascular 
disease (Model 3). Skewed variables (WMH volumes) were log10 transformed. P-values < .05 were 
considered statistically significant. Interaction terms with sex and diabetes-status were incorporated in 
the fully adjusted model (Model 3). All analyses were performed by use of commercial software (SPSS 
Statistics 23.0, IBM, Chicago, IL, USA). 
Mediation analysis 
Mediation analysis was used to test whether alterations in structural connectivity are on the potential 
causal pathway of the association between WMH volume and cognition, as it is biologically plausible that 
the white matter network is affected by WMHs (more details can be found in Supplementary Material 4). 
For this, we used bootstrapping (5000 samples) to calculate bias-corrected 95% confidence intervals (CIs) 
using the PROCESS statistical package for SPSS (26). Analyses were fully adjusted (Model 3).   
Results 
General Characteristics of the Study Population 
Table 5.1 shows the general characteristics of the study population, which consisted of 5083 individuals 
(Flowchart, Figure 5.1), had a mean age of 59 ± 9 years, 2491 (49%) women and 1027 (20%) had type 2 
diabetes (oversampled by design). From the 5547 participants invited for MRI, 224 were excluded due to 
missing data (5 did not show up/too late; 24 did not fit in scanner/coil; 162 with claustrophobia; 20 with 
metal implant; 4 with epilepsy; 9 with other contra-indications or known brain abnormalities). MRI brain 
assessment was performed for 5323 participants, but 79 of them did not full-fill the whole scan protocol, 
or the data contained artefacts or other data processing errors. From 5144 participants with correct MRI 
brain data available, 61 had other data missing, which led to 5083 participants with complete data. 
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5 Table 5.1: Characteristics of the study population 
Characteristic  n = 5083 
Demographics  
Age (years) 59±9 
Sex, female (%) 2491 [49] 
Education level (%), Low/Middle/High 32/28/40 
Cardiovascular risk factors  
BMI (kg/m2) 26.6±4.2 
Waist circumference (cm) 94.1±13.0 
Systolic blood pressure (mmHg) 132.9±17.3 
Diastolic blood pressure (mmHg)  75.5±9.7 




Hypertension, yes (%) 50 
Total cholesterol-to-HDL-ratio  3.6±1.2 
History of CVD, yes (%) 13 
Medication use  
Antihypertensive medication, yes (%) 34 
Lipid-modifying medication, yes (%) 28 
Lifestyle factors  
Alcohol (%), None/Low/High 17/59/24 
Smoking (%), Never/Former/Current 39/49/12 
Dutch Healthy Diet Index score 84.2±15.0 
Total physical activity (hours/week) 14.1±8.0 
Mild-to-vigorous physical activity (hours/week) 5.6±4.4 
Cognitive score  
MMSE total score [maximum score 30] 29 [29, 30] 
Information processing speed 0.11 [-0.41, 0.58] 
Executive function and attention 0.09 [-0.43, 0.61] 
Memory function 0.09 [-0.60, 0.75] 
Cerebral small vessel disease characteristics  
Total WMH volume (mL) 0.22 [0.07, 0.70] 
Periventricular WMH volume (mL) 0.15 [0.04, 0.48] 
Deep WMH volume (mL) 0.05 [0.01, 0.20] 
Fazekas 0/1/2/3 (%) 55.8/22.8/13.3/8.1 
Cerebral microbleeds present (%) 10.0 
Cerebral lacunar infarcts present (%)  4.3 
Structural connectivity graph measures  
Whole brain node degree 17.75±0.36 
Local efficiency 1.49±0.04 
Global efficiency 0.84±0.03 
Data are presented as means ± standard deviation, median [interquartile range] or percentage. BMI indicates body 
mass index; T2DM, type 2 diabetes; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; CVD, cardiovascular 
disease; MMSE, Mini-Mental State Examination; WMH, white matter hyperintensity. Detailed protocols of the general 
measurements are presented in Supplementary Material 2. 
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Median WMH volume was 0.22 mL (interquartile range [IQR], 0.07-0.70 mL); in 19.2% of the participants 
the total WMH volume was greater than or equal to 1 mL, and 44.2% had a Fazekas score greater than or 
equal to 1. Cerebral microbleeds and lacunar infarcts were less prevalent (in 10% and 4%, respectively). 
In Figure 5.5B, the spatial distribution of WMHs is depicted. Volumes of periventricular WMHs, near the 
lateral ventricles, were approximately three times larger compared to deep WMHs, located distant from 
the lateral ventricles in the subcortical white matter (Table 5.1).  
In the connectogram in Figure 5.3, the 100 connections between automated anatomical 
labeling atlas 2 regions with the largest difference in tract volume between subgroups with Fazekas 
scores 0 and greater than or equal to 1 are depicted. This figure indicates that in both hemispheres, 
especially the short connections between cortical regions located close to the corpus callosum, have 
smaller tract volumes in participants with WMHs. Connections between the left and right deep gray 
matters regions and cingulate cortex have larger tract volumes in participants with WMHs. 
 
Figure 5.3: Connectogram depicting qualitatively the 100 white matter tracts between AAL-atlas regions 
with the largest (absolute) difference in tract volume between groups with Fazekas scores. Red lines 
indicate the tracts with lower tract volumes in the group with WMHs (Fazekas score ≥ 1 versus 0), and 
blue lines the higher tract volumes. 
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5 Association Between WMH Volumes and Cognitive Function 
Larger WMH volumes were associated with lower information processing speed scores (standardized 
beta [stβ], -0.073 [95% CI: -0.101, -0.046], p<0.001) after adjusting for demographical and cardiovascular 
risk factors (Model 3, Supplementary Table 5.1). The associations were present for periventricular as well 
as deep WMHs. 
Association Between WMH Volumes and Network Measures 
Larger WMH volumes were associated with higher local network efficiency (0.065 [95% CI: 0.035, 0.096, 
p<0.001]), but not with whole brain node degree (-0.027 [95% CI: -0.058, 0.003], p=0.08) and global 
efficiency (-0.011 [95% CI: -0.044, 0.021], p=0.48). A comparable association was found for both 
periventricular and deep WMHs (Supplementary Table 5.2).  
Association Between Network Measures and Cognition 
Higher whole brain node degree (stβ, 0.113 [95% CI: 0.089, 0.1438], p<0.001) and lower local efficiency 
(stβ, -0.084 [95% CI: -0.109, -0.059], p<0.001) were associated with higher information processing speed 
scores. Global efficiency was not associated with information processing speed scores (stβ, -0.014 [95% 
CI: -0.038, 0.010], p=0.25, Supplementary Table 5.3).  
Mediation Analysis 
Local efficiency mediated for 7.2% ([95% CI: 3.5, 10.9], p<0.05; indirect effect: stβ, -0.005 [95% CI: -0.009, 
-0.002], p<0.05) the association between WMH volume and information processing speed (Figure 5.4, 
Supplementary Table 5.4). 
 
 
Figure 5.4: Associations between white matter hyperintensity (WMH) volume, local network efficiency, 
and information processing speed (IPS) score, and the mediation by local efficiency. Solid lines indicate 
direct effects (c’); dashed lines indicate indirect effects (a∙b) and percentage mediated (percentage 
mediated [PM] = indirect/total =indirect/[indirect+total]). Associations are given as standardized 
regression coefficients (standardized β), and are adjusted for age, sex, education, intracranial volume, 
diabetes status, MRI patch update, BMI, total cholesterol-to-HDL-ratio, systolic blood pressure, lipid-
modifying and antihypertensive medication, and prior cardiovascular disease.  
*P-value < .01. 
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The population‐based design, with oversampling of participants with type 2 diabetes, enabled an 
accurate comparison of individuals with and without diabetes. Participants with diabetes had 
approximately two times larger WMH volumes (without diabetes: median 0.19 [IQR, 0.06-0.58]; with 
diabetes: 0.38 [IQR, 0.13-1.28]) (27). Furthermore, participants with diabetes had slightly higher local 
efficiency (with diabetes: mean ± standard deviation, 1.51 ± 0.05; without diabetes: 1.49 ± 0.04, P < .01) 
and slightly lower information processing speed scores (with diabetes: median [IQR], -0.20 [IQR, -0.80-
0.29]; without diabetes: 0.18 [IQR, -0.32-0.62], P < .01 compared to participants without diabetes in the 
fully adjusted regression model (Model 3). We did not find interactions with diabetes-status or sex. 
Tract specific analysis 
For the majority of the tracts (9 out of 12) a larger WMH volume was significantly associated with slower 
information processing, and a comparable effect was found for the other cognitive domains 
(Supplementary Table 5.5, Supplementary Figure 5.1, and Supplementary Material 5). 
 
 
Figure 5.5: Tracts with significant associations (P < .05) of tract-specific WMH volume, with information 
processing speed (A) scores, adjusted for age, sex, education, diabetes-status, and cardiovascular risk 
factors (Model 3). (B) White matter hyperintensity prevalence map of the study sample. Note the higher 
prevalence and overlap of the white matter lesions in the periventricular region, while the deep lesions 
are more spread. Colors indicate the number of participants that had WMHs in that voxel. 
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5 Long Association Tracts 
We found the largest WMH volumes in the tracts fronto-occipital fasciculus and temporal-part of 
superior-longitudinal fasciculus (respectively 40 and 18% of the total WMH in the selected tracts). From 
Figure 5.5 can be appreciated that, the fronto-occipital fasciculus and temporal-part of superior-
longitudinal fasciculus (Figure 5.5A) both cross the anterior and posterior horns, which are regions with a 
high WMH prevalence (Figure 5.5B). For almost all association tracts (cingulum of cingulate gyrus, 
parietal- and temporal-part of superior-longitudinal fasciculus, uncinate fasciculus [P-values < .01], 
fronto-occipital fasciculus, and inferior-longitudinal fasciculus [P-values < .05]) larger WMH volumes 
(Figure 5.5A) were, after adjustment for demographic and cardiovascular risk factors, still strongly 
associated with lower information processing speed. 
Projection Tracts 
We did not find large WMH volumes in the projection tracts. However, the WMH volume in the superior 
thalamic radiation covers approximately 7% of the total WMH volume over all selected tracts 
(Supplementary Table 5.5). This tract traverses regions with WMHs that are mainly located in the deep 
subcortical structures of the frontal and parietal lobe. Larger WMH volumes in the superior thalamic 
radiation and cortico-spinal tract, but not in the anterior thalamic radiation and posterior thalamic 
radiation, were associated with lower information processing speed (P-values < .01).  
Commissural Tracts 
The forceps major and forceps minor have small absolute WMH volumes, which however cover a 
substantial part of their relatively small total tract volume (7 and 9%, respectively). The forceps major 
crosses the regions with high WMH prevalence located near the posterior horns, and the forceps minor 
near the anterior horns. Associations between WMH volumes and information processing speed were 
only found for the forceps major (P-value < .01). More details are provided in Supplementary Table 5.5. 
Discussion  
We set out to find interrelations between white matter hyperintensity (WMH) volumes, white matter 
connectivity, and domain specific cognitive function in a large adult population with cardiometabolic risk 
factors. Larger WMH volumes were associated with stronger local network efficiency and slower 
information processing. The relationship between WMHs and information processing speed was partly 
mediated by the local network efficiency. Additionally, larger WMH load in white matter tracts important 
for information processing were associated with cognitive slowing. 
In the white matter, the local but not the global network efficiency, acted as a mediator 
between WMHs and cognitive slowing. WMHs are focally isolated lesions that disturb connections of 
specific tracts, while the global brain network topology is preserved. We found a higher local efficiency 
for more WMHs, which indicates that the local network organization is compensated by use of 
alternative white matter pathways that strengthen connections (higher tract volume in Figure 5.3) with 
the neighboring regions (12). 
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   5 Two previous studies found that both lower local and global efficiency were associated with 
lower processing and/or psychomotor speed and mediated the associations between MRI markers for 
cSVD and cognition (8, 9). However, these studies involved participants with more severe (eg, 
symptomatic) cSVD as compared to our study population. In contrast, the current study comprises milder 
or commencing cSVD pathology without obvious global network impairment but with local adaptations. 
The majority of tracts with a substantial amount of WMHs, reveal negative effects on 
information processing speed for higher WMH load. In this study, we focused on the cognitive domain 
information processing speed as this is important for fluent execution of perceptual, cognitive, and 
psychomotor processes (28). Therefore, information processing speed is associated with the properties 
of connections between many distributed brain regions and does not appeal to highly distinctive tracts 
but more a variety of tracts (21, 29, 30).  
To put the degree of the cognitive decline into perspective, a 0.51 mL larger WMH volume was 
equivalent to 10 years of cognitive aging in the association between WMH volume and information 
processing speed, while 1.69 mL more WMHs was equivalent to 10 years of network aging in terms of 
local efficiency. This comparison suggests that the impact of WMHs on the local network topology is 
approximately three times stronger than would be expected for cognitive decline, which can be 
explained by compensatory network adaptations outside the lesions. Cerebral lacunar infarcts and 
microbleeds were less prominent in comparison to WMHs, and also provided associations with both 
cognitive function and structural connectivity, as expected from literature (8, 31), though less evident as 
for WMHs. Participants with type-2 diabetes had larger WMH volumes, higher local efficiency, and lower 
information processing speed scores compared to participants without. The lower cognitive scores were 
equivalent to 3.3 years of cognitive aging. For the other cardiometabolic risk factors no clear effects were 
found (only marginal differences between model 2 and 3), likely because these risk factors already led to 
higher WMH volumes. In addition, previous studies reported associations of hypertension (32, 33), 
visceral obesity (34), abnormal body-mass index (33), and metabolic syndrome (2) with increased risk of 
having WMHs. 
Strengths of this study were the large sample size, the population-based design, the extensive 
assessment of potential confounders, and the combined approach of whole-brain network and tract-
specific analysis to confirm the robustness of results. Furthermore, we used an automated atlas-guided 
tract reconstruction method based on whole brain fiber tractography, instead of a diffusion-weighted 
MRI atlas co-registered to a structural image to determine tract volumes. There were also some 
limitations. First, the cross-sectional design of the study implies that no conclusions about temporality of 
alterations in WMH, network properties and cognition can be made. Second, WMHs expressed at 
locations that are typical for ageing populations with cardiometabolic risk factors. Therefore, for the 
specific cognitive domains we are restricted to infer on the specific white tracts with the current 
distribution of WMHs and cannot infer on the susceptibility of other white matter regions, though the 
whole brain network analysis demonstrated widely distributed alterations. In line with this, standardized 
regression coefficients were small (<0.1), likely because of the relatively healthy population. The 
pathology of cSVD is rather limited, and cognition scores were relatively high. Therefore, the associations 
that were found, indicate that the first signs of cSVD pathology already relate to alterations in the 
structural network organization and cognitive decrements. 
In conclusion, we found that WMH volume, local efficiency, and information processing speed 
scores are interrelated. More specifically, the detrimental effect of larger WMH volume on cognitive 
function was mediated by local efficiency. Locally, we found that larger WMH volumes in white matter 
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5 tracts that are important for information processing were associated with cognitive slowing, which reflects cognitive decrements due to white matter pathology in aging individuals with cardiometabolic 
risk factors.  
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   5 Supplementary Material 
1. Identification and scoring of cSVD lesions 
1.1 Identification of white matter hyperinsities 
WMHs identified were summed to assess total WMH burden in mL. Two types of WMHs were 
distinguished, periventricular WMHs (pWMHs) are located around the horns of the ventricles, and deep 
WMHs (dWMHs) are located in the subcortical white matter distinct from the periventricular area. 
pWMHs were automatically defined as WMHs < 3 mm, and dWMHs as WMHs ≥ 3 mm from the 
cerebrospinal fluid (1).  
1.2 Scoring lacunar infarct and microbleeds 
Lacunar infarcts were defined as focal lesions of ≥3 mm and <15mm in size with a similar signal intensity 
as cerebrospinal fluid on all sequences and a hyperintense rim on T2 and FLAIR images (2).   
Cerebral microbleeds were rated on three-dimensional T2* GRE imaging with SWI by use of the 
Microbleed Anatomical Rating Scale (3), and were defined as focal lesions of ≥2 mm and ≤10mm in size 
with a hypointense signal on T2* GRE and SWI images (2). The number and location of lacunar infarcts 
and cerebral microbleeds were rated manually by three neuroradiologists. The intraclass correlation 
coefficient for the three raters based on 50 randomly selected scans was 0.84 [0.74; 0.91] and 0.83 [0.72; 
0.90] for the presence of lacunar infarcts and cerebral microbleeds, respectively. 
2. Detailed protocols of measurements performed within The Maastricht 
Study 
Questionnaires. As described elsewhere (4), we used web-based questionnaires to obtain information 
regarding smoking status (never/former/current), alcohol consumption, educational level, physical 
activity, diet, prior cardiovascular disease (CVD) and cognitive impairment. Alcohol consumption was 
classified as none, low (1– 7 glasses/wk for women and 1–14 glasses/wk for men) and high (>  7 
glasses/wk for women and > 14 glasses/wk for men). Educational level was classified as low (no 
education, primary education, lower vocational education), intermediate (intermediate general 
secondary education, intermediate vocational education, higher general secondary education), or high 
(higher vocational education or university). Diet was assessed by a tailor-made food frequency 
questionnaire (FFQ) developed by use of the National FFQ Tool. Prior CVD was defined as a history of 
myocardial infarction; stroke; or vascular surgery (including angioplasty) on coronary, carotid, abdominal 
aortic, or peripheral arteries based on the Rose questionnaire. Cognitive impairment was measured using 
the Mini-Mental State Examination (MMSE). Medication use was assessed in a medication interview 
where generic name, dose, and frequency were registered. Subjective physical activity was assessed by 
means of a modified version of the Champs questionnaire. 
 
Laboratory assessments. Plasma glucose is measured with a standard enzymatic hexokinase reference 
method, and serum total cholesterol, HDL cholesterol, and triglycerides are measured with standard 
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5 (enzymatic and/or colorimetric) methods by an automatic analyzer (until 9 May 2012: Beckman Synchron 
LX20, Beckman Coulter Inc., Brea, USA; after 9 May 2012: Cobas 6000, Roche diagnostics, Mannheim, 
Germany). When appropriate LDL cholesterol is calculated according to the Friedewald formula(5). 
HbA1c is measured with ion-exchange high performance liquid chromatography (HPLC) (Variant tm II, 
Bio-Rad, Hercules, California, USA).  
 
Glucose metabolism status. To determine glucose metabolism status, all participants, except those who 
used insulin, underwent a standardized 2-h 75g oral glucose tolerance test (OGTT) after an overnight 
fast. For safety reasons, participants with a fasting glucose level above 11·0 mmol/L, as determined by a 
finger prick, did not undergo the OGTT. For these individuals, fasting glucose level and information about 
diabetes medication were used to determine glucose metabolism status. Glucose metabolism status was 
defined according to the WHO 2006 criteria into normal glucose metabolism (NGM), prediabetes, and 
type 2 diabetes mellitus (T2DM) (6). Participants were considered to have T2DM if they had a fasting 
blood glucose (FBG) ≥7·0 mmol/l, or a 2hr post-load blood glucose ≥11·1 mmol/l or used oral glucose-
lowering medication or insulin, prediabetes if they had a FBG ≥6·1 mmol/l and/or a 2hr post-load blood 
glucose ≥7·8 mmol/l, and NGM if they had a FBG <6·1 mmol/l, and a 2hr post-load blood glucose <7·8 
mmol/l and no use of diabetes medication. Participants with type 1 diabetes or other types of diabetes 
were excluded from the analysis. 
 
Physical examination. Weight and height are measured without shoes and wearing light clothing using a 
scale and stadiometer to the nearest 0.5 kg or 0.1 cm (Seca, Hamburg, Germany). Waist circumference is 
measured with a flexible plastic tape measure (Seca, Hamburg, Germany) in a duplicate midway between 
the lower rib margin and the iliac crest at the end of expiration, to the nearest 0.5 cm. 
 
Blood pressure. Office blood pressure is determined three times on the right arm after a 10-minute rest 
period, using a non-invasive blood pressure monitor (Omron 705IT, Japan). When the difference 
between measurement two and three is more than 10mmHg, a fourth measurement is performed. All 
available measurements are used to calculate the average blood pressure. Ambulatory 24-h blood 
pressure (WatchBP O3, Microlife, Switzerland, respectively) is measured at the non-dominant arm, using 
an ambulatory device that is programmed to take blood pressure readings every 15 minutes from 8.00 – 
23.00 and every 30 minutes from 23.00 – 8.00. 
MRI. Contra-indications for MRI assessments were the presence of a cardiac pacemaker or implantable 
cardioverter-defibrillator, neurostimulator, non-detachable insulin pump, metallic vascular clips or stents 
in the head, cochlear implant, metal-containing intra-uterine device, metal splinters or shrapnel, 
dentures with magnetic clip, an inside bracket, pregnancy, epilepsy, claustrophobia, or did not fit in 
scanner/coil. Data was excluded whether participants did not full-fill the whole scan protocol, or the data 
contained artefacts or other data processing errors.  
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   5 3. Description of the individual cognitive tests used in the present study 
3.1 Verbal Learning Test (7) 
Fifteen unrelated, monosyllabic, words were presented on a computer screen in five subsequent trials. 
After each trial, participants were instructed to recall as many words as possible in any order. Twenty 
minutes after the last trial, participants were asked again to reproduce the words. Outcomes recorded 
included the total number of words correctly recalled over the five trials (total immediate recall) and the 
number of correctly recalled words during delayed recall (delayed recall). 
3.2 Stroop Colour Word Test (8) 
In this test that consisted of three parts participants were firstly asked to read aloud colour names (i.e. 
red, blue, yellow, and green) that were printed in black ink (Part I). Secondly, they were instructed to 
name solid colour patches (Part II). Finally, participants had to name the ink color of colour names that 
were printed in an incongruent colour (e.g. participants were asked to say red when the word yellow was 
printed in red) (Part III). The time needed to complete Part III was adjusted for the average time needed 
to complete Part I and II. 
3.3 Concept Shifting Test (9) 
This test, a modification of the Trailing Making Test, consisted of four subtasks. During each subtask, 
participants were shown 16 small circles aligned along a larger imaginary circle. The small circles 
contained (a combination of) digits, letters, or were empty. Participants were instructed to cross-out as 
quickly as possible the digits in ascending order (Part A), the letters in alphabetic order (Part B), and the 
letters and digits in alternating order (Part C). Thereafter, participants were asked to cross-out empty 
circles in a clockwise fashion in two consecutive trials (Part 0). In this way, test results could be 
accounted for basic motor speed. The time needed to complete subtasks A and B was adjusted for the 
average time needed to complete Part 0, the time needed to complete Part C for the average time of 
Part A and B.     
3.4 Letter-Digit Substitution Test (10) 
Participants were requested to match digits to letters according to a given key. This key included the 
numbers 1 to 9, each paired with a different letter. The outcome of interest was the number of correct 
substitutions within 90 seconds. 
3.5 Methods used to calculate domain scores  
Briefly, information processing speed was derived from the Stroop Color-Word Test, Part I and II (31), the 
Concept Shifting Test, Part A and B (32), and the Letter-Digit Substitution Test (33). Executive function 
and attention was assessed with the Stroop Color-Word Test Part III and the Concept Shifting Test Part C. 
The composite score for memory function was evaluated using the Verbal Learning Test (34) by 
calculating the average of standardized total immediate and delayed recall scores. Other domain scores 
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5 were calculated analogously. If necessary, individual test scores were log-transformed to fulfil the 
normality assumption and/or inverted so that higher scores indicated better cognitive performance. 
4. Additional explanation of the concept underlying the mediation analysis: 
In a mediation model, the relationship of an independent variable (e.g., WMH volume) with an outcome 
(processing speed) is hypothesized to be indirect and due to the influence of a mediator variable (local 
efficiency). Thus, the mediation analysis modelled the relationship by assuming that WMH volume 
affects the local efficiency, which in turn affects processing speed. The total effect of WMH volume on 
processing speed was decomposed into the natural direct effect (NDE) and the natural indirect effect 
(NIE) and the percentage mediated (PM) was computed as the ratio of the total effect to NIE, PM = 
NIE/(NIE + NDE). PM provides an estimate of the extent to which the total effect of WMH volume on 
processing speed is accounted for by the pathway through local efficiency. However, the PM is probably 
an underestimation of the influence of WMH, because according to the literature, WMHs affect also the 
white matter adjacent to the lesion (Reginold et al., 2018; Wardlaw et al., 2017). 
5. Additional discussion about tract-specific findings: 
More specifically, previous studies showed that impairments in the association tracts cingulum of 
cingulate gyrus, fronto-occipital fasciculus, inferior-longitudinal fasciculus, parietal- and temporal-part of 
superior-longitudinal fasciculus, the projection tract cortico-spinal tract, and the commissural tract 
forceps major were associated with lower information processing speed, but deficits in the association 
tracts hippocampal part of cingulate gyrus and uncinate fasciculus, the three thalamic radiations, i.e.,  
anterior thalamic radiation, superior thalamic radiation and posterior thalamic radiation, and the 
commissural tract forceps minor were not (11-13). Furthermore, previously associations of reduced 
white matter microstructure in terms of higher fractional anisotropy and lower mean diffusivity, with 
lower information processing speed scores were found, which were strongest in the association tracts 
fronto-occipital fasciculus, inferior-longitudinal fasciculus, parietal- and temporal-part of superior-
longitudinal fasciculus and uncinate fasciculus, in the projection tracts anterior thalamic radiation and 
posterior thalamic radiation, and in the commissural tracts forceps major and forceps minor (14-16). In 
the present study, we also found associations of higher WMH volumes in long association tracts between 
motor regions and the four lobes (cingulum of cingulate gyrus, fronto-occipital fasciculus, inferior-
longitudinal fasciculus, parietal- and temporal-part of superior-longitudinal fasciculus, and uncinate 
fasciculus) with lower information processing scores. Additional associations were observed in two 
projection tracts, i.e., superior thalamic radiation and cortico-spinal tract, and in the commissural tract 
forceps major, which connects the occipital lobes.  
5.1 Executive function and attention 
Larger WMH volumes (Supplementary Figure 1A) in a variety of long association tracts, i.e., cingulum of 
cingulate gyrus(p-value<0.01), fronto-occipital fasciculus, inferior-longitudinal fasciculus, parietal- and 
temporal-part of superior-longitudinal fasciculus, and uncinate fasciculus (p-values<0.05); projection 
tracts, i.e., superior thalamic radiation and cortico-spinal tract (p-values<0.001), were associated with 
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   5 lower executive function and attention scores. No associations between WMH volumes and executive 
function and attention scores were found in the association tract cingulum of cingulate gyrus, the 
projection tracts anterior thalamic radiation and posterior thalamic radiation, and in both commissural 
tracts.  
Executive function relies mainly on regions in the frontal and parietal lobes, cingulate gyrus and 
cerebellum (11, 17), and executive attention on the cingulate gyrus, prefrontal cortex, and basal ganglia 
(11, 18). The temporal part of the superior longitudinal fasciculus is a tract from angular gyrus to the 
temporal lobe, and is important for attention (19). In a previous cohort study, an association of lower 
executive attention scores with larger WMH volumes in the corticospinal tract and superior longitudinal 
fasciculus was found (13). Furthermore, another study found that WMHs in the frontal white matter 
adjacent to the frontal horns were much more pronounced in participants with worse performance in 
executive function, while participants with high cognitive performance in executive functions had less 
WMH in the frontal, periventricular white matter (12). This study found that all WMH locations with 
negative effects on cognition were bilateral with a symmetrical pattern. In the present study, 
associations were found between higher WMH volumes in a variety of long association tracts and lower 
executive function and attention scores. Furthermore, we found associations in the superior thalamic 
radiation and cortico-spinal tract, which are located adjacent to the frontal horns. 
5.2 Memory 
Higher tract-specific WMH volumes in all long association tracts, i.e., cingulum of cingulate gyrus, 
inferior-longitudinal fasciculus, parietal- and temporal-part of superior-longitudinal fasciculus, uncinate 
fasciculus (p-values<0.001), hippocampal part of cingulate gyrus, and fronto-occipital fasciculus(p-
values<0.05); in several projection tracts, i.e., anterior thalamic radiation, superior thalamic radiation, 
and cortico-spinal tract (p-values<0.05); and in the commissural forceps major (p-value<0.01) were 
associated with lower memory function scores (Supplementary Figure 1B). No associations were found in 
the projection tract posterior thalamic radiation and the commissural tract forceps minor. 
Memory function (short-term/working) is mainly facilitated by connections between the 
prefrontal cortex, regions in the parietal lobe, cerebellum, and basal ganglia (11, 20). The temporal part 
of the superior longitudinal fasciculus is a tract important memory function (19). One population based 
study found an association of lower memory function with more WMHs in the bilateral parietal-temporal 
white matter junctions adjacent to the posterior horns of the lateral ventricles (12). However, another 
cohort study found no associations for memory (13), but this study used a white matter tractography 
atlas instead of tract tracking on diffusion-weighted MRI scans. In our study, we found associations of 
higher WMH volumes in several long association tracts connecting the frontal and occipital lobe (fronto-
occipital fasciculus), the frontal, temporal and parietal lobe (parietal-and temporal-part of superior-
longitudinal fasciculus) and the basal ganglia (uncinate fasciculus), with lower memory scores. We also 
found associations in all the projection and commissural tracts, except for the posterior thalamic 
radiation, and the commissural tract forceps major. Another population-based study found similar 
associations between larger WMH volumes in association and projection tracts and worse memory 
function, but this study also used a white matter tract atlas instead of tractography (21). 
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Supplementary Figure 5.1: Flowchart with most important image processing steps. Left side: calculation 
of graph measures and total WMH volumes for mediation analysis. Right side: automated atlas-guided 
tract reconstruction for calculated of tract volumes and tract-specific WMH volumes.  




Supplementary Figure 5.2: Tracts with significant associations (p<0.05) of tract-specific WMH volume, 
with executive function and attention (A) and memory (B) scores, adjusted for age, sex, education, 




   5 Supplementary Tables 
Supplementary Table 5.1: Associations of cSVD markers with cognition scores.  
 
Supplementary Table 5.2: Associations of cSVD markers with structural connectivity measures.  
 
  






   5 Supplementary Table 5.5: Total tract and tract-specific WMH volumes, and associations of tract specific 
WMH volume with domain-specific cognition. 




IPS EF&A MEM 
 Median [IQR] Median [IQR] stβWMH stβWMH stβWMH 
Association      
CGC 3 [0, 74] 23.8 [14.7, 39.7] -0.084** -0.090** -0.064** 
CGH 0 [0, 2] 8.6 [6.5, 11.2] -0.023 -0.021 -0.034* 
IFO 278 [41, 1226] 31.8 [24.7, 38.4] -0.027* -0.038* -0.028* 
ILF 52 [3, 320] 28.6 [23.1, 34.7] -0.030* -0.035* -0.041** 
SLFPT 1 [0, 39] 18.5 [14.5, 23.0] -0.046** -0.029* -0.050** 
SLFT 123 [5, 1208] 60.1 [51.6, 69.0] -0.049** -0.030* -0.058** 
UNC 18 [1, 145] 17.1 [11.9, 23.0] -0.048** -0.036* -0.060** 
Projection      
ATR 19 [1, 140] 6.8 [4.9, 9.1] -0.022 0.017 -0.033* 
STR 48 [3, 347] 20.6 [15.3, 27.0] -0.054** -0.056** -0.048* 
PTR 36 [2, 255] 10.4 [7.3, 13.8] -0.032 -0.023 -0.030 
CST 0 [0, 27] 18.0 [14.1, 21.8] -0.049** -0.042** -0.039* 
Commissural      
Forceps major  51 [1, 499] 6.7 [3.7, 10.7] -0.044** -0.025 -0.044** 
Forceps minor  62 [3, 315] 8.0 [6.2, 9.7] -0.008 -0.026 -0.021 
Adjusted for tract volume, age, sex, education level, MRI date, intracranial volume, diabetes-status, BMI, total-
cholesterol-to-HDL-ratio, lipid-modifying medication systolic blood pressure, antihypertensive medication, and prior 
cardiovascular disease. *indicates p<0.05; **indicates p<0.01. WMH = white matter hyperintensity, IPS = information 
processing speed, EF&A = executive function & attention, MEM = memory, CGC = cingulum of cingulate gyrus, CGH = 
hippocampal part of cingulate gyrus, IFO = fronto-occipital fasciculus, ILF = inferior-longitudinal fasciculus, SLFPT = 
parietal part of the superior-longitudinal fasciculus, SLFT = temporal part of the superior-longitudinal fasciculus, UNC = 
uncinate fasciculus, CST = cortico-spinal tract, ATR = anterior thalamic radiation, PTR = posterior thalamic radiation, 
STR = superior thalamic radiation, Fmaj = forceps major, Fmin = forceps minor. 
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7 Outline  
Multiple cardiometabolic risk factors are associated with chronic diseases, including type 2 diabetes and 
cardiovascular conditions. Accumulating evidence shows that these risk factors are associated with a 
higher risk of late-life cognitive detriments and eventually brain diseases such as dementia. Brain imaging 
in population-based cohort studies plays a key role to reveal underlying mechanism between life style, 
cardiovascular risk factors, and brain alterations, by use of the combined data provided by brain imaging 
and advanced phenotyping. The main objectives of this thesis were twofold. We investigated whether 
cardiometabolic risk factors are associated with novel neuronal imaging markers and evaluated the value 
of structural and functional brain network measures for that purpose. 
This final chapter summarizes, combines, and discusses the main outcomes of this thesis in two 
parts:  
 The influences of cardiometabolic risk factors on brain imaging markers in a population-based 
cohort study; 
 A motivated selection of MR imaging measures and techniques. 
Influences of cardiometabolic risk factors on brain imaging 
markers 
Findings in population-based imaging studies 
In Chapter 2 of this thesis, we conducted a narrative review. In this review, we collected evidence from 
(mostly) cross-sectional MR imaging studies on the associations between cardiometabolic risk factors 
and brain atrophy, cerebral small vessel disease (cSVD), and white matter microstructure alterations. 
Less clear were the associations of an adverse lipid profile, as well as the association of relatively novel 
risk factors including physical inactivity and sedentary behavior, with MRI markers of the brain. In 
particular, the evidence from more advanced MRI measures, such as microstructural, functional, and 
perfusion MRI needs to be extended. Insight into more subtle brain alterations, which may represent 
early markers of brain disease, their change over time, and subsequent brain dysfunction and disease is 
needed to find new treatment targets. 
In Figure 7.1, the gray symbols indicate findings from studies as described in the review in 
Chapter 2. Our results were generally in agreement with literature. However, with this thesis, we were 
able to add to almost all the cardiometabolic risk factor categories structural connectivity and functional 
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Figure 7.1: Highest level of evidence in the available literature and in this thesis on the associations 
between cardiometabolic risk factors and conventional and advanced MRI measures. Gray symbols 
indicate findings from other studies, and blue symbols the additions from this thesis. 
Findings in The Maastricht Study 
In Chapter 3, we investigated whether hyperglycemia was associated with structural brain connectivity. 
We observed already in the prediabetes phase weaker white matter connections and altered 
organization of white matter networks. More specifically, we found that prediabetes, type 2 diabetes, 
and continuous measures of hyperglycemia were associated with a lower node degree, and thus globally 
fewer or weaker white matter connections. Furthermore, in prediabetes, the local efficiency and 
clustering coefficient were lower, which indicates that there was a weaker local connectivity. In addition, 
type 2 diabetes was associated with higher communicability, which was not yet observed in prediabetes, 
and which may reflect the use of alternative white matter connections to facilitate structural connectivity 
between brain regions. These outcomes support the concept that hyperglycemia, even in the 
prediabetes phase, may be harmful to the brain, and that type 2 diabetes affects the global and local 
organization of brain structures. 
In Chapter 4, we investigated whether physical inactivity and sedentary behavior were 
associated with markers of brain connectivity. We found that objectively measured lower high intensity 
physical activity, but not low intensity physical activity and sedentary time, were associated with lower 
whole brain node degree and node degree in specific brain regions highly specialized in motor function. 
This suggests that high intensity physical activity can slow down structural deterioration in the brain. 
In Chapter 5, we focused on the interrelations of white matter hyperintensities (WMH), white 
matter connectivity, and cognitive function. We found that WMH volume, white matter connectivity, and 
various cognitive functions display significant inter-relationships. In particular, larger WMH volumes were 
associated with lower local network efficiency and worse information processing. The relationship 
between WMHs and information processing speed was mediated by the local network efficiency. In tract 
specific analysis, we found that more WMHs in those white matter tracts that are important for 
information processing, were associated with cognitive slowing. 
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7 In Chapter 6, we investigated whether we could recognize physiological measures in the blood 
oxygen level dependent (BOLD) signal. We found that both neuronal and systemic non-neuronal 
physiological measures are associated with frequency subbands of the measured dynamic fMRI signal. 
Most importantly, the subband analysis showed an association of cognitive performance as well as blood 
pressure variations with the signal of the subband with the frequency range 31.2-62.5 mHz, which is 
usually thought to reflect the signal of spontaneous neuronal fluctuations. Finally, the measured BOLD 
signal is altered in participants with cardiometabolic risk factors, consistent with what was expected from 
vascular impairment which is characteristic for cardiometabolic risk factors. These findings highlight the 
strong intertwining of neuronal and cardiometabolic activity, emphasize the importance of a proper 
selection of the resting-state frequency range, and also advice cautiousness in the interpretation fMRI 
signal changes as pure neuronal signals, especially when  cardiometabolic risk factors are involved. 
Imaging measures and techniques 
In this thesis we used a number of MRI techniques, e.g., structural, diffusion-weighted, and resting-state 
functional MRI, and a variety of analysis techniques, e.g., graph theory, automated atlas-guided fiber 
tractography, and wavelet transformation, which provided various new insights. More specifically, the 
use of diffusion MRI scans to study structural connectivity measures enabled us to find more subtle brain 
alterations than gross brain volume changes. For example in Chapter 4, by using dMRI we were able to 
capture structural alterations, while there were no significant changes in white matter volumes found 
yet. Moreover, we used an automated atlas-guided tract reconstruction method based on whole brain 
fiber tractography, instead of a DTI atlas co-registered to a structural image to determine tract volumes. 
The automated atlas-guided tract reconstruction method has several advantages. Compared to manual 
ROI selection, it is automated, and thus better reproducible and less time consuming for the operator, 
and it enables the selection of tracts for which manual ROI placement is very difficult. Compared to a DTI 
atlas, it uses dMRI data, and thus actual streamlines instead of only structural scans. 
However, the imaging protocol used in this study also has some limitations. In Chapter 5, we 
investigated local tract changes due to WMHs, but as is known, WMHs are situated at locations that are 
typical for ageing populations with cardiometabolic risk factors. Therefore, for specific cognitive domains 
(e.g., information processing speed or memory function), we are restricted to infer on the specific white 
matter tracts with the current distribution of WMHs in this population and cannot infer on the 
susceptibility of other white matter regions, though the whole brain network analysis demonstrated 
widely distributed alterations. To investigate this in more detail a scan protocol with a smaller voxel size 
could be used to refine the fiber tractography, and participants with more severe WMHs could be 
included to study the influence of more widespread WMHs.  
In Chapter 3, 4, and 5, we employed structural connectivity analysis, which is easy to interpret, 
as it describes the white matter network. However, functional MRI (fMRI) techniques can provide more 
insight in the underlying mechanisms, for example in how the brain adapts to white matter damage. It is 
also possible to combine structural and functional connectivity analysis, but that was beyond the scope 
of the current thesis. In line with that, other graph measures could possibly provide more insight. The 
graph measure communicability (used in Chapter 3) could have been added to the analysis in Chapter 5, 
as this measure provides information about the compensatory mechanisms in case of white matter 
damage (e.g., WMHs). 
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   7 A relatively new interesting technique is dynamic functional connectivity (DFC), which is based 
on the observation that functional connectivity changes over time (non-stationarity (Jones, Vemuri et al. 
2012)). Sliding window analysis is the most common used analysis technique in DFC. In this method, FC 
analysis is performed on several signal time series. However, this method is not very suitable for 
population-based research, as interpretation of the data from sliding window analysis is most accurate in 
case-control studies. Another method to conduct DFC analysis is time-frequency analysis. In Chapter 6 of 
this thesis, we employed a technique to perform time-frequency analysis: Wavelet Transformation.  
Clinical implications 
Health perspectives 
Most advanced MRI outcome measures may be able to detect early changes prior to end-organ damage, 
which makes them potentially more useful as response markers for intervention studies than gross 
volumetric data or structural deviations. In this thesis, most associations of cardiometabolic risk factors 
with brain markers were comparable to accelerated brain aging. For instance, in participants with 
prediabetes and type 2 diabetes we found a lower node degree that was equivalent to 2 and 9 years of 
aging, respectively, as compared to participants with a normal glucose metabolism. In terms of cognitive 
impairment, a 0.51 mL larger WMH volume was equivalent to 10 years of cognitive aging, while 1.69 mL 
more WMHs was equivalent to 10 years of network aging in terms of structural connectivity. This 
comparison suggests that the impact of WMHs on the local network topology is approximately three 
times stronger than the impact on cognitive decline. Participants with diabetes had larger WMH 
volumes, higher local efficiency, and lower information processing speed scores compared to non-
diabetic participants. The lower cognitive scores in participants with diabetes were equivalent to 3.3 
years of cognitive aging.  
Furthermore, for physical activity, we showed that objectively measured higher high intensity 
physical activity was associated with both higher global structural connectivity and in specific brain 
regions that are highly specialized in motor function. The difference in whole brain node degree with 5 
minutes less high intensity physical activity per day was equivalent to one year of aging. 
It is known from literature that physical activity increases blood flow to the brain, resulting in 
increased vascularization of the brain, improved supply of nutrients and removal of metabolic waste. 
More specifically, higher levels of physical activity or cardiorespiratory fitness have been associated with 
an increase in cerebral perfusion and cerebral oxygen supply to the prefrontal cortex (Dupuy, Gauthier et 
al. 2015), which is an area involved in motor function (Goldman-Rakic 1987).  
Prevention strategies 
In general, advanced MRI techniques, including microstructural, functional, and perfusion MRI, may 
provide more insight into underlying processes that lead from cardiometabolic risk factors to brain 
dysfunction and disease, compared to structural MRI. These insights may help to develop treatment 
strategies to delay or even prevent brain alterations and eventually brain disease. In addition, early 
biomarkers for brain disease may enable us to identify people at risk, to prevent further escalation to 
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7 functional decrements and eventual disease. More specifically, we found that brain changes already 
occur in prediabetes, before the clinical diagnosis of type 2 diabetes. Therefore, treatment of 
prediabetes should be considered as a potential target of intervention for prevention of complications of 
type 2 diabetes, including structural brain changes. Furthermore, stimulating physical activity should still 
be considered as target of intervention in the general population, because more high intensity physical 
activity was associated with higher structural connectivity. This can be substantiated, because higher 
levels of physical activity stimulate processes of neurogenesis (formation of new neurons) and 
angiogenesis (formation of blood vessels) (Lei, Wu et al. 2019), and reduce inflammation (Trigiani and 
Hamel 2017). In addition, being physically active has been shown to reduce cardiovascular risk factors 
such as type 2 diabetes and hypertension through increasing neurotropic factors, reducing oxidative 
stress, and/or reducing beta-amyloid formation (Zimmerman, Sutton et al. 2014). Another study based 
on The Maastricht Study data revealed that replacement of 30 minutes of sedentary time per day to 
standing or stepping was associated with lower risk for type 2 diabetes, and more favorable waist 
circumference and BMI, and improved levels of cholesterol and blood glucose (Van Der Berg, Van Der 
Velde et al. 2017). These mechanisms may reduce the incidence of mild cognitive impairment and 
dementia (Gallaway, Miyake et al. 2017, Kennedy, Hardman et al. 2017). 
Methodological considerations 
Population study of brain imaging markers and influences of cardiometabolic 
risk factors 
Strengths of the analysis of cardiometabolic risk factors in this thesis were the large sample size and 
population-based design, and the extensive assessment of the cardiometabolic profile and potential 
confounders. Reduction of residual confounding is of key importance to correctly interpret the results, 
also because cardiometabolic risk factors are interrelated. Specific strengths were the use of HbA1c 
levels and a 2-hr OGTT to accurately characterize glucose metabolism, and the objective measurement of 
physical activity and sedentary behavior as opposed to self-reported questionnaire data, because 
questionnaires are prone to over- or underestimation. 
Limitations were that we cannot infer any conclusion about the causality/temporality of the 
associations found yet due to the cross-sectional design of the study. Therefore, future longitudinal 
studies are needed to address if cardiometabolic risk factors really precede the development of the 
observed brain abnormalities, and interventional studies to study to what extent specific brain 
alterations can be reversed or prevented by improving lifestyle to lower cardiometabolic risk. The 
Maastricht Study is already planning a follow-up to investigate changes over time, but this is a very 
expensive and time-consuming process. Furthermore, participants of The Maastricht Study in general 
were highly educated, intensively treated with regard to cardiovascular risk factors, and mainly of 
Caucasian race, because they were recruited through mass media campaigns, from municipal registries, 
and the regional Diabetes Patient Registry via mailings. This might have led to selective non‐response 
bias, as individuals who choose to participate may be different from individuals who do not wish to 
participate. Additionally, only participants that fulfilled the inclusion criteria for undergoing MRI were 
included, and these individuals had less often a history of prior cardiovascular disease, were younger, 
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   7 were less likely to have type 2 diabetes, were less often smokers, and less often had a low educational 
level, as compared to the study population which did not undergo MRI. This may have led to an 
underestimation of the observed associations, as our study population may have had a lower exposure 
to cardiovascular risk factors as compared to a general population. 
Imaging measures and techniques 
Strengths of MR imaging used in this thesis were the large amount of MRI scans available, the broad 
array of additional analyses, which all gave consistent results, and most findings remained statistically 
significant after adjustment for potential confounders.  
Limitations were that the rs-fMRI scan protocol used in this study was designed for the large 
population-based Maastricht Study, and not for the very specific type of analysis described in Chapter 6. 
Therefore, a commonly used repetition time of 2000 ms was available. However, to filter out cardiac and 
respiratory influences, scans with a shorter repetition time (and thus higher sampling frequency) might 
provide more information, as we were not able to detect to actual cardiac and respiratory frequencies 
from the current dataset. Moreover, we did not acquire the cardiac/respiratory physiological measures 
simultaneously with the rs-fMRI, which might be a constraint of our analysis, but on the other hand, we 
have an extensive data set with longer measurements. Furthermore, biases introduced during MRI data 
acquisition and/or processing might affect the connectivity data used in most chapters of this thesis. In 
the study of de Jong et al. (de Jong, Jansen et al. 2019), the influence of signal-to-noise ratio (SNR), head 
motion, and spatial mismatch between MRI-based anatomy and a brain atlas were investigated. 
According to this study, more head motion and low SNR were negatively associated with structural and 
functional connectivity, respectively, and image quality metrics had larger effects on brain connectivity 
estimates than demographic variables such as age or sex. To minimize confounding effect image quality, 
we adjusted for these image quality metrics. 
Future outlook 
Future studies and follow-up 
Longitudinal studies are needed to address the usefulness of these novel biomarkers in relation to 
disease outcomes. Furthermore, it would be interesting to evaluate whether brain alterations could be 
delayed or even reversed in participants that improved their lifestyle. For this purpose, structural 
connectivity and tract-specific analysis should be repeated and compared between time points. 
Additionally, the suggestion of performing functional connectivity analysis on both baseline and follow-
up data, in comparison with the SC data could be of great additive value, as brain function relies on the 
interplay of both structure and function. The future plans of The Maastricht Study are to start in fall 2020 
with inviting all the participants for follow-up measurements and MRI assessments. 
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With respect to the scanning protocol, other novel MRI approaches, such as dynamic contrast enhanced 
(DCE) MRI, to investigate blood-brain-barrier leakage; magnetic resonance spectroscopy (MRS), to 
investigate the metabolic characteristics of brain alterations; or ultra-high field MRI (>3Tesla) might 
provide alternative ways to elucidate the early signs and complex pathophysiology of brain diseases. 
However, not all of these options (e.g., contrast, high field) are feasible in a population-based setting due 
to ethical issues as for instance potential side effects. Furthermore, it would be interesting whether we 
could improve the rs-fMRI scan protocol in order to distinguish systemic circulatory dysfunction in 
pathologies such as hypertension and diabetes from the intrinsic neurogenic and neurovascular coupling 
effects in the rs-fMRI signal. 
Conclusion  
This thesis summarizes and extends the existing evidence on associations between cardiometabolic risk 
factors and subtle brain changes as assessed by structural and advanced imaging modalities. More 
specifically, in participants with several cardiometabolic risk factors, we found structural and functional 
network alterations beyond visible brain lesions. Future studies should clarify to which extent the 
observed brain alterations are predictive for health regression and are suitable biomarkers for 
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Summary 
171 
S Cardiometabolic risk factors, such as hyperglycemia, physical inactivity, sedentary behavior, central 
obesity, hypertension, and dyslipidemia, increase the risk of chronic diseases, such as (pre)diabetes and 
dementia. In particular, these risk factors may affect the smallest brain vessels and are thought to lead to 
cerebral small vessel disease (cSVD) and neurodegeneration (brain atrophy), which represent early 
features in the pathophysiology of cognitive decline and dementia. Currently, it is not fully understood 
how these risk factors exactly contribute to cognitive decline. Therefore, this thesis aims to gain more 
insight into the brain alterations underlying cognitive decline and brain pathology.  
Structural magnetic resonance imaging (MRI) techniques are able to detect macroscopically 
visible brain abnormalities, such as microvascular lesions and atrophy. More advanced MRI techniques 
also provide detailed insights into subtle brain changes, and thus early development of pathology. In this 
thesis, we focus on two advanced MRI techniques: diffusion-weighted MRI to analyze the structure and 
efficiency of the constellation of white matter fiber tracts, and functional MRI to study brain activity. We 
used population data from The Maastricht Study, which provided us a combination of advanced 
phenotyping and brain MRI data. 
Chapter 1 provides a general introduction on the associations between cardiometabolic risk 
factors, the developing, or expressing alterations of the brain tissue, and the emerging health detriments 
and disorders. Thereafter, the added value of MRI and brain population imaging studies is discussed. 
Furthermore, an explanation of the advanced MRI and analysis methods used in this thesis, and an 
overview of European population imaging studies with brain imaging are provided.  
In Chapter 2, a narrative review is conducted that summarizes the existing evidence on 
associations between cardiometabolic risk factors and subtle brain changes as assessed by structural and 
advanced MRI. Clear evidence was found that hyperglycemia, physical inactivity, central obesity, and 
hypertension are associated with both structural and functional brain alterations, while the role of 
dyslipidemia is far less clear. However, longitudinal evidence that assesses temporality of the 
associations with more advanced and thus more precise brain imaging methods is needed to improve 
insights into the complex etiology of brain diseases. 
In Chapter 3, the association of prediabetes and type 2 diabetes, with white matter network 
characteristics, in terms of the number (node degree) and organization (graph measures) of the white 
matter connections was investigated. The findings in this chapter indicated that prediabetes and type 2 
diabetes are associated with fewer white matter connections, and weaker organization of the 
corresponding networks. Additionally, type 2 diabetes was associated with higher communicability, 
which was not yet observed in prediabetes, which may reflect the use of alternative connections. These 
findings support the concept that hyperglycemia, even in the prediabetes phase, may be harmful to the 
connectivity of the brain, and that type 2 diabetes affects the global and local organization of brain 
structures.   
In Chapter 4, we investigate the association of objectively measured low- and high-intensity 
physical activity and sedentary time with structural connectivity, both throughout the whole brain, and in 
brain regions involved in motor function, as a measure of white matter integrity. Objectively measured 
lower high-intensity, but not lower low-intensity physical activity and higher sedentary time, were 
associated with lower node degree of the whole cerebrum and in specific brain regions highly specialized 
in motor function. These observations suggest that more high-intensity physical activity may preserve 




  S In Chapter 5, we investigate the association between cSVD lesions, cerebral networks, 
cognitive function, and cardiometabolic risk factors. The association found between white matter 
hyperintensities and information processing speed was partly mediated by the local network efficiency. 
Locally, larger white matter hyperintensity volumes in white matter tracts that are important for 
information processing were associated with cognitive slowing. These observations provide insight in 
how white matter pathology in aging individuals with cardiometabolic risk factors are biologically related 
to cognitive decrements. 
In Chapter 6, we decompose the dynamic resting-state fMRI brain signal into wavelet 
components and explore whether the various physiological measures, including cardiac activity, 
respiration, myogenic activity, neurogenic activity, and endothelial activity, are associated with the 
wavelet frequency subbands. Physiological measures were associated with the energy of certain 
frequency subbands of the fMRI signal spectrum. Cognitive performance and blood pressure variations, 
as measures of neurogenic and myogenic activity respectively, were associated with the energy of the 
frequency subband 3 (31.2-62.5 mHz). Furthermore, cardiac and respiratory activity were associated with 
the energy of high frequency subband 1 (125-250 mHz), and endothelial activity with the energy of low 
frequency subbands 6 and 7 (<10 mHz). Finally, the measured BOLD signal, including the frequency 
component relevant for neurogenic activity, was associated with cardiometabolic risk factors. These 
findings highlight the influence of systemic physiologic fluctuations to the dynamic BOLD signal, the 
strong intertwining of neuronal, vascular, and cardiometabolic activity and emphasize the importance of 
a proper selection of the resting-state frequency range in studies on cognitive function applying brain 
fMRI. 
Finally, Chapter 7 combines and discusses the key findings of this thesis. In addition, 
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Samenvatting 
177 
S Cardiometabole risicofactoren, zoals hyperglykemie, lichamelijke inactiviteit, sedentair gedrag, 
overgewicht, hoge bloeddruk (hypertensie), en hoog cholesterol (dyslipidemie), vergroten het risico op 
chronische ziektes, zoals (pre)diabetes en dementie. Deze risicofactoren tasten vooral de kleine vaatjes 
in de hersenen aan en men vermoedt dat ze kunnen leiden tot “cerebral small vessel disease” (cSVD) en 
neurodegeneratie (hersenatrofie), wat vroege kenmerken zijn van het ontstaan van cognitieve 
achteruitgang en dementie. Momenteel is het nog niet volledig duidelijk hoe deze risicofactoren precies 
bijdragen aan cognitieve achteruitgang. Daarom is het doel van dit proefschrift meer inzicht krijgen in de 
hersenveranderingen die ten grondslag liggen aan cognitieve achteruitgang en hersenaandoeningen. 
Structurele magnetic resonance imaging (MRI) technieken zijn in staat om macroscopisch 
zichtbare hersenafwijkingen, zoals microvasculaire laesies en atrofie te detecteren. Meer geavanceerde 
MRI technieken kunnen ook inzicht geven in subtielere hersenverandering, en dus vroege ontwikkeling 
van pathologie. In dit proefschrift focussen we op twee geavanceerde MRI technieken: diffusie-gewogen 
MRI om de structuur en efficiëntie van witte stof verbindingen te analyseren, en functionele MRI om 
hersenactiviteit te onderzoeken. We hebben hiervoor populatie data van De Maastricht Studie gebruikt, 
wat ons een combinatie van geavanceerde fenotypering en hersen MRI scans overleverde. 
Hoofdstuk 1 geeft een algemene inleiding over de associaties tussen cardiometabole 
risicofactoren, de ontwikkelende of al tot uiting gekomen veranderingen van het hersenweefsel, en het 
ontstaan van gezondheidsschade. Daarna wordt de toegevoegde waarde van MRI en populatie studies 
met beeldvorming van het brein bediscussieerd. Bovendien worden de geavanceerde MRI en analyse 
methoden die gebruikt worden in dit proefschrift uitgelegd, en wordt er een overzicht gegeven van 
Europese populatie studies met hersenscans.  
In Hoofdstuk 2, wordt de beschikbare literatuur over associaties tussen cardiometabole 
risicofactoren en subtiele hersenveranderingen, onderzocht met structurele en geavanceerde MRI 
samengevat. Er werd gevonden dat hyperglykemie, lichamelijke inactiviteit, centrale obesitas, en 
hypertensie geassocieerd zijn met zowel structurele als functionele hersenveranderingen, terwijl de 
invloed van dyslipidemie veel minder duidelijk is. Er zijn echter longitudinale studies nodig die de 
temporaliteit van de associaties met meer geavanceerde en dus nauwkeurigere beeldvormingsmethoden 
voor de hersenen beoordelen, om inzichten in de complexe etiologie van hersenziekten te verbeteren. 
In Hoofdstuk 3 worden de associaties van prediabetes en type 2 diabetes met structurele 
netwerk eigenschappen, in termen van het aantal (node degree) en de organisatie (graafmaten) van de 
witte stof verbindingen onderzocht. De bevindingen in dit hoofdstuk gaven aan dat prediabetes en type 2 
diabetes geassocieerd zijn met minder witte stof verbindingen, en een slechtere organisatie van de 
bijbehorende netwerken. Daarnaast was type 2 diabetes geassocieerd met een hogere 
“communicability”, wat het gebruik van alternatieve verbindingen reflecteert, en dit werd nog niet 
waargenomen in het voorstadium prediabetes. Deze bevindingen ondersteunen de opvatting dat 
hyperglykemie, zelfs in de prediabetes fase, schadelijk kan zijn voor de verbindingen in de hersenen, en 
dat type 2 diabetes de globale en lokale organisatie van hersenstructuren beïnvloedt. 
In Hoofdstuk 4 onderzoeken we de associatie tussen objectief gemeten laag- en hoog-
intensieve lichamelijke activiteit en zittijd en structurele connectiviteit, zowel voor het hele brein als in 
hersengebieden die belangrijk zijn voor motor functie. Objectief gemeten lagere hoog-intensieve, maar 
niet laag-intensieve lichamelijke activiteit en zittijd, waren geassocieerd met lagere node degree voor het 
hele cerebrum en in specifieke hersengebieden die gespecialiseerd zijn in motor functie. Deze 
bevindingen suggereren dat meer hoog-intensieve lichamelijke activiteit structurele hersen connectiviteit 
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   S kan behouden. Dit moet worden bevestigd door toekomstige studies na het stimuleren van meer 
lichamelijke activiteit. 
In Hoofdstuk 5, onderzoeken we de associatie tussen cSVD laesies, cerebrale netwerken, 
cognitieve functie, en cardiometabole risicofactoren. De associatie die gevonden werd tussen witte stof 
laesies en informatie verwerkingssnelheid werd deels gemedieerd door de lokale netwerk efficiëntie. 
Lokaal, waren grotere witte stof laesie volumes in verbindingen belangrijk voor informatie 
verwerkingssnelheid geassocieerd met cognitieve vertraging. Deze bevindingen geven inzicht in hoe 
witte stof pathologie in oudere personen met cardiometabole risicofactoren biologisch gerelateerd is aan 
cognitieve achteruitgang. 
In Hoofdstuk 6, ontbinden we het dynamische resting-state fMRI signaal in wavelet 
componenten en onderzoeken we of verschillende fysiologische maten, zoals hartactiviteit, ademhaling, 
myogene activiteit, neurogene activiteit, en endotheel activiteit, geassocieerd zijn met wavelet 
frequentie subbanden. Fysiologische maten waren geassocieerd met de energie van bepaalde frequentie 
subbanden van het fMRI signaal spectrum. Cognitieve functie en bloeddruk variaties, als maten van 
respectievelijk neurogene en myogene activiteit, waren geassocieerd met de energie van frequentie 
subband 3 (31.2-62.5 mHz). Bovendien waren hartactiviteit en ademhaling geassocieerd met de energie 
van hoge frequentie subband 1 (125-250 mHz), en endotheel activiteit met de energie van lage 
frequentie subbanden 6 en 7 (<10 mHz). Tenslotte was het gemeten BOLD signaal, inclusief de frequentie 
component relevant voor neurogene activiteit, geassocieerd met cardiometabolic risicofactoren. Deze 
bevindingen benadrukken de invloed van systemische fysiologische schommelingen op het dynamische 
BOLD signaal, de sterke verstrengeling van neuronale, vasculaire, en cardiometabole activiteit, en 
accentueren het belang van een goede selectie van de resting-state frequentie range in studies naar 
cognitieve functie met fMRI. 
Tenslotte worden in Hoofdstuk 7 de belangrijkste bevindingen van dit proefschrift 
gecombineerd en bediscussieerd. Daarnaast worden methodologische overwegingen en ideeën voor 
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IP Main findings 
In this thesis, we investigated whether life style related risk factors are associated with novel neuronal 
imaging markers and evaluated the value of structural and functional brain network measures for that 
purpose. The life style related risk factors, also called cardiometabolic risk factors, studied in this thesis 
are (pre)diabetes, physical inactivity, high sedentary time, high blood pressure, obesity, and high 
cholesterol. We summarized and extended the existing evidence on associations between 
cardiometabolic risk factors and subtle brain changes as assessed by structural and advanced MRI. More 
specifically, we found that high blood sugar was associated with structural brain alterations, even in the 
prediabetes phase. Physical inactivity was also associated with structural brain alteration, especially in 
brain regions highly specialized in motor function. Furthermore, we found an interrelation of brain 
damage in the form of white matter hyperintensities (WMH), structural brain alterations, and cognitive 
function. In particular, WMHs in structural brain connections important for information processing speed 
were associated with cognitive slowing. Finally, we observed that neuronal and non-neuronal 
physiological signals could be recognized in the functional MRI signal, and that this signal is altered in 
people with cardiometabolic risk factors. To show the relevance of our findings, we can express brain 
changes in years of aging. The impact on the amount of connections between regions in prediabetes and 
type 2 diabetes was equivalent to 2 and 9 years of aging, respectively, as compared to participants with a 
normal glucose metabolism, and for cognition scores of participants with diabetes this was equivalent to 
3.3 years of cognitive aging. Physical inactivity also led to brain changes, participants with on average 5 
minutes less high intensity physical activity per day had a lower node degree equivalent to one year of 
aging. As cardiometabolic risk factors are also associated with small lesions in the brain, we also made 
such a comparison in participants with WMH presence. A larger WMH volume of 0.51 mL was equivalent 
to 10 years of cognitive aging, while a larger WMH volume of 1.69 mL was equivalent to 10 years of 
network aging. 
Relevance 
Due to the aging population, there is an increase in age-associated conditions such as cognition problems 
and Alzheimer’s disease. However, there is currently no medication available for treatment of cognitive 
decline. Accumulating evidence shows that cardiometabolic risk factors are associated with a higher risk 
of late-life cognitive detriments and eventually brain diseases such as dementia. Additionally, 
cardiometabolic risk factors are associated with chronic diseases, including type 2 diabetes, heart 
disease, and renal failure. In The Netherlands, more than 1.2 million people have type 2 diabetes, which 
is 1 in 14, and this group increases with 1000 every week. Even more people, over 1.6 million, suffer from 
cardiovascular conditions. As cardiometabolic risk factors are often behavioural and therefore 
modifiable, these are an interesting target for prevention of brain diseases. Therefore, it is important to 
reveal underlying mechanism between life style, cardiovascular risk factors, and brain alterations. Brain 
imaging in population studies is ideal for this due to the use of the combined data provided by brain 
imaging and the availability of multiple other characteristics of the participants.  
The results from the advanced MRI techniques presented in this thesis, provide more insight 
into underlying processes that lead from cardiometabolic risk factors to brain dysfunction and disease, 
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  IP compared to structural MRI. Since we were able to detect early brain changes, these insights may help to 
develop treatment strategies to delay or even prevent brain alterations and eventually brain disease. 
Simply stimulating a healthier lifestyle, by for example more physical activity or a diet, might already 
contribute to prevention of future brain alterations. In addition, early signs for brain disease may enable 
us to identify people at risk, to prevent further escalation to functional problems and eventual disease. 
Additionally, these findings acquired from advance brain MRI also emphasize the importance of further 
development of MRI scan protocols and analysis techniques. 
Target group 
The findings from this thesis are important for the general aging population, but probably also for more 
specific target groups. This thesis extended the insight into the association of cardiometabolic risk factors 
and brain alterations, and the results underline the importance of promoting a healthier lifestyle and its 
importance in the battle to prevent brain disorders. More specifically, the finding that modifiable 
cardiometabolic risk factors are associated with brain alterations might be interesting for healthcare 
policy makers, for instance, to promote physical activity in order to prevent for brain alterations. The 
new insights on the early MR imaging markers is interesting for neuroscientists, in order to early detect 
brain abnormalities before onset of cognitive problems, but also for the MRI vendors, to improve their 
software, and finally, the pharmaceutical industry might be interested, as these new insights emphasize 
the importance of treatment of cardiometabolic risk factors. All studies in this thesis were conducted in 
the large population-based Maastricht Study. The Maastricht Study is characterized by an extensive 
phenotyping approach. This made it possible to obtain findings that are likely also applicable to the 
general population, in particular to middle-aged people with cardiometabolic risk factors.  
Activities 
The findings from this study could be used by policy makers to inform, to comprehend and to convince 
people that improving lifestyle is not only good for their general health, but also specifically for their 
brain. The Maastricht Study is also committed to informing the participants by its website and the local 
media. For instance, the findings from Chapter 3 of this thesis were published in a local newspaper (de 
Limburger), and national media (Elsevier and Libelle). Furthermore, there is an annual Maastricht Study 
symposium, which is an interactive meeting for the participants of the study to inform them about the 




IP Future directions 
Future longitudinal studies should clarify the usefulness of novel biomarkers in relation to disease 
outcome and to which extent the observed brain alterations are predictive for health regression. 
Furthermore, the suitability of biomarkers for monitoring treatment and prevention strategies, and 
whether brain changes are merely adaptive and able to compensate for initial brain impairments, needs 
to be addressed. The Maastricht Study will start in fall 2020 with inviting all the participants of The 
Maastricht Study for follow-up measurements and MRI assessments. Finally, intervention studies will be 
essential to evaluate whether brain alterations could be delayed or even reversed in people that 
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